Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Signaling By ROBO Receptors R-HSA-376176,-0.6560922248413806,-2.789712470512269,0.0,0.0,0.0,95/190,14.14%,UBB;RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;PSMA3;RPLP1;PSMD7;PSMB3;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;PSMC6;RPS17;RPS15;RPS4X;RPL12;PSMC1;NCK1;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;CDC42;RPL34;ELOB;PSMB6;PSMC3;UBA52;RPL30;PFN2;RPL7A;UBC;RPS5;PSMA2;PSMA7;RPS2;RPS13;PFN1;PSMB7;PSMB1;RPL7;PSMC5;CAP1;RPS12;RPL36A;RPS16;ROBO1;RHOA;PSMB5;MAGOHB;GSPT2;RPL35;PSMD11;RPS6;PSMA4;RPL9;PABPC1;PSMF1;RPL31;CXCL12
gsea,Cellular Response To Starvation R-HSA-9711097,-0.7266604451254334,-2.7688181387107487,0.0,0.0,0.0,75/136,9.44%,ATP6V0B;RPS29;RPL37;RPL6;RPS28;RPL38;ATP6V1G2;ATP6V0C;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;LAMTOR2;RPS20;RPLP1;RPL36AL;RPS27A;MLST8;RPS25;RPL37A;ATP6V1F;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;LAMTOR3;RPL12;ATP6V0E2;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;ATP6V1A;RRAGA;UBA52;RPL30;RPL7A;CEBPB;RPS5;IMPACT;RPS2;RPS13;LAMTOR1;RHEB;RPL7;RPS12;RPL36A;RPS16
gsea,rRNA Processing R-HSA-72312,-0.6394215252314286,-2.762992603537254,0.0,0.0,0.0,85/190,15.98%,LAS1L;RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPP21;RPL4;RPL23A;RPL22;NOP10;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;TRMT112;RPS5;RPS2;RPS13;SNU13;RPL7;WDR46;BOP1;RPS12;RPL36A;RPS16;MTERF4;MRM3;RRP9;RPP38;PDCD11;RPL35;RPS6;NOB1;RPL9;RPP25;UTP3;RPL31;EXOSC7;THUMPD1;RPL22L1;TSR3;RPS15A
gsea,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.7039579787665485,-2.7604403032772002,0.0,0.0,0.0,88/152,14.00%,UBB;RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;PSMA3;RPLP1;PSMD7;PSMB3;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;PSMC6;RPS17;RPS15;RPS4X;RPL12;PSMC1;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;ELOB;PSMB6;PSMC3;UBA52;RPL30;RPL7A;UBC;RPS5;PSMA2;PSMA7;RPS2;RPS13;PSMB7;PSMB1;RPL7;PSMC5;RPS12;RPL36A;RPS16;ROBO1;PSMB5;MAGOHB;GSPT2;RPL35;PSMD11;RPS6;PSMA4;RPL9;PABPC1;PSMF1;RPL31
gsea,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.6587494894413507,-2.759672136425773,0.0,0.0,0.0,76/170,14.00%,LAS1L;RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPP21;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;SNU13;RPL7;WDR46;BOP1;RPS12;RPL36A;RPS16;RRP9;RPP38;PDCD11;RPL35;RPS6;NOB1;RPL9;RPP25;UTP3;RPL31
gsea,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.6489998343590335,-2.7587115187675293,0.0,0.0,0.0,83/180,15.98%,LAS1L;RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPP21;RPL4;RPL23A;RPL22;NOP10;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;TRMT112;RPS5;RPS2;RPS13;SNU13;RPL7;WDR46;BOP1;RPS12;RPL36A;RPS16;RRP9;RPP38;PDCD11;RPL35;RPS6;NOB1;RPL9;RPP25;UTP3;RPL31;EXOSC7;THUMPD1;RPL22L1;TSR3;RPS15A
gsea,Influenza Infection R-HSA-168255,-0.6960516528429221,-2.7539969992496443,0.0,0.0,0.0,72/143,9.98%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RAN;RPLP1;CALR;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;CLTA;RPL12;RPL4;RPL23A;RPL22;POLR2K;RPL11;RPL13A;CANX;RPS24;FAU;RPL34;KPNA4;TGFB1;UBA52;RPL30;RPL7A;RPS5;NUP43;RPS2;RPS13;KPNA3;RPL7;RPS12;RPL36A;RPS16;HSP90AA1;POLR2G
gsea,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.709592159190963,-2.7186250466467516,0.0,0.0,0.0,65/126,9.98%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;POLR2K;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;NUP43;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16;HSP90AA1;POLR2G
gsea,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.7590830772239362,-2.7093998678913334,0.0,0.0,0.0,69/105,13.15%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;PPP2R1A;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16;MAGOHB;GSPT2;PPP2CA;RPL35;RPS6;RPL9;PABPC1
gsea,Translation R-HSA-72766,-0.6165016639326079,-2.7022935265365016,0.0,0.0,0.0,132/254,19.28%,RPS29;RPL37;RPL6;RPS28;RPL38;EEF1A1;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;EEF1G;RPLP1;SEC61G;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;EEF1B2;SPCS2;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;MRPL53;RPL34;SRPRB;MRPS5;MRPL38;UBA52;RPL30;MRPL21;RPL7A;TRMT112;RPS5;EIF2B4;RPS2;EIF2B1;MRPL52;RPS13;MRPL23;MARS2;EIF3C;SSR4;EIF5;RPL7;MRPL41;MRPL20;MTIF2;RPS12;RPL36A;RPS16;MRPL35;GSPT2;MRPL18;MRPL57;MRPS36;SSR1;MRPL36;TARS2;SEC11C;RPL35;SEC61B;MRPL55;SSR2;MRPL50;RPN2;OXA1L;RPS6;RPL9;PABPC1;EIF3K;MRPL4;MRPL15;MRPL58;RPL31;MRPS10;MRPL46;EEF1D;MRPS26;EIF4H;MRPS31;EEF2;RPL22L1;MRPL19;MRPL40;RPS15A;MRPS24;MRPS7;MRPL11;RPL14;SSR3;MRPL33;SPCS1;EIF2S2;MRPL14;RPL32;RPS9;AURKAIP1;MRPS16;MRPS17
gsea,Selenoamino Acid Metabolism R-HSA-2408522,-0.7928079302720925,-2.694846849626195,0.0,0.0,0.0,64/95,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;PAPSS2;RPS13;PSTK;SEPHS2;RPL7;RPS12;RPL36A;RPS16
gsea,Cap-dependent Translation Initiation R-HSA-72737,-0.7739017207284448,-2.673246772618158,0.0,0.0,0.0,65/107,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;EIF2B4;RPS2;EIF2B1;RPS13;EIF3C;EIF5;RPL7;RPS12;RPL36A;RPS16
gsea,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.7866016453227157,-2.6616912942685262,0.0,0.0,0.0,63/100,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;EIF3C;EIF5;RPL7;RPS12;RPL36A;RPS16
gsea,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.6180316770870116,-2.6515802508783524,0.0,0.0,0.0,75/139,17.54%,IDH3B;COX6C;COX8A;COX7C;NDUFC1;UQCRQ;COX4I1;NDUFB3;NDUFA1;COX19;VDAC1;UQCR10;NDUFB1;NDUFA13;TIMMDC1;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;NDUFB2;GLO1;COX5B;UQCR11;MDH2;NDUFS8;CYCS;ATP5PB;NDUFAF4;UQCRC1;NDUFB11;NDUFB9;NDUFAF7;COX6A1;TMEM186;COX7A2L;COQ10B;SUCLG1;COX6B1;NDUFA7;NDUFC2;NDUFAF1;COX14;NDUFAB1;UQCRB;NDUFB8;LDLR;BSG;CCNI;NDUFS7;MPC2;COX20;NDUFA5;NDUFA8;NDUFS6;NDUFV3;IDH3G;NDUFV1;NDUFA11;HAGH;SLC16A1;PLPP6;PDP2;NDUFB5;NDUFA6;LDHB;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;COX5A;UQCRH;SCO2;NDUFB4
gsea,Eukaryotic Translation Termination R-HSA-72764,-0.8260337131467334,-2.649276459382422,0.0,0.0,0.0,62/83,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;TRMT112;RPS5;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16
gsea,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.6607147891561385,-2.6477214493494072,0.0,0.0,0.0,61/94,17.54%,COX6C;COX8A;COX7C;NDUFC1;UQCRQ;COX4I1;NDUFB3;NDUFA1;COX19;UQCR10;NDUFB1;NDUFA13;TIMMDC1;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;NDUFB2;COX5B;UQCR11;NDUFS8;CYCS;ATP5PB;NDUFAF4;UQCRC1;NDUFB11;NDUFB9;NDUFAF7;COX6A1;TMEM186;COX7A2L;COQ10B;COX6B1;NDUFA7;NDUFC2;NDUFAF1;COX14;NDUFAB1;UQCRB;NDUFB8;CCNI;NDUFS7;COX20;NDUFA5;NDUFA8;NDUFS6;NDUFV3;NDUFV1;NDUFA11;NDUFB5;NDUFA6;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;COX5A;UQCRH;SCO2;NDUFB4
gsea,Respiratory Electron Transport R-HSA-611105,-0.6716234418830465,-2.6447385397323635,0.0,0.0,0.0,60/89,17.54%,COX6C;COX8A;COX7C;NDUFC1;UQCRQ;COX4I1;NDUFB3;NDUFA1;COX19;UQCR10;NDUFB1;NDUFA13;TIMMDC1;UQCRFS1;COX7B;NDUFS5;NDUFA3;NDUFB10;NDUFB2;COX5B;UQCR11;NDUFS8;CYCS;NDUFAF4;UQCRC1;NDUFB11;NDUFB9;NDUFAF7;COX6A1;TMEM186;COX7A2L;COQ10B;COX6B1;NDUFA7;NDUFC2;NDUFAF1;COX14;NDUFAB1;UQCRB;NDUFB8;CCNI;NDUFS7;COX20;NDUFA5;NDUFA8;NDUFS6;NDUFV3;NDUFV1;NDUFA11;NDUFB5;NDUFA6;NDUFA12;NDUFA2;NDUFA10;NDUFS1;SDHB;COX5A;UQCRH;SCO2;NDUFB4
gsea,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.8109706705192734,-2.6427863327856715,0.0,0.0,0.0,61/85,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16
gsea,Selenocysteine Synthesis R-HSA-2408557,-0.8288188905961132,-2.641107169888761,0.0,0.0,0.0,63/82,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;PSTK;SEPHS2;RPL7;RPS12;RPL36A;RPS16
gsea,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.8086048423564155,-2.6398780046355728,0.0,0.0,0.0,62/90,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;EIF3C;RPL7;RPS12;RPL36A;RPS16
gsea,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.785595316372711,-2.6346844856717335,0.0,0.0,0.0,73/99,13.07%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;SEC61G;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;SPCS2;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;SRPRB;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;SSR4;RPL7;RPS12;RPL36A;RPS16;SSR1;SEC11C;RPL35;SEC61B;SSR2;RPN2;RPS6;RPL9
gsea,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.7996199019234023,-2.632692069283679,0.0,0.0,0.0,63/87,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;CEBPB;RPS5;IMPACT;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16
gsea,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.5612373055290528,-2.6246336427973835,0.0,0.0,0.0,110/296,15.98%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;PSMA3;RPLP1;PSMD7;PSMB3;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;PSMC6;RPS17;RPS15;RPS4X;RPL12;PSMC1;CHGA;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;PRODH;PSMB6;PSMC3;UBA52;RPL30;RPL7A;CKB;HOGA1;RPS5;PSMA2;PSMA7;RPS2;CHDH;PAPSS2;RPS13;DIO3;NDUFAB1;PHGDH;OAZ1;PSTK;PSMB7;SEPHS2;PCBD1;PSMB1;RPL7;PSMC5;TDO2;SLC7A5;CRYM;TXN2;RPS12;RPL36A;RPS16;PSMB5;GLUL;KMO;RPL35;PSMD11;RPS6;PSMA4;RPL9;PSMF1;RPL31;SERINC1;TXNRD1;SLC3A2;HIBCH;PSAT1;AFMID;NAT8L;RPL22L1;PIPOX;RPS15A
gsea,Viral mRNA Translation R-HSA-192823,-0.8133815460528043,-2.6166480417199933,0.0,0.0,0.0,61/83,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16
gsea,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.7809124271347723,-2.605291721223632,0.0,0.0,0.0,62/99,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;EIF3C;RPL7;RPS12;RPL36A;RPS16
gsea,Eukaryotic Translation Elongation R-HSA-156842,-0.8254739840559279,-2.6003811226861884,0.0,0.0,0.0,64/83,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;EEF1A1;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;EEF1G;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;EEF1B2;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16
gsea,Peptide Chain Elongation R-HSA-156902,-0.8321395732895597,-2.5859588232072914,0.0,0.0,0.0,62/79,9.44%,RPS29;RPL37;RPL6;RPS28;RPL38;EEF1A1;RPL21;RPS21;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;RPL29;RPL8;RPS11;RPL27;RPL18;RPS20;RPLP1;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;RPL15;RPS3;RPS17;RPS15;RPS4X;RPL12;RPL4;RPL23A;RPL22;RPL11;RPL13A;RPS24;FAU;RPL34;UBA52;RPL30;RPL7A;RPS5;RPS2;RPS13;RPL7;RPS12;RPL36A;RPS16
gsea,Complex I Biogenesis R-HSA-6799198,-0.709892917324063,-2.565984434755794,0.0,0.0,0.0,40/50,22.54%,NDUFC1;NDUFB3;NDUFA1;NDUFB1;NDUFA13;TIMMDC1;NDUFS5;NDUFA3;NDUFB10;NDUFB2;NDUFS8;NDUFAF4;NDUFB11;NDUFB9;NDUFAF7;TMEM186;NDUFA7;NDUFC2;NDUFAF1;NDUFAB1;NDUFB8;NDUFS7;NDUFA5;NDUFA8;NDUFS6;NDUFV3;NDUFV1;NDUFA11;NDUFB5;NDUFA6;NDUFA12;NDUFA2;NDUFA10;NDUFS1;NDUFB4;NDUFB6;NDUFS2;ECSIT;NDUFA9;NDUFS4
gsea,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.5950979149929132,-2.4453425152161796,0.0,0.0,0.0,33/67,20.01%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;H2AZ1;PSMC1;PSMB6;PSMC3;UBA52;UBC;H2AJ;PSMA2;PSMA7;H2BC4;PSMB7;PSMB1;PSMC5;PSMB5;TCF12;PSMD11;PSMA4;CBFB;PSMF1;H2AZ2;SEM1;H2BC21;PSMB4;LMO1;YAP1;PSMD2;H2AX
gsea,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.762191532012355,-2.4155935068498677,0.0,0.0,0.0,27/44,9.44%,RPS29;RPS28;RPS21;RPS8;RPS23;RPSA;RPS10;RPS7;RPS27;RPS11;SNRPF;RPS20;SNRPG;RPS27A;RPS25;RPS3;RPS17;RPS15;RPS4X;RPS24;FAU;RPS5;RPS2;RPS13;SNRPD2;RPS12;RPS16
gsea,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.7560463896380777,-2.3979660304569164,0.0,0.0,0.0,25/45,9.44%,RPS29;RPS28;RPS21;RPS8;RPS23;RPSA;RPS10;RPS7;RPS27;RPS11;RPS20;RPS27A;RPS25;RPS3;RPS17;RPS15;RPS4X;RPS24;FAU;RPS5;RPS2;RPS13;EIF3C;RPS12;RPS16
gsea,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.7222271039221523,-2.3818809774342187,0.0,0.0,0.0,26/52,9.44%,RPS29;RPS28;RPS21;RPS8;RPS23;RPSA;RPS10;RPS7;RPS27;RPS11;RPS20;RPS27A;RPS25;RPS3;RPS17;RPS15;RPS4X;RPS24;FAU;RPS5;RPS2;RPS13;EIF3C;EIF5;RPS12;RPS16
gsea,Translation Initiation Complex Formation R-HSA-72649,-0.7168326161525514,-2.3816360380392174,0.0,0.0,0.0,30/52,15.98%,RPS29;RPS28;RPS21;RPS8;RPS23;RPSA;RPS10;RPS7;RPS27;RPS11;RPS20;RPS27A;RPS25;RPS3;RPS17;RPS15;RPS4X;RPS24;FAU;RPS5;RPS2;RPS13;EIF3C;RPS12;RPS16;RPS6;PABPC1;EIF3K;EIF4H;RPS15A
gsea,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.7117060739156841,-2.38030716046054,0.0,0.0,0.0,30/53,15.98%,RPS29;RPS28;RPS21;RPS8;RPS23;RPSA;RPS10;RPS7;RPS27;RPS11;RPS20;RPS27A;RPS25;RPS3;RPS17;RPS15;RPS4X;RPS24;FAU;RPS5;RPS2;RPS13;EIF3C;RPS12;RPS16;RPS6;PABPC1;EIF3K;EIF4H;RPS15A
gsea,Mitochondrial Protein Import R-HSA-1268020,-0.6053075531232852,-2.367228406604586,0.0,0.0,0.0,31/58,22.08%,SLC25A4;DNAJC19;COX19;VDAC1;COX17;CHCHD10;COQ2;MTX1;TOMM6;CHCHD4;TIMM23;NDUFB8;CCNI;TIMM17A;IDH3G;HSPD1;COA6;TOMM20;TOMM5;BCS1L;CHCHD2;MTX2;TOMM7;TIMM8B;TIMM13;SAMM50;PAM16;TIMM10B;TIMM17B;TIMM10;GRPEL1
gsea,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.6313966239229433,-2.356236634804617,0.0,0.0,0.0,22/49,13.87%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;NFE2L2;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.6060567710936059,-2.311770616227293,0.0,4.283565930081945e-05,0.001,22/51,13.87%,UBB;HSP90AB1;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;HSP90AA1;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Regulation Of RAS By GAPs R-HSA-5658442,-0.5843846827122547,-2.305935809913849,0.0,4.170840510869262e-05,0.001,27/60,19.29%,UBB;HRAS;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;RASAL2;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;KBTBD7;PSMB4;SPRED1;PSMD2
gsea,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.6191886548534242,-2.2987679090736193,0.0,4.0638958823854345e-05,0.001,23/45,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.6097167763591247,-2.293192682390694,0.0,3.962298485325799e-05,0.001,25/51,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;YWHAZ;PSMD11;AKT1;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.5807924576344266,-2.2929068712331095,0.0,3.865657058854438e-05,0.001,26/54,22.47%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2;CCNE2;CDKN1B;PSMC2
gsea,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.6128309776335052,-2.290837481373938,0.0,3.773617605072189e-05,0.001,24/47,19.29%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Antigen processing-Cross Presentation R-HSA-1236975,-0.5355632098054876,-2.2884600686445946,0.0,3.685859056117022e-05,0.001,39/83,22.47%,UBB;HMGB1;PSMA3;PSMD7;SEC61G;CALR;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;BTK;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;CYBA;NCF1;B2M;SEC61B;PSMD11;PSMA4;VAMP3;PSMF1;NDUFA2;CTSL;SEM1;PSMB4;PSMD2;CTSS;IKBKG;ITGAV;LY96;PSMC2
gsea,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.6142521313622961,-2.286658373524682,0.0,3.602089532114362e-05,0.001,24/48,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;ELOB;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Regulation Of Apoptosis R-HSA-169911,-0.6002047914507928,-2.2838714519187118,0.0,3.522043098067377e-05,0.001,23/48,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.6113620189204892,-2.279441725857924,0.0,3.4454769437615645e-05,0.001,23/46,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Protein Localization R-HSA-9609507,-0.4956806581976151,-2.270566472739703,0.0,3.372168923681531e-05,0.001,67/145,25.54%,UBB;SLC25A4;DNAJC19;VAMP2;COX19;VDAC1;COX17;SEC61G;RPS27A;CHCHD10;SYCP2;PRNP;COQ2;UBA52;MTX1;TOMM6;UBC;NUDT19;ABCD3;CHCHD4;TIMM23;SERP1;NDUFB8;TYSND1;CCNI;TIMM17A;IDH3G;HSPD1;BAG6;COA6;TOMM20;TOMM5;BCS1L;CHCHD2;SEC61B;CROT;MTX2;GNPAT;AGPS;TOMM7;TIMM8B;UBE2D3;ZFAND6;TIMM13;PIPOX;ACOT2;PEX7;PEX26;SAMM50;PAM16;PEX10;PEX19;EMD;TIMM10B;UBE2J2;ACOX1;IDH1;TIMM17B;TIMM10;AMACR;GRPEL1;PECR;TOMM22;ACOX2;FIS1;ACBD5;TIMM22
gsea,Chaperone Mediated Autophagy R-HSA-9613829,-0.7793317035792614,-2.2668208264787504,0.0,3.301915404438166e-05,0.001,11/18,12.19%,UBB;EEF1A1;HSP90AB1;RPS27A;HSPA8;UBA52;UBC;PARK7;HSP90AA1;PLIN3;GFAP
gsea,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.569875215039798,-2.2646437005262734,0.0,3.234529375776162e-05,0.001,26/58,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;P4HB;PSMB5;PSMD11;PSMA4;NOTUM;PSMF1;SEM1;DISP2;PSMB4;PSMD2
gsea,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.5276274633686054,-2.2610621841380927,0.0,3.169838788260639e-05,0.001,34/98,13.87%,CALM1;UBB;PPIA;HRAS;FKBP1A;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;NCK1;LYN;PSMB6;PSMC3;UBA52;UBC;AHCYL1;BTK;PPP3R1;PSMA2;PSMA7;PPP3CA;PSMB7;PSMB1;ORAI2;PSMC5;DAPP1;PSMB5;MALT1;FBXW11;PSMD11;PSMA4;PSMF1
gsea,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.599796276706863,-2.2583365354661815,0.0,3.107685086530039e-05,0.001,23/49,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,SARS-CoV-2-host Interactions R-HSA-9705683,-0.5026989749091135,-2.251892032176488,0.0,6.0958438235781514e-05,0.001,48/154,13.11%,RPS29;RPS28;YWHAG;RPS21;HSP90AB1;RPS8;RPS23;RPSA;RPS10;RPS7;RPS27;RPS11;SNRPF;RPS20;YWHAE;SNRPG;RPS27A;RPS25;RPS3;YWHAB;RPS17;RPS15;RPS4X;RPS24;FAU;MAP1LC3B;YWHAH;SAR1B;RPS5;NUP43;RPS2;RPS13;TRAF6;AKT3;SNRPD2;RPS12;CNBP;RPS16;HSP90AA1;B2M;UBE2V1;MASP2;GJA1;YWHAZ;RPS6;NUP50;AKT1;TYK2
gsea,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.5987995601598163,-2.2486663908727813,0.0,5.980827902378564e-05,0.001,23/45,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.5487606939410583,-2.2485697058149867,0.0,8.805107745168442e-05,0.002,28/74,13.87%,CALM1;UBB;PPIA;HRAS;FKBP1A;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PPP3R1;PSMA2;PSMA7;PPP3CA;PSMB7;PSMB1;PSMC5;PSMB5;MALT1;FBXW11;PSMD11;PSMA4;PSMF1
gsea,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.7669582190900375,-2.2470017512225215,0.0,8.645014877074471e-05,0.002,17/19,17.76%,TUBB2A;TUBA1A;TUBB2B;TUBB4B;TUBA4A;CCT5;TUBB3;TUBA1B;CCT3;CCT7;CCT8;CCT6A;CCT2;TUBB4A;CCT4;TCP1;TUBB6
gsea,ER-Phagosome Pathway R-HSA-1236974,-0.538909749917945,-2.2467144371344068,0.0,8.490639611412427e-05,0.002,34/72,22.47%,UBB;HMGB1;PSMA3;PSMD7;SEC61G;CALR;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;BTK;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;B2M;SEC61B;PSMD11;PSMA4;VAMP3;PSMF1;NDUFA2;SEM1;PSMB4;PSMD2;IKBKG;LY96;PSMC2
gsea,HSF1 Activation R-HSA-3371511,-0.7025971518007398,-2.2440882972606757,0.0,0.0001390280170289754,0.004,9/24,10.71%,UBB;EEF1A1;HSP90AB1;YWHAE;HSBP1;HSPH1;PTGES3;HSP90AA1;MRPL18
gsea,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.5947262984177388,-2.2335616565647465,0.0,0.0001639571787031365,0.004,22/49,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;HSPA8;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PABPC1;PSMF1
gsea,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.5686607428255841,-2.233126984233338,0.0,0.00016117824347087995,0.004,26/56,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;FBXW11;PSMD11;PSMA4;PSMF1;NFKB2;RELA;SEM1;PSMB4;PSMD2
gsea,Interleukin-1 Signaling R-HSA-9020702,-0.5085881479707354,-2.2238582583639097,0.0,0.00023773790911954794,0.005,40/99,19.29%,UBB;HMGB1;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PELI2;PSMC3;UBA52;UBC;PSMA2;PSMA7;TRAF6;PSMB7;LRRC14;PSMB1;PSMC5;PSMB5;IL1RAP;SQSTM1;S100B;UBE2V1;TIFA;PELI3;FBXW11;PSMD11;PSMA4;PSMF1;CASP8;IL1R2;NKIRAS2;NFKB2;RELA;MAP2K1;SEM1;PSMB4;PSMD2
gsea,SARS-CoV-2 Infection R-HSA-9694516,-0.461861311855051,-2.2213190352408123,0.0,0.0002338405663470963,0.005,64/234,13.41%,UBB;RPS29;DDX5;RPS28;YWHAG;RPS21;HSP90AB1;RPS8;RPS23;RPSA;RPS10;RPS7;RPS27;RPS11;GSK3B;SNRPF;RPS20;YWHAE;SNRPG;RPS27A;RPS25;RPS3;YWHAB;RPS17;RPS15;RPS4X;DAD1;CANX;RPS24;FAU;UBA52;ISCU;MAP1LC3B;UBC;YWHAH;SAR1B;RPS5;NUP43;RPS2;RPS13;TRAF6;AKT3;MGAT4B;SNRPD2;GOLGA7;CHMP2A;RPS12;CNBP;RPS16;HSP90AA1;ZCRB1;CHMP4B;GPC4;B2M;UBE2V1;MASP2;GJA1;YWHAZ;RPN2;RPS6;NUP50;AKT1;TYK2;SDC4
gsea,Cellular Response To Chemical Stress R-HSA-9711123,-0.48034651800724293,-2.2209999919147094,0.0,0.00023006894430923993,0.005,66/159,20.70%,UBB;COX6C;COX8A;COX7C;COX4I1;COX19;PRDX5;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;COX7B;PSMC6;PSMC1;COX5B;CYCS;PSMB6;COX6A1;PSMC3;UBA52;NFE2L2;MAP1LC3B;UBC;COX7A2L;COX6B1;SRXN1;PSMA2;PSMA7;COX14;PHGDH;PSMB7;PSMB1;PSMC5;AKT3;TXN2;FBXL17;P4HB;COX20;PSMB5;CYBA;NCF1;HMOX2;SQSTM1;PSMD11;ATF4;AKT1;PSMA4;PRDX2;CSNK2B;PSMF1;TXNRD1;GPX8;SOD1;ATOX1;PPARA;COX5A;GPX1;SEM1;SCO2;PSMB4;MAFK;PSMD2;MYC;IDH1;TBL1XR1
gsea,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.5727704974110077,-2.2175309474926257,0.0,0.0002515745070048126,0.005,23/52,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.5743561009577839,-2.2122201685952425,0.0,0.0002724080208661487,0.006,23/51,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.7062499172313343,-2.206854100077646,0.0,0.0002926005035317513,0.006,19/25,17.76%,TUBB2A;TUBA1A;TUBB2B;TUBB4B;TUBA4A;CCT5;TUBB3;TUBA1B;PFDN4;PFDN5;CCT3;CCT7;CCT8;CCT6A;CCT2;TUBB4A;CCT4;TCP1;TUBB6
gsea,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.5662519311551004,-2.205362340654921,0.0,0.000288167162569149,0.006,25/54,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;FBXW11;PSMD11;PSMA4;PSMF1;NFKB2;SEM1;PSMB4;PSMD2
gsea,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.569194756392225,-2.201711327337465,0.0,0.00028386616014274376,0.006,25/58,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;ELOB;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;UBE2D3;SEM1;PSMB4;PSMD2
gsea,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.5101051372366054,-2.200680195078481,0.0,0.00030299929593667873,0.006,39/90,23.12%,CALM1;UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;AHCYL1;PPP3R1;PSMA2;PSMA7;TRAF6;PPP3CA;PSMB7;PSMB1;PSMC5;PSMB5;UBE2V1;MALT1;FBXW11;PSMD11;PSMA4;PSMF1;CASP8;NFKB2;RELA;SEM1;PSMB4;PSMD2;IKBKG;UBE2N;PYCARD;PSMC2;NFATC1
gsea,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.7131858916742939,-2.193004486173452,0.0,0.000390487386959644,0.007,18/23,17.76%,TUBB2A;TUBA1A;TUBB2B;TUBB4B;TUBA4A;CCT5;TUBB3;PFDN4;PFDN5;CCT3;CCT7;CCT8;CCT6A;CCT2;TUBB4A;CCT4;TCP1;TUBB6
gsea,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.5303340143554967,-2.186772544816247,0.0,0.00043019240697822963,0.009,33/71,22.47%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;LYN;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;TRAF6;PSMB7;PSMB1;PSMC5;PSMB5;UBE2V1;MALT1;FBXW11;PSMD11;PSMA4;PSMF1;RELA;SEM1;PSMB4;PSMD2;IKBKG;UBE2N;RASGRP4;PSMC2
gsea,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.5811571391066401,-2.1816565458879027,0.0,0.00046877897572868604,0.009,23/49,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.5514569236214628,-2.178204279131146,0.0,0.0005283064647101064,0.01,28/57,20.48%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PARD6A;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;VANGL2;PSMF1;FZD1;SEM1;PSMB4;FZD9;PSMD2;FZD2
gsea,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.5827787502754084,-2.177005165490175,0.0,0.0005644918390053193,0.01,23/47,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Orc1 Removal From Chromatin R-HSA-68949,-0.546694018593847,-2.1753701835390302,0.0,0.0005782814005610626,0.011,25/61,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;ORC4;SEM1;PSMB4;MCM6;PSMD2
gsea,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.5349613499619138,-2.1702400557222057,0.0,0.0006128354990637236,0.011,28/63,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;PSMB5;PSMD11;AKT1;PSMA4;CSNK2B;PSMF1;SEM1;PSMB4;STUB1;PREX2;PSMD2
gsea,Interaction Between L1 And Ankyrins R-HSA-445095,0.681596594546232,2.1617273991800943,0.0,0.00892703353934655,0.011,17/24,19.04%,SPTBN4;SCN8A;SPTAN1;ANK3;SCN1A;NFASC;SCN2A;L1CAM;ANK1;SPTBN2;ANK2;SPTBN1;SCN5A;KCNQ2;KCNQ3;SPTB;NRCAM
gsea,Signaling By NOTCH4 R-HSA-9013694,-0.5125476359644889,-2.1409020033889132,0.0,0.000875876507282545,0.016,31/77,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;ACTA2;PSMB7;MAML3;PSMB1;PSMC5;SNW1;PSMB5;YWHAZ;PSMD11;AKT1;PSMA4;PSMF1;JAG1;SEM1;MAML2;PSMB4;PSENEN;PSMD2
gsea,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.555633963473205,-2.1366527612641715,0.0,0.0009262515939722646,0.018,22/50,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;TGFB1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;CBFB;PSMF1
gsea,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.48148793512372584,-2.127276175328407,0.0,0.0011988492853037033,0.027,42/105,23.12%,CALM1;UBB;HRAS;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;LYN;MUC15;PSMB6;PSMC3;UBA52;UBC;AHCYL1;PPP3R1;PSMA2;PSMA7;TRAF6;PPP3CA;PSMB7;PSMB1;PSMC5;PSMB5;UBE2V1;MALT1;FBXW11;PSMD11;PSMA4;PSMF1;CASP8;NFKB2;RELA;SEM1;PSMB4;PSMD2;IKBKG;UBE2N;PYCARD;PSMC2;NFATC1
gsea,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.550800234530566,-2.1185530493062505,0.0,0.001243860790330124,0.027,21/54,13.87%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Translesion Synthesis By REV1 R-HSA-110312,-0.7143120466371755,-2.1157873643396385,0.0,0.0012283125304509976,0.027,5/16,8.40%,UBB;RPS27A;UBA52;UBC;PCNA
gsea,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.5190976011709556,-2.115462951085694,0.0020161290322580645,0.0012131481782232075,0.027,33/73,20.65%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;NFE2L2;UBC;SRXN1;PSMA2;PSMA7;PHGDH;PSMB7;PSMB1;PSMC5;PSMB5;SQSTM1;PSMD11;ATF4;PSMA4;PSMF1;TXNRD1;SEM1;PSMB4;MAFK;PSMD2;MYC;IDH1
gsea,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.5964975799677452,-2.1139895524643277,0.0,0.0011983536882448757,0.027,18/36,21.05%,HSP90AB1;DYNLL2;HSPA2;DYNLL1;HSPA8;CAPZA2;DNAJA2;FKBP5;DCTN1;PTGES3;HSP90AA1;NR3C2;DNAJA1;ACTR10;DCTN4;CAPZA1;DCTN3;FKBP4
gsea,Host Interactions Of HIV Factors R-HSA-162909,-0.4772981194774965,-2.112254312827846,0.0,0.0012030111063880738,0.028,37/115,14.28%,UBB;SLC25A4;SLC25A5;PPIA;PSMA3;RAN;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;ELOB;PSMB6;PSMC3;UBA52;UBC;NUP43;PSMA2;PSMA7;BANF1;PSMB7;PSMB1;PSMC5;AP1S1;PSMB5;B2M;AP2M1;NPM1;AP1S3;PSMD11;CD247;NUP50;PSMA4;RANBP1;PSMF1;KPNA1;DOCK2
gsea,Axon Guidance R-HSA-422475,-0.4134120015713539,-2.1075633899573734,0.0,0.0012264257216484614,0.029,136/468,15.41%,UBB;RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;HSP90AB1;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;HRAS;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;ARPC3;RPL29;RPL8;RPS11;GSK3B;RPL27;RPL18;RPS20;PSMA3;ACTG1;RPLP1;PSMD7;PSMB3;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;MYL6;RPL15;RPS3;PSMC6;RPS17;RPS15;CLTB;RPS4X;CLTA;PRNP;RPL12;PSMC1;NCK1;YES1;ARPC1B;RPL4;RPL23A;RPL22;LYN;HSPA8;RPL11;RPL13A;RHOB;EPHA7;RPS24;FAU;CDC42;RPL34;ELOB;PSMB6;PSMC3;UBA52;RPL30;PFN2;RPL7A;UBC;COL4A2;RPS5;PSMA2;PSMA7;ARPC2;RPS2;RPS13;PFN1;WASL;GFRA4;PSMB7;PSMB1;RPL7;PSMC5;DPYSL2;IRS2;ARPC5;COL6A1;SEMA5A;CAP1;RPS12;UNC5D;RPL36A;RPS16;ROBO1;HSP90AA1;RHOA;PSMB5;MAGOHB;TRPC4;GSPT2;ACTR3;AP2M1;RPL35;EFNB2;PSMD11;RPS6;PSMA4;EPHA4;RPL9;PABPC1;MYL9;SCN9A;CSNK2B;PSMF1;RPL31;CXCL12;TYROBP;LAMB1;SCN1B;CACNB3;MYO10;RPL22L1;ACTR2
gsea,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.506259541165333,-2.1063222453686925,0.0,0.001211997183746715,0.029,32/77,14.22%,YWHAG;COX6C;COX8A;COX7C;COX4I1;COX19;PRDX5;LAMTOR2;YWHAE;MLST8;YWHAB;COX7B;LAMTOR3;COX5B;CYCS;DDIT4;COX6A1;RRAGA;YWHAH;COX7A2L;COX6B1;COX14;LAMTOR1;RHEB;AKT3;TXN2;COX20;YWHAZ;RRM2B;AKT1;PRDX2;TXNRD1
gsea,Degradation Of DVL R-HSA-4641258,-0.5461696084618167,-2.1004356043994505,0.0,0.0012716213743603725,0.031,20/51,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.5311512900311944,-2.0993623381682562,0.0,0.0012752225010243948,0.031,20/56,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.562401971463496,-2.098666098896612,0.0,0.0012607313362400269,0.031,19/42,19.29%,PSMA3;PSMD7;PSMB3;PSMC6;PSMC1;PSMB6;PSMC3;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2
gsea,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.4927331147018206,-2.097363637609027,0.0,0.0012821819817683486,0.032,31/77,22.73%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;PSMB5;PSMD11;AKT1;PSMA4;LIN37;PSMF1;SEM1;PSMB4;PSMD2;CCNE2;MYC;CDKN1B;PSMC2;E2F4
gsea,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.5454842857003777,-2.0938031558517958,0.0,0.0013207661617752663,0.034,21/54,13.87%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.5551677731061991,-2.0923014852702955,0.0,0.0013236689445483988,0.034,21/46,19.29%,PSMA3;PSMD7;PSMB3;PSMC6;PSMC1;PSMB6;PSMC3;PSMA2;PSMA7;OAZ1;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;OAZ3;PSMB4;PSMD2
gsea,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.48618704733833207,-2.0915972786033876,0.0,0.0013092812386293945,0.034,32/92,14.22%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;NFE2L2;MAP1LC3B;UBC;SRXN1;PSMA2;PSMA7;PHGDH;PSMB7;PSMB1;PSMC5;AKT3;FBXL17;PSMB5;SQSTM1;PSMD11;ATF4;AKT1;PSMA4;CSNK2B;PSMF1;TXNRD1
gsea,Cellular Response To Hypoxia R-HSA-1234174,-0.5209960541353699,-2.088711478454742,0.0,0.001363371521832533,0.037,23/65,14.69%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;HIGD1A;PSMC1;ELOB;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;UBE2D3
gsea,Nervous System Development R-HSA-9675108,-0.4085909131624431,-2.0853829316351677,0.0,0.0014331717925646506,0.039,166/490,20.62%,UBB;RPS29;RPL37;RPL6;RPS28;RPL38;RPL21;RPS21;HSP90AB1;RPL39;RPL5;RPL27A;RPL23;RPS8;RPL19;HRAS;RPS23;RPL18A;RPL41;RPL28;RPL36;RPL26;RPSA;RPS10;RPLP2;RPL10A;RPS7;RPS27;ARPC3;RPL29;RPL8;RPS11;GSK3B;RPL27;RPL18;RPS20;PSMA3;ACTG1;RPLP1;PSMD7;PSMB3;RPL36AL;RPS27A;RPS25;RPL37A;RPL3;MYL6;RPL15;RPS3;PSMC6;RPS17;RPS15;CLTB;RPS4X;CLTA;PRNP;RPL12;PSMC1;NCK1;YES1;ARPC1B;RPL4;RPL23A;RPL22;LYN;HSPA8;RPL11;RPL13A;RHOB;EPHA7;RPS24;FAU;CDC42;RPL34;ELOB;PSMB6;PSMC3;SREBF2;UBA52;RPL30;PFN2;RPL7A;UBC;COL4A2;RPS5;PSMA2;PSMA7;ARPC2;RPS2;RPS13;PFN1;WASL;GFRA4;PSMB7;PSMB1;RPL7;PSMC5;DPYSL2;IRS2;ARPC5;COL6A1;SEMA5A;CAP1;RPS12;UNC5D;RPL36A;RPS16;ROBO1;HSP90AA1;RHOA;PSMB5;MAGOHB;TRPC4;GSPT2;ACTR3;AP2M1;RPL35;EFNB2;PSMD11;RPS6;PSMA4;EPHA4;RPL9;PABPC1;MYL9;SCN9A;CSNK2B;PSMF1;RPL31;CXCL12;TYROBP;LAMB1;SCN1B;CACNB3;MYO10;RPL22L1;ACTR2;WWTR1;RPS15A;HMGCR;MAP2K1;GAP43;NELL2;SEM1;RNMT;RPL14;DOCK1;EPHA5;COL9A2;PSMB4;RPL32;YAP1;ROBO2;PSENEN;RPS9;PSMD2;DOK6;SDCBP;CXCR4;AP2B1;MAPK3;RPS14;PTPRC;NAB1;DCC;EGFR
gsea,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.4947201925432327,-2.0767929357620325,0.0,0.0016016027561737965,0.046,32/79,22.47%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PPP2R1A;PSMA7;PSMB7;PSMB1;PSMC5;TLE5;PSMB5;PPP2CA;PSMD11;PSMA4;PSMF1;SEM1;CTBP2;PSMB4;PSMD2;FRAT1;MYC;PPP2R5B;PSMC2
gsea,Downstream TCR Signaling R-HSA-202424,-0.4996325042791777,-2.075977877561381,0.0,0.0016014289711525104,0.047,32/75,22.47%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;TRAF6;PSMB7;PSMB1;PSMC5;PSMB5;UBE2V1;MALT1;FBXW11;PSMD11;CD247;PSMA4;PSMF1;RELA;SEM1;PSMB4;PSMD2;IKBKG;UBE2N;PSMC2
gsea,SARS-CoV Infections R-HSA-9679506,-0.4216617348392917,-2.075731797452021,0.0,0.0015849193941303195,0.047,76/307,13.41%,UBB;RPS29;DDX5;RPS28;ATP1B1;YWHAG;RPS21;HSP90AB1;RPS8;RPS23;FKBP1A;RPSA;RPS10;RPS7;RPS27;RPS11;GSK3B;SNRPF;RPS20;YWHAE;SNRPG;RPS27A;RPS25;RPS3;YWHAB;RPS17;RPS15;RPS4X;NCK1;DAD1;SIGMAR1;CHD3;CANX;RPS24;FAU;IFNGR2;UBA52;ISCU;NFE2L2;MAP1LC3B;UBC;YWHAH;BTK;SAR1B;RPS5;NUP43;RPS2;RPS13;TRAF6;ATP1A2;AKT3;MGAT4B;SNRPD2;ATP1B2;GOLGA7;CHMP2A;RPS12;CNBP;RPS16;PTGES3;HSP90AA1;ZCRB1;CHMP4B;GPC4;B2M;UBE2V1;MASP2;GJA1;AP2M1;YWHAZ;RPN2;RPS6;NUP50;AKT1;TYK2;SDC4
gsea,Degradation Of AXIN R-HSA-4641257,-0.5357373973507864,-2.0724344683266787,0.0,0.0016010920410092003,0.047,20/50,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Stabilization Of P53 R-HSA-69541,-0.5412743199821114,-2.0689635112661326,0.001968503937007874,0.001616937967749114,0.048,20/49,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Mitochondrial Translation Elongation R-HSA-5389840,-0.47304218763184747,-2.0648501858875883,0.0,0.0017275621396020482,0.051,53/82,34.65%,MRPL53;MRPS5;MRPL38;MRPL21;MRPL52;MRPL23;MRPL41;MRPL20;MRPL35;MRPL18;MRPL57;MRPS36;MRPL36;MRPL55;MRPL50;OXA1L;MRPL4;MRPL15;MRPL58;MRPS10;MRPL46;MRPS26;MRPS31;MRPL19;MRPL40;MRPS24;MRPS7;MRPL11;MRPL33;MRPL14;AURKAIP1;MRPS16;MRPS17;MRPS22;MRPS14;MRPS18C;MRPS34;MRPL43;MRPL34;MRPL42;MRPL51;CHCHD1;MRPL10;MRPL39;MRPL30;MRPL17;MRPS21;MRPS15;MRPS23;MRPL48;MRPS33;TSFM;MRPL47
gsea,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.5167259400050396,-2.0635634140356585,0.0,0.001726149835191437,0.052,24/56,19.36%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2;CCNE2
gsea,Mitochondrial Translation Termination R-HSA-5419276,-0.4749188015714654,-2.0619237775586945,0.0,0.0017247652230241715,0.053,53/82,34.65%,MRPL53;MRPS5;MRPL38;MRPL21;MRPL52;MRPL23;MRPL41;MRPL20;MRPL35;MRPL18;MRPL57;MRPS36;MRPL36;MRPL55;MRPL50;OXA1L;MRPL4;MRPL15;MRPL58;MRPS10;MRPL46;MRPS26;MRPS31;MRPL19;MRPL40;MRPS24;MRPS7;MRPL11;MRPL33;MRPL14;AURKAIP1;MRPS16;MRPS17;MRPS22;MRPS14;MRPS18C;MRPS34;MRRF;MRPL43;MRPL34;MRPL42;MRPL51;CHCHD1;MRPL10;MRPL39;MRPL30;MRPL17;MRPS21;MRPS15;MRPS23;MRPL48;MRPS33;MRPL47
gsea,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.5367134297025681,-2.061676431427094,0.0,0.0017387950634633602,0.054,20/53,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.48827556275644746,-2.0609394648048136,0.0,0.0017373154897197733,0.055,32/80,19.29%,UBB;PSMA3;SET;PSMD7;PSMB3;RPS27A;YWHAB;PSMC6;PSMC1;HSPA8;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;ELAVL1;PSMB5;YWHAZ;PSMD11;AKT1;PSMA4;PABPC1;PSMF1;EXOSC7;SEM1;EXOSC5;PSMB4;PSMD2
gsea,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.673404410034367,-2.059192311489254,0.0,0.0017358640983332072,0.056,14/21,22.03%,TUBB2A;TUBA1A;TUBB2B;TUBB4B;TUBA4A;TUBB3;TUBA1B;CHMP2A;CHMP4B;TUBB4A;CHMP4C;TUBB6;SPAST;VPS4A
gsea,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.646319831031331,-2.0579742036921465,0.0,0.0017643442312016764,0.058,7/23,9.60%,FTH1;APOE;CALR;HSPH1;APOA1;COL4A2;HSP90AA1
gsea,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.589161404328108,-2.0557696338344202,0.0,0.0017774796943517603,0.059,10/30,13.30%,UBB;RPS27A;POLD4;USP1;UBA52;UBC;PCNA;UBE2B;POLE4;POLE3
gsea,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.47715815438333287,-2.043206354040576,0.0,0.001937123703937057,0.064,31/79,22.73%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;PSMB5;PSMD11;AKT1;PSMA4;LIN37;PSMF1;SEM1;PSMB4;PSMD2;CCNE2;MYC;CDKN1B;PSMC2;E2F4
gsea,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.5046081538859716,-2.0412182274490704,0.0019305019305019305,0.001992054651338108,0.068,26/65,19.29%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;CBFB;PSMF1;SEM1;PSMB4;STUB1;PSMD2
gsea,Translesion Synthesis By POLI R-HSA-5656121,-0.6830122739209454,-2.0369894745595873,0.0,0.002103620286754788,0.073,5/17,8.40%,UBB;RPS27A;UBA52;UBC;PCNA
gsea,Translesion Synthesis By POLH R-HSA-110320,-0.657127930053024,-2.032116669683984,0.0,0.0021703400712415185,0.077,6/19,8.40%,UBB;RPS27A;UBA52;UBC;SPRTN;PCNA
gsea,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.4859259557154375,-2.0315941908114037,0.0022026431718061676,0.0021792641669291894,0.079,28/74,19.29%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;TNFRSF1A;PSMB1;PSMC5;TNFRSF9;PSMB5;FBXW11;PSMD11;PSMA4;CD27;PSMF1;NFKB2;SEM1;PSMB4;PSMD2
gsea,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.505329641188884,-2.0291389663607307,0.0,0.002174004478674332,0.08,27/61,20.37%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;MALT1;FBXW11;PSMD11;PSMA4;PSMF1;RELA;SEM1;PSMB4;PSMD2;IKBKG
gsea,G1/S DNA Damage Checkpoints R-HSA-69615,-0.5029953880074521,-2.027905053277415,0.0,0.0021549342639491185,0.08,24/58,19.36%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2;CCNE2
gsea,UCH Proteinases R-HSA-5689603,-0.4740779826145855,-2.0232693181886137,0.0,0.0022602328751075863,0.087,34/82,22.47%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;MBD5;NEDD8;TGFB1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;SENP8;INO80B;PSMD11;PSMA4;SMAD7;PSMF1;SEM1;RUVBL1;PSMB4;PSMD2;INO80D;FOXK1;H2AC25;PSMC2
gsea,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.47512742339292197,-2.021636915583315,0.0,0.002295400501843911,0.089,33/84,20.33%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;TGFB1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;MAML3;PSMB1;PSMC5;SNW1;PSMB5;BRD2;PSMD11;PSMA4;CBFB;PSMF1;WWTR1;JAG1;SEM1;MAML2;PSMB4;YAP1;PSMD2;MYC
gsea,Cargo Concentration In ER R-HSA-5694530,-0.6024697670308806,-2.0180292609154904,0.0,0.002478976488255115,0.096,11/24,17.03%,CNIH2;CNIH1;TMED2;PREB;SAR1B;CTSZ;LMAN1;TGFA;CTSC;MCFD2;LMAN2
gsea,Iron Uptake And Transport R-HSA-917937,-0.5413596214698139,-2.0154114323257843,0.0,0.002525125814377119,0.098,13/47,6.36%,FTH1;ATP6V0B;UBB;ATP6V1G2;ATP6V0C;RPS27A;ATP6V1F;ATP6V0E2;NEDD8;ATP6V1A;UBA52;UBC;SLC22A17
gsea,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.5633888428265872,-2.012560578928472,0.0,0.002570499521572703,0.101,15/33,20.01%,H2AZ1;ITGB3BP;H2AJ;H2BC4;CENPP;MIS18BP1;HJURP;NPM1;CENPW;SMARCA5;H2AZ2;MIS18A;RUVBL1;H2BC21;H2AX
gsea,ABC Transporter Disorders R-HSA-5619084,-0.48718365785564655,-2.009276257128515,0.0,0.0026151170003150272,0.106,21/67,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;APOA1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,G1/S Transition R-HSA-69206,-0.44151660916629865,-2.00851192100923,0.0,0.002632799985290861,0.107,40/116,22.73%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PPP2R1A;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;RBL1;PCNA;PSMB5;POLE4;PPP2CA;PSMD11;AKT1;PSMA4;LIN37;POLE3;PSMF1;POLA2;ORC4;SEM1;PSMB4;MCM6;PSMD2;CCNE2;MYC;CDKN1B;PSMC2;E2F4
gsea,Translesion Synthesis By POLK R-HSA-5655862,-0.666290439428058,-2.006631434519073,0.0,0.00266318422784193,0.109,5/17,8.40%,UBB;RPS27A;UBA52;UBC;PCNA
gsea,Mitochondrial Translation Initiation R-HSA-5368286,-0.4621293139743497,-2.0065219385111193,0.0,0.0026415323235505325,0.109,53/82,34.65%,MRPL53;MRPS5;MRPL38;MRPL21;MRPL52;MRPL23;MRPL41;MRPL20;MTIF2;MRPL35;MRPL18;MRPL57;MRPS36;MRPL36;MRPL55;MRPL50;OXA1L;MRPL4;MRPL15;MRPL58;MRPS10;MRPL46;MRPS26;MRPS31;MRPL19;MRPL40;MRPS24;MRPS7;MRPL11;MRPL33;MRPL14;AURKAIP1;MRPS16;MRPS17;MRPS22;MRPS14;MRPS18C;MRPS34;MRPL43;MRPL34;MRPL42;MRPL51;CHCHD1;MRPL10;MRPL39;MRPL30;MRPL17;MRPS21;MRPS15;MRPS23;MRPL48;MRPS33;MRPL47
gsea,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.44213302702046414,-2.0027997936979554,0.0,0.002722482507659339,0.112,43/118,23.12%,CALM1;UBB;HRAS;PSMA3;JUN;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;LYN;PSMB6;PSMC3;UBA52;UBC;AHCYL1;BTK;PPP3R1;PSMA2;PSMA7;TRAF6;PPP3CA;PSMB7;PSMB1;PSMC5;PSMB5;UBE2V1;MALT1;FBXW11;PSMD11;PSMA4;PSMF1;RELA;FOS;SEM1;PSMB4;PSMD2;MAPK3;IKBKG;UBE2N;RASGRP4;PSMC2;NFATC1
gsea,Attenuation Phase R-HSA-3371568,-0.6464443961385862,-2.002798710714334,0.0,0.0027007026475980647,0.112,9/21,10.71%,UBB;HSP90AB1;HSPA2;HSBP1;HSPA8;HSPH1;PTGES3;HSP90AA1;MRPL18
gsea,Activation Of BH3-only Proteins R-HSA-114452,-0.6203027310795619,-2.000732996717162,0.0,0.0027044259503017356,0.113,11/25,15.59%,YWHAG;DYNLL2;YWHAE;YWHAB;DYNLL1;YWHAH;PPP3R1;AKT3;YWHAZ;AKT1;BCL2
gsea,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.685052551430538,-1.994748186264495,0.0,0.0029077655026170427,0.121,7/15,10.40%,UBB;RPS27A;ITGB3BP;UBA52;UBC;TRAF6;SQSTM1
gsea,Kinesins R-HSA-983189,0.5639302083786248,1.9932757196655684,0.0,0.040841178442510465,0.112,13/33,11.60%,KIF1B;KIFC2;KIF5A;KIF5B;KIF21A;KIF3C;KIF16B;KIF13B;KIF11;KIF1A;KIF3A;KIFC1;KLC4
gsea,DNA Replication Pre-Initiation R-HSA-69002,-0.456790240294716,-1.982521582009491,0.0,0.0031946031537939254,0.139,35/97,20.01%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;H2AZ1;PSMC1;PSMB6;PSMC3;UBA52;UBC;H2AJ;PSMA2;PSMA7;H2BC4;PSMB7;PSMB1;PSMC5;PSMB5;POLE4;PSMD11;PSMA4;POLE3;PSMF1;POLA2;ORC4;KPNA1;H2AZ2;SEM1;H2BC21;PSMB4;MCM6;PSMD2;H2AX
gsea,TCR Signaling R-HSA-202403,-0.4558762498329175,-1.9801941336755535,0.0,0.0031821249851143626,0.14,34/93,22.47%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;NCK1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;TRAF6;PSMB7;PSMB1;PSMC5;PSMB5;UBE2V1;MALT1;FBXW11;PSMD11;CD247;PSMA4;PSMF1;RELA;SEM1;PSMB4;PSMD2;PTPRC;IKBKG;UBE2N;PSMC2
gsea,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.4245340087044018,-1.9798931772634412,0.0,0.0031820304759077956,0.141,34/130,14.04%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;LYN;PSMB6;PSMC3;UBA52;UBC;PSMA2;PPP2R1A;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;RBL1;PCNA;CCND3;PSMB5;POLE4;PPP2CA;PSMD11;AKT1;PSMA4;LIN37;POLE3;PSMF1;POLA2;ORC4;CDKN2D
gsea,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.6352064767075501,1.9760995505972383,0.0,0.033625159664872,0.14,9/21,12.64%,PTPRS;GRIA4;MPP3;LRFN2;LRFN1;RTN3;PTPRF;PTPRD;GRIN2D
gsea,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.590964345070854,-1.9744211118983244,0.0,0.003315022244211508,0.147,12/26,17.04%,PRDX5;CYCS;TXN2;P4HB;CYBA;NCF1;PRDX2;TXNRD1;GPX8;SOD1;ATOX1;GPX1
gsea,Metabolism Of Polyamines R-HSA-351202,-0.5083377901368753,-1.971252491665165,0.0,0.0034459989857227396,0.155,21/51,19.29%,PSMA3;PSMD7;PSMB3;PSMC6;PSMC1;PSMB6;PSMC3;PSMA2;PSMA7;OAZ1;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;OAZ3;PSMB4;PSMD2
gsea,PCP/CE Pathway R-HSA-4086400,-0.4643298000339015,-1.9678249808324761,0.0,0.003586922839347565,0.163,34/79,20.48%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;CLTB;CLTA;PSMC1;PARD6A;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PFN1;PSMB7;PSMB1;PSMC5;RHOA;PSMB5;AP2M1;PSMD11;PSMA4;VANGL2;PSMF1;FZD1;SEM1;PSMB4;FZD9;PSMD2;AP2B1;FZD2
gsea,Mitochondrial Translation R-HSA-5368287,-0.4469615867929867,-1.9652040191587823,0.0,0.0037139155952008976,0.168,55/88,34.65%,MRPL53;MRPS5;MRPL38;MRPL21;MRPL52;MRPL23;MRPL41;MRPL20;MTIF2;MRPL35;MRPL18;MRPL57;MRPS36;MRPL36;MRPL55;MRPL50;OXA1L;MRPL4;MRPL15;MRPL58;MRPS10;MRPL46;MRPS26;MRPS31;MRPL19;MRPL40;MRPS24;MRPS7;MRPL11;MRPL33;MRPL14;AURKAIP1;MRPS16;MRPS17;MRPS22;MRPS14;MRPS18C;MRPS34;MRRF;MRPL43;MRPL34;MRPL42;MRPL51;CHCHD1;MRPL10;MRPL39;MRPL30;MRPL17;MRPS21;MRPS15;MRPS23;MRPL48;MRPS33;TSFM;MRPL47
gsea,Amyloid Fiber Formation R-HSA-977225,-0.5404072865621441,-1.9633423695606236,0.0,0.0037333656839514196,0.171,14/42,10.68%,UBB;CST3;TTR;ITM2B;SNCA;APOE;RPS27A;H2AZ1;APOA1;UBA52;UBC;H2BC4;B2M;CALB1
gsea,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.4686362205821775,-1.9624195522187067,0.0,0.0037408759229105334,0.173,32/82,20.01%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;H2AZ1;PSMC1;PSMB6;PSMC3;UBA52;UBC;H2AJ;PSMA2;PSMA7;H2BC4;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;ORC4;KPNA1;H2AZ2;SEM1;H2BC21;PSMB4;MCM6;PSMD2;H2AX
gsea,Apoptosis R-HSA-109581,-0.42201238328505447,-1.9590991093001318,0.0,0.003817689051554784,0.177,41/149,15.94%,UBB;YWHAG;HMGB1;DYNLL2;YWHAE;PSMA3;PSMD7;PSMB3;RPS27A;GSDME;YWHAB;DYNLL1;PSMC6;PSMC1;MAGED1;CYCS;PSMB6;PSMC3;UBA52;UBC;YWHAH;C1QBP;PPP3R1;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;DFFB;PSMB5;YWHAZ;PSMD11;AKT1;PSMA4;PSMF1;KPNA1;CASP8;NDUFA2;BCL2;FADD
gsea,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.5910853232377687,-1.954187795544707,0.0,0.0038933889464505675,0.182,9/27,11.16%,FGFR2;UBB;FGF1;RPS27A;UBA52;UBC;PPP2R1A;FGF10;PPP2CA
gsea,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.6676939029675368,1.9516945275343704,0.003883495145631068,0.03381113953027505,0.181,10/16,21.20%,STAT1;ZMYM2;GRB2;MYO18A;CUX1;LRRFIP1;STAT5B;PIK3CA;CEP43;CNTRL
gsea,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.4939436752551535,-1.949923386458404,0.0,0.004002206527624044,0.188,20/60,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Budding And Maturation Of HIV Virion R-HSA-162588,-0.5697613131818757,-1.943934929778068,0.0,0.004211357247260563,0.204,11/27,17.28%,UBB;PPIA;RPS27A;UBA52;UBC;CHMP2A;CHMP5;CHMP4B;MVB12B;CHMP4C;VPS37C
gsea,Interleukin-1 Family Signaling R-HSA-446652,-0.42739559295428386,-1.943092519965146,0.0,0.0042489328438387285,0.208,45/123,22.47%,UBB;HMGB1;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PELI2;PSMC3;UBA52;UBC;PSMA2;PSMA7;TRAF6;PSMB7;LRRC14;PSMB1;PSMC5;PSMB5;IL1RAP;SQSTM1;S100B;UBE2V1;TIFA;PELI3;FBXW11;PSMD11;PSMA4;PSMF1;CASP8;IL1R2;NKIRAS2;NFKB2;RELA;MAP2K1;SEM1;PSMB4;PSMD2;GSDMD;IKBKG;UBE2N;IL18;PSMC2
gsea,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.47600050450390785,-1.9349146845349587,0.0,0.004544174486667349,0.22,21/65,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;BUB3;PSMF1
gsea,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.47600050450390785,-1.9349146845349587,0.0,0.004544174486667349,0.22,21/65,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;BUB3;PSMF1
gsea,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.5212291846664935,-1.9331255826892104,0.0,0.004611675181531971,0.226,15/47,15.59%,YWHAG;DYNLL2;YWHAE;GSDME;YWHAB;DYNLL1;CYCS;YWHAH;C1QBP;PPP3R1;AKT3;YWHAZ;AKT1;CASP8;BCL2
gsea,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.6786684467435045,-1.928141546769043,0.002061855670103093,0.004732897225230541,0.235,8/16,9.68%,UBB;FKBP1A;RPS27A;PARD6A;TGFB1;UBA52;UBC;RHOA
gsea,Programmed Cell Death R-HSA-5357801,-0.40581743630311196,-1.9279997990642508,0.0,0.0047004801209481395,0.235,54/171,20.56%,UBB;YWHAG;HMGB1;DYNLL2;YWHAE;PSMA3;PSMD7;PSMB3;RPS27A;GSDME;YWHAB;DYNLL1;PSMC6;PSMC1;MAGED1;CYCS;PSMB6;PSMC3;UBA52;UBC;YWHAH;C1QBP;PPP3R1;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;DFFB;CHMP2A;HSP90AA1;PSMB5;CHMP4B;YWHAZ;PSMD11;AKT1;PSMA4;PSMF1;KPNA1;CASP8;NDUFA2;BCL2;FADD;CHMP4C;SEM1;PSMB4;STUB1;PSMD2;SDCBP;MAPK3;GSDMD;DCC;IRF1
gsea,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.4728074106980963,-1.9223768737202829,0.0,0.004948829944937528,0.244,21/66,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;BUB3;PSMF1
gsea,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.4810870144672453,-1.9213714163072417,0.001953125,0.004968936478895056,0.247,20/61,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Late Endosomal Microautophagy R-HSA-9615710,-0.5679935476634194,-1.920493685252106,0.0,0.004967499040663485,0.247,12/28,17.28%,UBB;RPS27A;HSPA8;UBA52;UBC;PARK7;CHMP2A;PLIN3;CHMP4B;MVB12B;CHMP4C;VPS37C
gsea,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6266812878158841,-1.9199410621483135,0.004032258064516129,0.004955514638980799,0.248,10/21,14.69%,UBB;RPS27A;LYN;ELOB;UBA52;UBC;SOCS1;TYK2;RNF7;UBE2D3
gsea,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.47074322845233885,-1.9145690413888028,0.0,0.005153612069655542,0.254,21/67,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;BUB3;PSMF1
gsea,DNA Replication R-HSA-69306,-0.4208739830052787,-1.9134676578149754,0.0,0.0051509880309235385,0.255,40/123,20.01%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;H2AZ1;PSMC1;POLD4;PSMB6;PSMC3;UBA52;UBC;H2AJ;PSMA2;PSMA7;H2BC4;PSMB7;PSMB1;PSMC5;PCNA;PSMB5;POLE4;PSMD11;PSMA4;POLE3;PSMF1;POLA2;ORC4;KPNA1;H2AZ2;SEM1;GINS4;H2BC21;PSMB4;MCM6;PSMD2;CCNE2;GINS2;H2AX
gsea,EGFR Downregulation R-HSA-182971,-0.5537880387007581,-1.9033704667325504,0.001949317738791423,0.005645627907196237,0.276,8/28,10.19%,UBB;RPS27A;CDC42;UBA52;SH3GL1;UBC;TGFA;STAM2
gsea,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.4968062756503706,-1.9012958715094472,0.002061855670103093,0.0057118848294956314,0.284,12/49,7.33%,ATP6V0B;ATP6V1G2;ATP6V0C;LAMTOR2;MLST8;ATP6V1F;LAMTOR3;ATP6V0E2;ATP6V1A;RRAGA;LAMTOR1;RHEB
gsea,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.6243461452145984,-1.900880552088905,0.0,0.005705709818869151,0.285,4/17,5.23%,UBB;RPS27A;UBA52;UBC
gsea,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.4618175881372045,-1.8995213511892288,0.0,0.0057300931941634626,0.288,21/71,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;BUB3;PSMF1
gsea,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.4667358221075545,-1.8955939200621263,0.0020325203252032522,0.00594597148498572,0.299,24/66,19.36%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;PSMD2;CCNE2
gsea,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.6721368205686196,-1.8930165218436457,0.005893909626719057,0.006149086003809405,0.308,11/16,17.76%,TUBB2A;TUBA1A;TUBB2B;TUBB4B;TUBA4A;TBCA;TUBB3;TUBA1B;TUBB4A;TBCC;TUBB6
gsea,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.671582579228899,-1.892516800157485,0.0,0.006150284692945957,0.31,9/15,15.59%,YWHAG;YWHAE;YWHAB;YWHAH;PPP3R1;AKT3;YWHAZ;AKT1;BCL2
gsea,RHO GTPases Activate PKNs R-HSA-5625740,-0.5370854314068872,-1.8906611883287077,0.0021645021645021645,0.006339677576521279,0.319,16/36,20.01%,YWHAG;YWHAE;MYL6;YWHAB;H2AZ1;RHOB;YWHAH;H2AJ;H2BC4;RHOA;YWHAZ;MYL9;H2AZ2;H2BC21;CDC25C;H2AX
gsea,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.5253502768958435,-1.884745169342738,0.0,0.0066645368312187965,0.332,16/38,23.68%,UBB;HRAS;RPS27A;YWHAB;PEBP1;UBA52;UBC;PPP2R1A;PPP2CA;MAP2K1;DUSP6;DUSP4;MAPK3;PPP2R5B;DUSP12;DUSP7
gsea,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.5139342223748248,-1.8775704732367253,0.0021598272138228943,0.0071614876327369984,0.352,14/38,16.01%,UBB;HMGB1;RPS27A;UBA52;UBC;TRAF6;LRRC14;S100B;UBE2V1;TIFA;CASP8;NKIRAS2;NFKB2;RELA
gsea,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.582965633066069,-1.8771658570508778,0.0,0.007156445853251013,0.352,9/22,19.98%,UBB;RPS27A;UBA52;UBC;B2M;PGK1;KPNA1;RAB5A;MAPK3
gsea,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.4686581601189346,-1.8726717784124074,0.00202020202020202,0.007480046408883337,0.367,20/65,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,HSF1-dependent Transactivation R-HSA-3371571,-0.5420251605777536,-1.8709257381534365,0.0,0.007569190803482981,0.371,11/30,10.71%,UBB;HSP90AB1;HSPA2;MLST8;HSBP1;HSPA8;HSPH1;CRYAB;PTGES3;HSP90AA1;MRPL18
gsea,SARS-CoV-1 Infection R-HSA-9678108,-0.4961330131932953,-1.8708097874458012,0.0,0.0075235932685222395,0.371,15/48,17.19%,UBB;DDX5;GSK3B;RPS27A;CANX;UBA52;MAP1LC3B;UBC;CHMP2A;ZCRB1;CHMP4B;PARP10;SUMO1;CTSL;CHMP4C
gsea,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.5692276309195938,-1.8673315837124818,0.00205761316872428,0.007725295729473533,0.379,8/26,11.16%,UBB;FGF1;RPS27A;UBA52;UBC;PPP2R1A;FGF10;PPP2CA
gsea,Plasma Lipoprotein Clearance R-HSA-8964043,-0.5544434005490535,-1.8672462388950126,0.002105263157894737,0.007679311826321905,0.379,10/28,11.16%,UBB;APOE;RPS27A;CLTA;APOA1;UBA52;UBC;NCEH1;LDLR;AP2M1
gsea,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.42367794895415956,-1.86541256298219,0.002053388090349076,0.007783923651645948,0.384,32/99,19.98%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;YES1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;PSMB5;PSMD11;AKT1;PSMA4;CBFB;PSMF1;WWTR1;SEM1;PSMB4;YAP1;STUB1;PSMD2;MAPK3
gsea,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.5676544770535352,-1.8559888714576263,0.006896551724137931,0.008577210838822907,0.409,7/25,9.48%,CALM1;NCK1;LYN;AHCYL1;BTK;ORAI2;DAPP1
gsea,Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.6023655129255654,1.8522216827271327,0.005870841487279843,0.07900424682321695,0.439,9/17,13.68%,ZMYM2;ETV6;TRIP11;GRB2;MYO18A;GOLGB1;SPTBN1;STAT5B;PIK3CA
gsea,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.5435060702476152,-1.8518865029672256,0.002070393374741201,0.008832913348574237,0.419,11/28,17.28%,UBB;RPS27A;UBA52;UBC;CHMP2A;CHMP5;CHMP4B;STAM2;MVB12B;CHMP4C;VPS37C
gsea,HIV Infection R-HSA-162906,-0.38015155895858843,-1.84525224382647,0.0,0.009408155240738698,0.44,84/207,28.78%,UBB;SLC25A4;SLC25A5;PPIA;PSMA3;RAN;PSMD7;PSMB3;RPS27A;XRCC6;PSMC6;PSMC1;POLR2K;ELOB;PSMB6;PSMC3;UBA52;TAF13;UBC;NUP43;PSMA2;PSMA7;BANF1;ERCC3;PSMB7;PSMB1;PSMC5;AP1S1;TAF11;CHMP2A;CHMP5;GTF2H5;PSMB5;POLR2G;CHMP4B;MVB12B;B2M;AP2M1;NPM1;AP1S3;PSMD11;CD247;NUP50;GTF2B;PSMA4;POLR2F;RANBP1;PSMF1;KPNA1;DOCK2;TCEA1;CCNK;TAF7L;CHMP4C;SEM1;VPS37C;RNMT;PSMB4;PSMD2;CXCR4;AP2B1;AP1S2;POLR2E;GTF2E2;VPS4A;AP2S1;PSMC2;NUP35;GTF2F2;AP1M1;TAF10;GTF2A1;CTDP1;MVB12A;LRIG1;PSMD4;PSIP1;PSMD8;TAF12;LIG4;NCBP2;NELFA;POLR2J;FURIN
gsea,Regulated Necrosis R-HSA-5218859,-0.4927758881718953,-1.8446019240387121,0.0,0.009436225294533116,0.442,18/43,22.07%,UBB;HMGB1;RPS27A;GSDME;CYCS;UBA52;UBC;CHMP2A;HSP90AA1;CHMP4B;CASP8;FADD;CHMP4C;STUB1;SDCBP;GSDMD;IRF1;IL18
gsea,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.5682222319698316,-1.8438916576136382,0.0020920502092050207,0.00942753777543035,0.445,18/32,19.98%,ARPC3;ACTG1;WIPF3;NCK1;ARPC1B;CDC42;BTK;ARPC2;WASL;ARPC5;ACTR3;ABI2;ABI1;ACTR2;BAIAP2;BRK1;WASF1;MAPK3
gsea,Autophagy R-HSA-9612973,-0.40983028425223644,-1.8384423364976226,0.002070393374741201,0.009908010383877541,0.459,35/122,13.93%,UBB;EEF1A1;HSP90AB1;DYNLL2;GABARAPL1;VDAC1;LAMTOR2;RPS27A;MLST8;DYNLL1;GABARAP;LAMTOR3;HSPA8;GABARAPL2;RRAGA;UBA52;MAP1LC3B;TOMM6;UBC;LAMTOR1;RHEB;PARK7;CHMP2A;HSP90AA1;PLIN3;CHMP4B;MVB12B;SQSTM1;ATG10;UBE2V1;TOMM20;TOMM5;GFAP;CSNK2B;TOMM7
gsea,p75NTR Signals Via NF-kB R-HSA-193639,-0.6346455850605592,-1.8372361372347468,0.0,0.010013808899277927,0.466,7/15,16.01%,UBB;RPS27A;UBA52;UBC;TRAF6;SQSTM1;RELA
gsea,Signaling By FGFR1 R-HSA-5654736,-0.4886623484530789,-1.8368345445456573,0.0020325203252032522,0.009993051095194556,0.467,10/42,11.16%,UBB;HRAS;FGF1;RPS27A;FLRT2;UBA52;UBC;PPP2R1A;FGF10;PPP2CA
gsea,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.5478647265614474,-1.8366140713676966,0.004424778761061947,0.00998143056640499,0.468,10/26,14.54%,NME2;DTYMK;NME4;AK6;TXN2;DUT;RRM2B;AK1;TXNRD1;GLRX
gsea,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.4414597334765765,-1.8340656875656889,0.004032258064516129,0.01017358873662423,0.475,21/75,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;BUB3;PSMF1
gsea,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.5547583443237785,-1.8276126582301213,0.0020833333333333333,0.010786256987831342,0.489,8/25,13.30%,UBB;RPS27A;POLD4;UBA52;UBC;PCNA;POLE4;POLE3
gsea,Platelet Degranulation R-HSA-114608,-0.4173342514726565,-1.8250936801585875,0.0,0.011033140533724877,0.5,28/92,20.43%,CALM1;TMSB4X;TTR;PPIA;MANF;APOA1;TUBA4A;TGFB1;TIMP3;OLA1;HSPA5;PFN1;PCDH7;CAP1;CLU;ENDOD1;PCYOX1L;VTI1B;CD63;VEGFB;SOD1;SPARC;CLEC3B;FAM3C;VEGFC;APLP2;FERMT3;LHFPL2
gsea,ABC-family Proteins Mediated Transport R-HSA-382556,-0.42060272351659933,-1.8212284493547914,0.0,0.011486311433285117,0.507,28/87,19.51%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;APOA1;PSMB6;PSMC3;UBA52;UBC;PSMA2;ABCD3;PSMA7;PSMB7;PSMB1;ABCB10;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;SEM1;PSMB4;EIF2S2;PSMD2;PEX19
gsea,G2/M Checkpoints R-HSA-69481,-0.39764356077291524,-1.8162367240524415,0.0,0.012055780309450299,0.522,36/116,20.01%,UBB;YWHAG;YWHAE;PSMA3;PSMD7;PSMB3;RPS27A;YWHAB;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;YWHAH;PSMA2;PSMA7;H2BC4;PSMB7;PSMB1;PSMC5;RAD9B;PSMB5;BABAM2;YWHAZ;PSMD11;PSMA4;PSMF1;ORC4;SEM1;H2BC21;CDC25C;PSMB4;MCM6;PSMD2;H2AX
gsea,Synthesis Of DNA R-HSA-69239,-0.40192769789030247,-1.8105177708010285,0.0,0.012860242692590038,0.547,33/110,19.54%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;POLD4;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PCNA;PSMB5;POLE4;PSMD11;PSMA4;POLE3;PSMF1;POLA2;ORC4;SEM1;GINS4;PSMB4;MCM6;PSMD2;CCNE2;GINS2
gsea,Signaling By EGFR In Cancer R-HSA-1643713,-0.581515713668527,-1.809774527718295,0.007952286282306162,0.012850697790245834,0.548,7/21,9.87%,UBB;HRAS;RPS27A;UBA52;UBC;HSP90AA1;TGFA
gsea,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.5973721138216228,-1.807018135741149,0.003875968992248062,0.013190619473729756,0.56,11/21,13.93%,UBB;VDAC1;RPS27A;UBA52;MAP1LC3B;TOMM6;UBC;SQSTM1;TOMM20;TOMM5;TOMM7
gsea,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.4380829568410704,-1.8068584460122052,0.0,0.013137032411240616,0.56,22/62,23.10%,TUBB2A;TUBA1A;RAN;TUBB2B;TUBB4B;TUBA4A;NUP43;PPP2R1A;TUBB3;BANF1;TUBA1B;CHMP2A;CHMP4B;PPP2CA;TUBB4A;SUMO1;CHMP4C;TUBB6;EMD;SPAST;VPS4A;NUP35
gsea,Assembly Of HIV Virion R-HSA-175474,-0.5898458972105711,-1.8065494356033913,0.0037735849056603774,0.013092445846193545,0.561,6/17,10.32%,UBB;PPIA;RPS27A;UBA52;UBC;MVB12B
gsea,EPHB-mediated Forward Signaling R-HSA-3928662,-0.5377690370135373,-1.806214133674073,0.00199203187250996,0.013081874364250257,0.563,12/31,10.64%,HRAS;ARPC3;ACTG1;YES1;ARPC1B;LYN;CDC42;ARPC2;WASL;ARPC5;RHOA;ACTR3
gsea,Pyroptosis R-HSA-5620971,-0.5966969277373093,-1.805147964678522,0.004301075268817204,0.01317151433332513,0.566,9/17,22.07%,HMGB1;GSDME;CYCS;CHMP2A;CHMP4B;CHMP4C;GSDMD;IRF1;IL18
gsea,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.5032637713408767,-1.8034727320303796,0.0019083969465648854,0.013359791751569709,0.57,17/35,29.28%,UBB;CALR;RPS27A;PSMC1;CANX;UBA52;UBC;RNF139;EDEM1;MLEC;RNF185;NGLY1;RNF5;RAD23B;DERL2;DERL1;TRIM13
gsea,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.49335429553440213,-1.7979557993059454,0.004201680672268907,0.013958847372262344,0.591,23/52,17.96%,HSP90AB1;ARPC3;ACTG1;WIPF3;NCK1;ARPC1B;CDC42;BTK;ARPC2;WASL;ELMO2;ARPC5;HSP90AA1;ACTR3;ABI2;CD247;ABI1;MYO10;ACTR2;BAIAP2;BRK1;DOCK1;WASF1
gsea,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.5261327716749676,1.7972818971490145,0.0,0.12125887224279062,0.612,9/31,9.86%,SPTAN1;MAPT;FNTA;PTK2;SATB1;ACIN1;ROCK1;ADD1;GAS2
gsea,Signaling By Interleukins R-HSA-449147,-0.35666147610619203,-1.7959042857186582,0.0,0.014100034195449525,0.592,101/323,22.65%,UBB;HMGB1;PPIA;VAMP2;RALA;PSMA3;JUN;PSMD7;PSMB3;RPS27A;PSMC6;VRK3;FSCN1;NDN;PSMC1;YES1;CEBPD;LYN;HSPA8;CANX;CDC42;TGFB1;PSMB6;PELI2;PSMC3;UBA52;UBC;POU2F1;PSMA2;PPP2R1A;PSMA7;TRAF6;PTK2B;PSMB7;TNFRSF1A;GSTO1;LRRC14;PSMB1;PSMC5;IRS2;SOCS1;P4HB;HSP90AA1;PSMB5;IL1RAP;SQSTM1;S100B;UBE2V1;PPP2CA;YWHAZ;TIFA;PELI3;CSF1R;FBXW11;PSMD11;MCL1;AKT1;PSMA4;TYK2;IL16;PSMF1;SOD1;CASP8;IL1R2;HNRNPA2B1;POMC;NKIRAS2;BCL2;NFKB2;RELA;FOS;MAP2K1;IL12RB2;SEM1;HNRNPDL;TCP1;DUSP6;PSMB4;IL21R;AURKAIP1;PSMD2;IL17RB;DUSP4;CAPZA1;MAPK3;GSDMD;PRTN3;CRLF1;LAMA5;MYC;IKBKG;INPPL1;CRLF2;FOXO1;UBE2N;ITGAM;FGF13;IL18;PSMC2;HNRNPF;CNTFR
gsea,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.41610832969476097,-1.794459636370151,0.0,0.014239765484377047,0.595,29/84,21.42%,UBB;HMGB1;JUN;RPS27A;VRK3;PELI2;UBA52;UBC;PPP2R1A;TRAF6;LRRC14;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;NKIRAS2;NFKB2;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;ECSIT;UBE2N
gsea,G2/M Transition R-HSA-69275,-0.38081514753124046,-1.7928476847940769,0.0,0.014313041297761502,0.596,40/162,14.06%,UBB;YWHAG;TUBA1A;HSP90AB1;NME7;YWHAE;PSMA3;PSMD7;PSMB3;RPS27A;DYNLL1;PSMC6;PSMC1;TUBB4B;TUBA4A;PSMB6;PSMC3;UBA52;UBC;CEP72;PSMA2;PPP2R1A;PSMA7;PSMB7;PSMB1;PSMC5;DCTN1;CEP78;HSP90AA1;PSMB5;TUBG2;PPP2CA;FBXW11;PSMD11;SSNA1;PSMA4;LIN37;TUBB4A;PSMF1;LCMT1
gsea,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.5775289189341982,-1.7880309812066197,0.00808080808080808,0.015056734244238035,0.607,8/20,19.98%,UBB;RPS27A;UBA52;UBC;PGK1;KPNA1;RAB5A;MAPK3
gsea,Mitotic G2-G2/M Phases R-HSA-453274,-0.3792668642311465,-1.7863746116436998,0.0,0.01516534547175458,0.611,40/164,14.06%,UBB;YWHAG;TUBA1A;HSP90AB1;NME7;YWHAE;PSMA3;PSMD7;PSMB3;RPS27A;DYNLL1;PSMC6;PSMC1;TUBB4B;TUBA4A;PSMB6;PSMC3;UBA52;UBC;CEP72;PSMA2;PPP2R1A;PSMA7;PSMB7;PSMB1;PSMC5;DCTN1;CEP78;HSP90AA1;PSMB5;TUBG2;PPP2CA;FBXW11;PSMD11;SSNA1;PSMA4;LIN37;TUBB4A;PSMF1;LCMT1
gsea,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.5902905574410333,-1.786076700048738,0.007782101167315175,0.015136780678285021,0.612,6/18,9.60%,UBB;HRAS;RPS27A;UBA52;UBC;HSP90AA1
gsea,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.46614119208814125,-1.785006621932959,0.003861003861003861,0.015243898092288601,0.617,15/48,16.01%,IDH3B;VDAC1;GLO1;MDH2;SUCLG1;LDLR;BSG;MPC2;IDH3G;HAGH;SLC16A1;PLPP6;PDP2;LDHB;SDHB
gsea,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.40649407044830893,-1.7818296600911985,0.0,0.01562730522612495,0.628,33/94,21.90%,UBB;HMGB1;JUN;RPS27A;VRK3;PELI2;UBA52;UBC;BTK;PPP2R1A;TRAF6;LRRC14;SOCS1;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;NDUFA2;NKIRAS2;NFKB2;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;ECSIT;UBE2N;LY96
gsea,Mitophagy R-HSA-5205647,-0.5402600468437503,-1.7797073064301812,0.007984031936127744,0.015793997743497663,0.631,12/27,13.93%,UBB;VDAC1;RPS27A;UBA52;MAP1LC3B;TOMM6;UBC;SQSTM1;TOMM20;TOMM5;CSNK2B;TOMM7
gsea,Chaperonin-mediated Protein Folding R-HSA-390466,-0.42436641712215706,-1.778245004750009,0.0019646365422396855,0.015911963026219247,0.635,28/75,21.89%,TUBB2A;TUBA1A;TUBB2B;TUBB4B;TUBA4A;CCT5;GNG7;TUBB3;GAPDHS;TUBA1B;PFDN4;PFDN5;CCT3;CCT7;CCT8;CCT6A;CCT2;TUBB4A;CSNK2B;CCT4;FBXW2;TCP1;TUBB6;FBXW4;CCNE2;GNG3;GNA15;GNB2
gsea,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.615309184974756,-1.773250992803526,0.005870841487279843,0.01654406007961649,0.642,6/15,10.19%,UBB;RPS27A;UBA52;SH3GL1;UBC;STAM2
gsea,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.4035003996041252,-1.765574483419589,0.0,0.01749566360316673,0.663,31/89,21.90%,UBB;HMGB1;JUN;RPS27A;VRK3;PELI2;UBA52;UBC;PPP2R1A;TRAF6;LRRC14;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;NDUFA2;NKIRAS2;NFKB2;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;ECSIT;UBE2N;LY96
gsea,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.4035003996041252,-1.765574483419589,0.0,0.01749566360316673,0.663,31/89,21.90%,UBB;HMGB1;JUN;RPS27A;VRK3;PELI2;UBA52;UBC;PPP2R1A;TRAF6;LRRC14;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;NDUFA2;NKIRAS2;NFKB2;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;ECSIT;UBE2N;LY96
gsea,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.4035003996041252,-1.765574483419589,0.0,0.01749566360316673,0.663,31/89,21.90%,UBB;HMGB1;JUN;RPS27A;VRK3;PELI2;UBA52;UBC;PPP2R1A;TRAF6;LRRC14;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;NDUFA2;NKIRAS2;NFKB2;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;ECSIT;UBE2N;LY96
gsea,Signaling By FGFR3 R-HSA-5654741,-0.4933670973025551,-1.7654500158561985,0.00408997955010225,0.017434113335433515,0.663,9/34,13.06%,UBB;HRAS;FGF1;RPS27A;UBA52;UBC;PPP2R1A;PPP2CA;FGFR3
gsea,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.6102548208249977,-1.7628134093705632,0.004132231404958678,0.01779224416006873,0.673,11/15,33.19%,UBB;RPS27A;UBA52;UBC;NDUFA2;LY96;TLR4;TICAM1;PTPN11;TANK;SARM1
gsea,Signaling By FGFR4 R-HSA-5654743,-0.5044724313468173,-1.7621015619097535,0.004166666666666667,0.017767780576303054,0.675,7/32,6.07%,UBB;HRAS;FGF1;RPS27A;UBA52;UBC;PPP2R1A
gsea,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.4168751303506981,-1.7618911469346052,0.0,0.017720908273419,0.676,26/81,19.36%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1;ORC4;SEM1;PSMB4;MCM6;PSMD2;CCNE2
gsea,Calnexin/calreticulin Cycle R-HSA-901042,-0.5361085047141658,-1.761722789424362,0.00390625,0.017659457325120288,0.676,6/26,5.23%,UBB;CALR;RPS27A;CANX;UBA52;UBC
gsea,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.4262379082791458,-1.7583243272659326,0.004032258064516129,0.018084528369817183,0.68,24/76,13.87%,UBB;PSMA3;JUN;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;CDC42;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;CCND3;PSMB5;CDC42EP3;PSMD11;PSMA4;PSMF1
gsea,Translation Of Structural Proteins R-HSA-9683701,-0.506928089077708,-1.7582129020466413,0.004081632653061225,0.01802938822524772,0.681,6/29,5.23%,UBB;GSK3B;RPS27A;CANX;UBA52;UBC
gsea,Macroautophagy R-HSA-1632852,-0.39864035252309693,-1.756208395697141,0.002074688796680498,0.018233979197891808,0.691,29/109,11.54%,UBB;DYNLL2;GABARAPL1;VDAC1;LAMTOR2;RPS27A;MLST8;DYNLL1;GABARAP;LAMTOR3;HSPA8;GABARAPL2;RRAGA;UBA52;MAP1LC3B;TOMM6;UBC;LAMTOR1;RHEB;PARK7;CHMP2A;HSP90AA1;PLIN3;CHMP4B;SQSTM1;ATG10;UBE2V1;TOMM20;TOMM5
gsea,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.535032867801394,-1.7473301988916885,0.01593625498007968,0.019711974232113832,0.72,10/26,14.69%,UBB;RPS27A;LYN;ELOB;UBA52;UBC;SOCS1;TYK2;RNF7;UBE2D3
gsea,Selective Autophagy R-HSA-9663891,-0.4435161762736376,-1.7458394369477659,0.00390625,0.019877530734717756,0.721,19/58,13.93%,UBB;DYNLL2;VDAC1;RPS27A;DYNLL1;HSPA8;UBA52;MAP1LC3B;TOMM6;UBC;PARK7;HSP90AA1;PLIN3;SQSTM1;UBE2V1;TOMM20;TOMM5;CSNK2B;TOMM7
gsea,Glutathione Conjugation R-HSA-156590,-0.5204248674836514,-1.74432399985258,0.0021551724137931034,0.02003425759492842,0.724,14/25,32.32%,PRNP;HPGDS;GSTO1;AKR1A1;GSTM5;CNDP2;ESD;CHAC2;GSTT2;GGCT;GSTP1;GSTZ1;MGST3;GGT7
gsea,Protein Folding R-HSA-391251,-0.40927872963901735,-1.7422606732101082,0.0,0.020276789863437894,0.728,32/81,24.16%,TUBB2A;TUBA1A;TUBB2B;TUBB4B;TUBA4A;CCT5;TBCA;GNG7;TUBB3;GAPDHS;TUBA1B;PFDN4;PFDN5;CCT3;CCT7;CCT8;CCT6A;CCT2;TUBB4A;CSNK2B;TBCC;CCT4;FBXW2;TCP1;TUBB6;FBXW4;CCNE2;GNG3;GNA15;GNB2;PFDN2;ARL2
gsea,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.5927144850047915,-1.7417048254134448,0.01195219123505976,0.02024933545560107,0.732,5/15,6.69%,UBB;RPS27A;UBA52;UBC;TRAF6
gsea,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.40006107977408967,-1.740881273762462,0.00205761316872428,0.020330193319253464,0.734,29/90,21.42%,UBB;HMGB1;JUN;RPS27A;VRK3;UBA52;UBC;PPP2R1A;TRAF6;LRRC14;S100B;UBE2V1;PPP2CA;TIFA;FBXW11;CASP8;UBE2D3;TLR3;NKIRAS2;NFKB2;FADD;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;UBE2N
gsea,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.5416222609225035,-1.7394163739193171,0.010526315789473684,0.020553751056911745,0.738,8/24,13.06%,UBB;FGF1;RPS27A;UBA52;UBC;PPP2R1A;PPP2CA;FGFR3
gsea,Aggrephagy R-HSA-9646399,-0.5547197729049,-1.7390459810940844,0.0039447731755424065,0.02048258442234183,0.738,9/23,10.81%,UBB;DYNLL2;RPS27A;DYNLL1;UBA52;UBC;PARK7;HSP90AA1;UBE2V1
gsea,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.39374282827617374,-1.7352767450220974,0.0,0.021144104024832737,0.751,29/96,20.43%,CALM1;TMSB4X;TTR;PPIA;MANF;APOA1;TUBA4A;TGFB1;TIMP3;OLA1;HSPA5;PFN1;PCDH7;CAP1;CLU;ENDOD1;PCYOX1L;VTI1B;CD63;VEGFB;SOD1;SPARC;CLEC3B;FAM3C;VEGFC;APLP2;FERMT3;STXBP3;LHFPL2
gsea,Gluconeogenesis R-HSA-70263,-0.5284209290221826,-1.7325362117049574,0.004140786749482402,0.0216582065421112,0.761,9/24,15.43%,TPI1;MDH2;ENO2;ALDOC;GAPDHS;MDH1;PGK1;PGAM2;SLC25A11
gsea,Mitotic Anaphase R-HSA-68882,-0.3547523380511042,-1.7322528127464603,0.0,0.02160421236354529,0.762,44/200,13.87%,UBB;TUBB2A;TUBA1A;DYNLL2;RPS27;PSMA3;RAN;PSMD7;PSMB3;RPS27A;DYNLL1;PSMC6;PSMC1;TUBB2B;TUBB4B;ITGB3BP;TUBA4A;PSMB6;PSMC3;UBA52;UBC;NUP43;PSMA2;PPP2R1A;PSMA7;TUBB3;BANF1;NUDC;PSMB7;TUBA1B;PSMB1;PSMC5;NDEL1;CHMP2A;PSMB5;CENPP;CHMP4B;PPP2CA;MIS12;PSMD11;PSMA4;BUB3;TUBB4A;PSMF1
gsea,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.49834536275707036,-1.730730756289711,0.0,0.02181017396347475,0.767,8/30,13.30%,UBB;RPS27A;POLD4;UBA52;UBC;PCNA;POLE4;POLE3
gsea,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.3545820770336645,-1.7274141404362227,0.0,0.022244727707925984,0.772,44/201,13.87%,UBB;TUBB2A;TUBA1A;DYNLL2;RPS27;PSMA3;RAN;PSMD7;PSMB3;RPS27A;DYNLL1;PSMC6;PSMC1;TUBB2B;TUBB4B;ITGB3BP;TUBA4A;PSMB6;PSMC3;UBA52;UBC;NUP43;PSMA2;PPP2R1A;PSMA7;TUBB3;BANF1;NUDC;PSMB7;TUBA1B;PSMB1;PSMC5;NDEL1;CHMP2A;PSMB5;CENPP;CHMP4B;PPP2CA;MIS12;PSMD11;PSMA4;BUB3;TUBB4A;PSMF1
gsea,Cytoprotection By HMOX1 R-HSA-9707564,-0.4559594860523184,-1.7264603422693254,0.004056795131845842,0.022320948134001997,0.777,15/49,10.22%,COX6C;COX8A;COX7C;COX4I1;COX19;COX7B;COX5B;CYCS;COX6A1;NFE2L2;COX7A2L;COX6B1;COX14;COX20;HMOX2
gsea,Neddylation R-HSA-8951664,-0.35048843248029316,-1.7264161758155716,0.0,0.022230397790159766,0.777,60/215,20.25%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;FBXL16;PSMC6;PSMC1;NEDD8;COMMD3;ELOB;PSMB6;PSMC3;UBA52;NFE2L2;UBC;FBXL14;PSMA2;PSMA7;ASB14;PSMB7;PSMB1;PSMC5;COPS5;WSB2;LRRC41;OBSL1;PSMB5;SQSTM1;DCAF17;FBXL22;SENP8;FBXW11;PSMD11;COPS6;FBXO9;PSMA4;DDA1;PSMF1;RNF7;COMMD9;COMMD4;FBXL8;UBE2D3;COMMD1;DCAF6;FBXO15;FBXO27;COPS8;SEM1;FBXW2;KBTBD7;ASB13;FBXW4;RBBP5;PSMB4;PSMD2;BTBD1;ANKRD9;KLHL25
gsea,FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.5704718311094066,-1.7226715842671672,0.010040160642570281,0.02284351213713917,0.783,3/17,1.07%,FGFR2;HRAS;FGF1
gsea,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.48288591523271274,-1.7215324107701901,0.0021551724137931034,0.023053373005531917,0.786,23/51,17.96%,ARPC3;ACTG1;WIPF3;NCK1;YES1;ARPC1B;LYN;CDC42;BTK;ARPC2;WASL;ELMO2;ARPC5;ACTR3;ABI2;CD247;ABI1;MYO10;ACTR2;BAIAP2;BRK1;DOCK1;WASF1
gsea,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.4319373615490949,-1.715689067957779,0.0064794816414686825,0.02413586301492422,0.8,27/76,17.96%,HSP90AB1;ARPC3;ACTG1;WIPF3;NCK1;YES1;ARPC1B;LYN;CDC42;AHCYL1;BTK;ARPC2;WASL;ELMO2;ARPC5;HSP90AA1;ACTR3;ABI2;CD247;ABI1;MYO10;ACTR2;BAIAP2;BRK1;PLD3;DOCK1;WASF1
gsea,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.5341215672736046,-1.7084339177371455,0.01639344262295082,0.025753239597327855,0.814,7/23,11.16%,UBB;FGF1;RPS27A;UBA52;UBC;PPP2R1A;PPP2CA
gsea,Interleukin-12 Signaling R-HSA-9020591,-0.480890180892293,-1.7063522045391128,0.008032128514056224,0.02613085052373835,0.817,14/34,22.62%,PPIA;RALA;CDC42;GSTO1;P4HB;TYK2;SOD1;HNRNPA2B1;IL12RB2;HNRNPDL;TCP1;AURKAIP1;CAPZA1;HNRNPF
gsea,Defective B3GALTL Causes PpS R-HSA-5083635,0.47824671925949075,1.704640814866864,0.005474452554744526,0.24606730305955948,0.843,20/35,27.22%,THBS2;ADAMTSL3;ADAMTS19;B3GLCT;ADAMTS20;ADAMTS2;ADAMTS5;ADAMTSL5;THSD4;ADAMTS14;ADAMTS17;ADAMTSL1;ADAMTS10;ADAMTS15;THBS1;SEMA5B;SBSPON;ADAMTSL4;ADAMTS16;ADAMTS8
gsea,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.5244681803406738,-1.7041198486014495,0.018329938900203666,0.02641082701027375,0.822,8/25,10.21%,ATP6V0B;ATP6V1G2;ATP6V0C;ATP6V1F;ATP6V0E2;ATP6V1A;CYBA;NCF1
gsea,Spry Regulation Of FGF Signaling R-HSA-1295596,-0.5915087258691278,-1.7035284357327103,0.016129032258064516,0.026453379209658172,0.823,6/16,11.16%,UBB;RPS27A;UBA52;UBC;PPP2R1A;PPP2CA
gsea,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.5490578246363114,-1.701001860598491,0.015503875968992248,0.02696369197102721,0.83,8/19,18.78%,UBB;RPS27A;UBA52;SH3GL1;UBC;STAM2;RNMT;CBLL1
gsea,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.4572161634640765,-1.6982511000363232,0.002066115702479339,0.027483035040234572,0.834,9/37,13.30%,UBB;RPS27A;POLD4;UBA52;UBC;SPRTN;PCNA;POLE4;POLE3
gsea,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.5687189302039833,-1.6931605593778656,0.011834319526627219,0.028661178332348287,0.84,10/17,21.42%,UBB;RPS27A;UBA52;UBC;TRAF6;UBE2V1;UBE2D3;TLR3;IKBKG;UBE2N
gsea,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.4269226513726244,-1.6919217515313283,0.002145922746781116,0.028891759788833953,0.844,19/55,21.20%,UBB;HMGB1;HSP90AB1;RPS27A;UBA52;UBC;TRAF6;HSP90AA1;S100B;UBE2K;CASP8;UBE2D3;NKIRAS2;NFKB2;FADD;RELA;ATG12;IKBKG;MAVS
gsea,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.5538646680860677,-1.6917516303707463,0.012096774193548387,0.028824488400303695,0.845,11/19,28.80%,VAMP2;SEC61G;PRNP;SERP1;BAG6;SEC61B;EMD;UBE2J2;GET1;VAPA;UBL4A
gsea,Post-translational Protein Phosphorylation R-HSA-8957275,-0.3986430258321196,-1.690098937889897,0.004310344827586207,0.029137629687957814,0.849,28/76,25.70%,CST3;SCG2;GOLM1;APOE;VGF;CHGB;APOA1;PPP3CA;LGALS1;FAM20A;P4HB;TMEM132A;NOTUM;SPARCL1;LAMB1;SHISA5;IGFBP4;DNAJC3;PENK;APLP2;SERPINA10;MFGE8;LTBP1;FSTL1;IGFBP5;EVA1A;SERPINC1;RCN1
gsea,DNA Damage Bypass R-HSA-73893,-0.4371873437186018,-1.689101698412445,0.0,0.029272091526159977,0.853,11/46,13.30%,UBB;RPS27A;POLD4;USP1;UBA52;UBC;SPRTN;PCNA;UBE2B;POLE4;POLE3
gsea,Cyclin D Associated Events In G1 R-HSA-69231,-0.4480129982513389,-1.6867612653346127,0.004166666666666667,0.029756212067668004,0.863,10/40,14.04%,UBB;RPS27A;LYN;UBA52;UBC;PPP2R1A;RBL1;CCND3;PPP2CA;CDKN2D
gsea,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.3674995583913889,-1.685811940414074,0.0,0.02983529896215932,0.864,46/128,23.12%,CALM1;UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;CLTB;CLTA;PSMC1;PARD6A;PSMB6;PSMC3;UBA52;UBC;GNG7;PPP3R1;PSMA2;PSMA7;PPP3CA;PFN1;PSMB7;PSMB1;PSMC5;RHOA;PSMB5;AP2M1;PLCB1;PSMD11;PSMA4;VANGL2;PSMF1;FZD1;PRKG1;SEM1;PSMB4;FZD9;PSMD2;AP2B1;GNG3;MYC;FZD2;GNB2;AP2S1;PSMC2;NFATC1
gsea,FOXO-mediated Transcription R-HSA-9614085,-0.41815317333096436,-1.6846285535708103,0.008948545861297539,0.029952399444357135,0.864,23/57,24.80%,YWHAG;BTG1;YWHAB;NPY;SIRT3;AKT3;AGRP;TXN2;NFYA;YWHAZ;AKT1;SMAD2;POMC;GADD45A;STK11;FOXO4;FOXO1;CDKN1B;SIN3A;CITED2;BBC3;FOXG1;DDIT3
gsea,MyD88-independent TLR4 Cascade R-HSA-166166,-0.3882312605119533,-1.68432621742948,0.0021231422505307855,0.029888884768660036,0.864,30/93,21.90%,UBB;HMGB1;JUN;RPS27A;VRK3;UBA52;UBC;PPP2R1A;TRAF6;LRRC14;S100B;UBE2V1;PPP2CA;TIFA;FBXW11;CASP8;UBE2D3;NDUFA2;NKIRAS2;NFKB2;FADD;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;UBE2N;LY96
gsea,L1CAM Interactions R-HSA-373760,0.3909638534907255,1.6843110483865262,0.0,0.2572101538524224,0.879,17/89,4.15%,SPTBN4;SCN8A;SPTAN1;ANK3;SCN1A;CLTC;NFASC;DNM2;SCN2A;DNM1;L1CAM;RPS6KA2;ANK1;CNTN2;EPHB2;MPP3;CNTNAP1
gsea,Inflammasomes R-HSA-622312,-0.5633905231449732,-1.6839957036558086,0.010822510822510822,0.029800319092055157,0.864,9/17,25.92%,HSP90AB1;AIM2;TXN2;NLRC4;BCL2;NFKB2;RELA;PYCARD;PSTPIP1
gsea,Metabolism Of Steroid Hormones R-HSA-196071,-0.5491224571298658,-1.6820664115446693,0.02510460251046025,0.030056182245314735,0.866,8/18,15.43%,CHGA;STARD4;FDX1;HSD17B12;FDXR;HSD11B1;POMC;FDX2
gsea,Protein Methylation R-HSA-8876725,-0.5695008758295661,-1.6813887512106516,0.01968503937007874,0.030069090745440424,0.867,4/17,6.13%,CALM1;EEF1A1;HSPA8;RPS2
gsea,Biological Oxidations R-HSA-211859,-0.37190863079607084,-1.6813067548248288,0.0023923444976076554,0.029987180090537396,0.867,31/106,19.66%,HSP90AB1;CYP7B1;PRNP;HPGDS;TRMT112;PTGS1;PAPSS2;FDX1;GSTO1;AKR1A1;GSTM5;ACY1;CNDP2;TPMT;ESD;PTGES3;VDAC2;SULT4A1;PODXL2;CHAC2;SLC38A3;FDXR;PTGIS;POMC;FDX2;BPNT1;GSTT2;CYB5B;AURKAIP1;NQO2;GGCT
gsea,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.5412517386312811,-1.679512825977116,0.01867219917012448,0.030396489808856484,0.871,4/20,5.23%,UBB;RPS27A;UBA52;UBC
gsea,Toll-like Receptor Cascades R-HSA-168898,-0.3628400116766334,-1.6773636345745333,0.002136752136752137,0.030808828380762498,0.871,43/131,21.98%,UBB;HMGB1;JUN;RPS27A;GSDME;VRK3;CTSB;PELI2;UBA52;UBC;BTK;PPP2R1A;TRAF6;LRRC14;SOCS1;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;UBE2D3;TLR3;NDUFA2;NKIRAS2;NFKB2;FADD;RELA;FOS;MAP2K1;CNPY3;CTSL;DUSP6;CTSS;DUSP4;MAPK3;GSDMD;IKBKG;ECSIT;UBE2N;LY96;ITGAM
gsea,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.4309998540986518,-1.6769282827293555,0.008385744234800839,0.0307811313828538,0.871,13/52,14.79%,PIGK;NRN1;DPM1;LY6H;DPM2;DPM3;THY1;NEGR1;LY6E;RTN4RL2;PIGP;SPRN;PIGW
gsea,Signaling By EGFR R-HSA-177929,-0.42849959731841547,-1.6768796764508713,0.0019083969465648854,0.03067906717422454,0.871,9/46,10.19%,UBB;HRAS;RPS27A;CDC42;UBA52;SH3GL1;UBC;TGFA;STAM2
gsea,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.5145143439639264,-1.676388062075241,0.012711864406779662,0.030645902347441727,0.872,6/26,6.87%,CALM1;LYN;AHCYL1;BTK;PPP3R1;PPP3CA
gsea,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.5418022276488307,-1.6722825058841109,0.017130620985010708,0.03146404182433032,0.875,7/19,15.43%,CYP7B1;PRNP;FDX1;ACY1;TPMT;FDXR;FDX2
gsea,Hedgehog On State R-HSA-5632684,-0.39356028240838214,-1.6716699803745223,0.007766990291262136,0.03147723633923937,0.876,20/77,13.87%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;PSMD11;PSMA4;PSMF1
gsea,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.556739131105694,-1.6643324301994664,0.015414258188824663,0.03318539719833483,0.884,5/15,10.32%,UBB;RPS27A;UBA52;UBC;MVB12B
gsea,PTEN Regulation R-HSA-6807070,-0.3579769486864342,-1.6640355042020738,0.0,0.03314310286879441,0.884,41/128,19.98%,UBB;LAMTOR2;PSMA3;JUN;PSMD7;PSMB3;RPS27A;MLST8;PSMC6;LAMTOR3;PSMC1;CHD3;CNOT6L;PSMB6;RRAGA;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;LAMTOR1;RHEB;PSMB1;PSMC5;AKT3;PSMB5;PSMD11;AKT1;PSMA4;CBX4;CSNK2B;PSMF1;MAF1;SEM1;RRAGD;PSMB4;STUB1;PREX2;PSMD2;MAPK3
gsea,Interleukin Receptor SHC Signaling R-HSA-912526,0.5443131913098174,1.6636853005952579,0.028225806451612902,0.2757957417350342,0.906,8/19,17.06%,SHC1;PIK3R2;GRB2;JAK3;CLSTN1;JAK2;PIK3CA;PTPN6
gsea,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.5039191024142646,-1.6612518396987883,0.010101010101010102,0.03379946876524658,0.892,7/24,20.62%,UBB;RPS27A;UBA52;UBC;JAG1;PSENEN;EGFR
gsea,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.46481685249152577,-1.6587596400748963,0.012096774193548387,0.03437823250703285,0.896,7/33,9.68%,UBB;RPS27A;UBA52;UBC;TRAF6;OTUB1;RHOA
gsea,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.3776742284664611,-1.6587422220093246,0.00641025641025641,0.03425354310356173,0.896,31/93,21.90%,UBB;HMGB1;JUN;RPS27A;VRK3;PELI2;UBA52;UBC;PPP2R1A;TRAF6;LRRC14;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;NDUFA2;NKIRAS2;NFKB2;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;ECSIT;UBE2N;LY96
gsea,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.4867829872642764,-1.6569477657019673,0.008146639511201629,0.03462808736872607,0.901,16/26,33.71%,FGFR2;FGF1;POLR2K;FGF10;POLR2G;POLR2F;POLR2E;FGF7;FGF13;GTF2F2;NCBP2;FGF18;POLR2J;FGF9;POLR2L;POLR2H
gsea,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.5362097285950903,-1.6511060430559392,0.011904761904761904,0.03597467983280706,0.904,12/20,24.30%,UBB;RPS27A;UBA52;UBC;TRAF6;UBE2V1;UBE2D3;NDUFA2;IKBKG;UBE2N;LY96;TLR4
gsea,PIP3 Activates AKT Signaling R-HSA-1257604,-0.32834796998911386,-1.6489766494601819,0.0020242914979757085,0.03646506275217126,0.909,70/233,22.47%,FGFR2;UBB;FGF1;GSK3B;LAMTOR2;PSMA3;JUN;PSMD7;PSMB3;RPS27A;MLST8;PSMC6;LAMTOR3;PSMC1;CHD3;CNOT6L;NRG3;PSMB6;RRAGA;PSMC3;UBA52;UBC;PSMA2;PPP2R1A;PSMA7;TRAF6;PIP4K2A;PSMB7;LAMTOR1;RHEB;PSMB1;PSMC5;AKT3;IRS2;PDGFRA;RPS6KB2;FGF10;TGFA;PSMB5;IL1RAP;PPP2CA;PSMD11;AKT1;PSMA4;FGFR3;IER3;NR4A1;CBX4;CSNK2B;PSMF1;NRG4;MAF1;SEM1;RNMT;RRAGD;PSMB4;STUB1;PREX2;PSMD2;MAPK3;EGFR;FOXO4;FGF7;MKRN1;FOXO1;CDKN1B;FGF13;PPP2R5B;THEM4;PSMC2
gsea,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.48462120745004655,-1.6485812523257164,0.014462809917355372,0.03638784976037026,0.909,14/29,30.26%,PPIA;RALA;CDC42;GSTO1;SOD1;HNRNPA2B1;HNRNPDL;TCP1;AURKAIP1;CAPZA1;HNRNPF;MSN;CNN2;TALDO1
gsea,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.3490022456859603,-1.6477867122512528,0.0,0.03648271545667888,0.91,29/132,14.31%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;APOA1;PSMB6;PSMC3;UBA52;UBC;SLC24A5;NUP43;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;BSG;SLC35A1;PSMB5;SLC16A1;PSMD11;NUP50;PSMA4;SLC12A6;PSMF1;SLC3A2
gsea,SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.5645761495534061,-1.6464116123715535,0.03501945525291829,0.03680665968450597,0.911,3/15,1.07%,FGFR2;HRAS;FGF1
gsea,Long-term Potentiation R-HSA-9620244,-0.5239395259663997,-1.6459475629822,0.02495201535508637,0.036805350374804084,0.911,3/23,1.62%,NRGN;CALM1;NEFL
gsea,RORA Activates Gene Expression R-HSA-1368082,0.5489639237282687,1.6393572538930314,0.021032504780114723,0.3046796546978977,0.937,7/17,9.45%,EP300;CREBBP;NCOA6;NCOA1;CARM1;RORA;RXRA
gsea,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.5633936768264123,-1.6387318219582476,0.027777777777777776,0.03885684300591086,0.918,9/15,23.74%,H2AZ1;H2AJ;H2BC4;ORC4;KPNA1;H2AZ2;H2BC21;H2AX;ORC5
gsea,Signaling By ERBB4 R-HSA-1236394,-0.40726797811438936,-1.6347060760426795,0.009416195856873822,0.039885195782433956,0.923,20/54,22.03%,UBB;HRAS;APOE;RPS27A;NRG3;UBA52;UBC;S100B;GABRB3;GFAP;GABRG2;CXCL12;NRG4;SPARC;YAP1;PSENEN;GABRB2;STMN1;EGFR;MXD4
gsea,RAS Processing R-HSA-9648002,-0.537317509480052,-1.633228509971353,0.01768172888015717,0.040267402628893396,0.925,4/17,9.24%,CALM1;HRAS;ABHD17A;GOLGA7
gsea,RNA Polymerase I Promoter Escape R-HSA-73772,-0.4424616702717108,-1.6324742834143242,0.023060796645702306,0.040398091418270624,0.926,15/37,21.19%,H2AZ1;POLR2K;H2AJ;CBX3;H2BC4;ERCC3;GTF2H5;POLR1D;POLR2F;POLR1H;H2AZ2;H2BC21;H2AX;POLR2E;POLR1G
gsea,Leishmania Infection R-HSA-9658195,-0.35138300088049,-1.6321786785968944,0.0,0.040337639416429476,0.927,51/167,22.07%,CALM1;GLP2R;HSP90AB1;ARPC3;JUN;ACTG1;WIPF3;NCK1;CHGA;YES1;ARPC1B;LYN;RAMP1;PTRH2;CDC42;PTGER4;GNG7;AHCYL1;BTK;ARPC2;WASL;HTR4;ELMO2;ARPC5;TXN2;CYBA;ACTR3;ABI2;GNAS;CD247;ABI1;MYO10;POMC;ACTR2;BAIAP2;NFKB2;RELA;BRK1;ENTPD1;CALCB;PTHLH;DOCK1;WASF1;GNG3;MAPK3;GSDMD;CALCA;NOXO1;PYCARD;GNB2;IL18
gsea,Neutrophil Degranulation R-HSA-6798695,-0.32329512354487966,-1.6321325761376575,0.00437636761487965,0.04019723101055158,0.927,101/324,21.98%,FTH1;CST3;EEF1A1;TTR;HMGB1;ATP6V0C;ACTR1B;PPIA;HSP90AB1;RAB3A;NME2;PRDX5;LAMTOR2;PSMD7;DYNLL1;XRCC6;SYNGR1;LAMTOR3;PDAP1;ARL8A;CTSB;TUBB4B;HSPA8;COMMD3;RAB5B;PSMC3;FUCA1;RAB6A;PSMA2;CTSZ;NDUFC2;ALDOC;PKM;PSMB7;LAMTOR1;PSMB1;CREG1;PGRMC1;ATP6AP2;ARPC5;PGLYRP1;RAB18;CAP1;GOLGA7;SLC2A5;EGFL7;HSP90AA1;RHOA;CYBA;HMOX2;CTSC;B2M;BIN2;CCT8;PRCP;PSMD11;RAB14;GM2A;CCT2;ORMDL3;VAT1;CSNK2B;CD63;COMMD9;ERP44;DOCK2;APRT;TYROBP;HEBP2;DEGS1;CYSTM1;EEF2;PRDX4;NDUFA2;ACTR2;TMBIM1;ACTR10;PFKL;DNAJC3;AGA;ATP6V1D;GRN;TMC6;S100A11;PSMD2;SDCBP;RAP2B;GNS;CTSS;GSDMD;PRTN3;COTL1;MLEC;PTPRC;CRACR2A;IDH1;ITGAV;PDXK;PYCARD;ITM2C;ITGAM
gsea,mTORC1-mediated Signaling R-HSA-166208,-0.5047780733168076,-1.6303118124879956,0.004201680672268907,0.04065289637290946,0.928,8/24,7.33%,FKBP1A;LAMTOR2;MLST8;YWHAB;LAMTOR3;RRAGA;LAMTOR1;RHEB
gsea,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.47584315232881563,-1.628221244892538,0.02053388090349076,0.04107107667379432,0.931,10/31,17.19%,DDX5;ISCU;MAP1LC3B;CHMP2A;ZCRB1;CHMP4B;GPC4;SDC4;CTSL;CHMP4C
gsea,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.49510392043333135,-1.6262887355045164,0.023622047244094488,0.041565789271869345,0.933,3/22,1.07%,FGFR2;HRAS;FGF1
gsea,Phase II - Conjugation Of Compounds R-HSA-156580,-0.40135632012535954,-1.625008771879767,0.006550218340611353,0.04178526774096435,0.934,16/57,16.64%,PRNP;HPGDS;TRMT112;PAPSS2;GSTO1;AKR1A1;GSTM5;CNDP2;TPMT;ESD;SULT4A1;PODXL2;CHAC2;SLC38A3;BPNT1;GSTT2
gsea,Transcriptional Regulation By VENTX R-HSA-8853884,0.45299465570670605,1.6246976466068048,0.02066115702479339,0.3126896384282023,0.948,11/34,12.56%,EHMT1;TNRC6B;TNRC6A;ANAPC1;MOV10;AGO4;ANAPC5;CDC23;TNRC6C;ANAPC11;CDC27
gsea,Separation Of Sister Chromatids R-HSA-2467813,-0.34194657151942176,-1.6236799613158968,0.0020408163265306124,0.042087788323845,0.935,32/151,13.87%,UBB;DYNLL2;RPS27;PSMA3;PSMD7;PSMB3;RPS27A;DYNLL1;PSMC6;PSMC1;ITGB3BP;PSMB6;PSMC3;UBA52;UBC;NUP43;PSMA2;PPP2R1A;PSMA7;NUDC;PSMB7;PSMB1;PSMC5;NDEL1;PSMB5;CENPP;PPP2CA;MIS12;PSMD11;PSMA4;BUB3;PSMF1
gsea,Protein-protein Interactions At Synapses R-HSA-6794362,0.39439703021938366,1.619067080625782,0.01364522417153996,0.30065505041057566,0.953,29/85,12.68%,PTPRS;DLGAP1;EPB41L1;GRIA4;PPFIA3;DLGAP4;SHANK1;DLGAP2;MPP3;STXBP1;LRFN2;DLGAP3;SLITRK1;PPFIA1;EPB41;SYT2;APBA1;LRFN1;RTN3;PTPRF;MPP2;EPB41L2;PTPRD;STX1A;SHANK3;NLGN2;IL1RAPL2;GRIN2D;EPB41L3
gsea,FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.5529752408029004,-1.6169270231487198,0.022573363431151242,0.04418665346330699,0.938,8/16,27.62%,BTG1;SMAD2;GADD45A;FOXO4;FOXO1;CDKN1B;FOXG1;FOXO3
gsea,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.47854064904362664,-1.6147236913292913,0.02574257425742574,0.04470816792700474,0.939,11/27,20.62%,UBB;RPS27A;NRG3;UBA52;UBC;AKT3;HSP90AA1;AKT1;NRG4;STUB1;EGFR
gsea,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.5098358725261259,-1.6146580498049712,0.01782178217821782,0.04456190620468521,0.939,10/21,29.28%,UBB;RPS27A;UBA52;UBC;RNF139;EDEM1;RNF185;RNF5;DERL2;TRIM13
gsea,Hedgehog Off State R-HSA-5610787,-0.3697221781868788,-1.6136741332716316,0.007984031936127744,0.04473921587992428,0.939,22/90,13.87%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;PSMB5;GNAS;PSMD11;PSMA4;PSMF1
gsea,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.5506218536096594,-1.613448513785774,0.01910828025477707,0.04465482684581159,0.939,6/16,7.43%,UBB;RPS27A;UBA52;UBC;TRAF6;LRRC14
gsea,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.45256641573603,1.6124872524963156,0.018218623481781375,0.2916049840371932,0.958,13/31,11.19%,TNRC6B;TNRC6A;KDM3A;EP300;MOV10;AGO4;ABCA1;NCOR1;NCOA1;HDAC3;ABCG1;RXRA;TNRC6C
gsea,M Phase R-HSA-68886,-0.313107736538382,-1.6108859663862474,0.0,0.04544355991044739,0.941,81/317,20.19%,UBB;YWHAG;TUBB2A;TUBA1A;DYNLL2;RPS27;NME7;YWHAE;PSMA3;RAN;SET;PSMD7;PSMB3;RPS27A;DYNLL1;PSMC6;H2AZ1;PSMC1;TUBB2B;TUBB4B;ITGB3BP;TUBA4A;PSMB6;PSMC3;UBA52;UBC;CEP72;H2AJ;NUP43;PSMA2;PPP2R1A;RAB2A;PSMA7;H2BC4;TUBB3;BANF1;NUDC;PSMB7;NCAPH;TUBA1B;PSMB1;PSMC5;DCTN1;CEP78;NDEL1;CHMP2A;HSP90AA1;PSMB5;CENPP;CHMP4B;TUBG2;PPP2CA;MIS12;NCAPD2;PSMD11;SSNA1;NUP50;PSMA4;BUB3;ARPP19;TUBB4A;CSNK2B;PSMF1;NEK7;GORASP2;HAUS5;SUMO1;HAUS2;CETN2;H2AZ2;CHMP4C;SEM1;TUBB6;H2BC21;PSMB4;KNTC1;PSMD2;EMD;MAPK3;H2AX;DCTN3
gsea,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.516576232143541,-1.60973849084151,0.033268101761252444,0.04572602515912786,0.942,6/21,16.01%,IDH3B;MDH2;SUCLG1;LDLR;IDH3G;SDHB
gsea,G-protein Beta:Gamma Signaling R-HSA-397795,-0.46332876078638174,-1.6085461629379958,0.028017241379310345,0.04601750393130627,0.943,12/28,26.46%,CDC42;GNG7;BTK;AKT3;RHOA;PLCB1;AKT1;PIK3CG;GNG3;GNB2;PLCB2;GNG10
gsea,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.4124920990061066,-1.6085394237170794,0.008695652173913044,0.045864288122557384,0.943,13/50,11.16%,UBB;APOE;RPS27A;CLTA;PLTP;APOA1;UBA52;UBC;SAR1B;NCEH1;LDLR;P4HB;AP2M1
gsea,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.4695745764880317,-1.606288617925598,0.014141414141414142,0.046490968894489365,0.947,10/27,15.80%,UBB;RPS27A;UBE2A;UBA52;UBC;OTULIN;UBE2B;UBE2R2;UBE2K;UBE2E3
gsea,Interleukin-12 Family Signaling R-HSA-447115,-0.43170258739013845,-1.5941671792531709,0.018947368421052633,0.0510865114299814,0.952,15/42,20.04%,PPIA;RALA;CANX;CDC42;GSTO1;P4HB;TYK2;SOD1;HNRNPA2B1;IL12RB2;HNRNPDL;TCP1;AURKAIP1;CAPZA1;CRLF1
gsea,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.3517719924700427,-1.5922324100631138,0.004415011037527594,0.05171272835455923,0.955,36/115,21.98%,UBB;HMGB1;JUN;RPS27A;VRK3;PELI2;UBA52;UBC;BTK;PPP2R1A;TRAF6;LRRC14;SOCS1;S100B;UBE2V1;PPP2CA;TIFA;PELI3;FBXW11;CASP8;UBE2D3;NDUFA2;NKIRAS2;NFKB2;FADD;RELA;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;ECSIT;UBE2N;LY96;ITGAM
gsea,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.36777996926575324,-1.5904735298096873,0.004366812227074236,0.052237649418785025,0.957,29/84,25.70%,CST3;SCG2;GOLM1;APOE;VGF;CHGB;APOA1;PPP3CA;LGALS1;FAM20A;P4HB;TMEM132A;NOTUM;SPARCL1;LAMB1;SHISA5;IGFBP4;PAPPA;DNAJC3;PENK;APLP2;SERPINA10;MFGE8;LTBP1;FSTL1;IGFBP5;EVA1A;SERPINC1;RCN1
gsea,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.4164924045589574,1.5888137922901489,0.018108651911468814,0.3237962593771555,0.973,23/50,21.63%,PLEKHA6;INPP5K;SYNJ1;PIK3R2;PLEKHA1;PIK3C2B;OCRL;PI4K2B;CLSTN1;INPP5J;MTM1;MTMR2;SYNJ2;PIK3CA;INPP4A;SBF2;PIK3C2G;MTMR14;PIP5K1C;PIP5K1A;PLEKHA3;PLEKHA8;PLEKHA5
gsea,Cytokine Signaling In Immune System R-HSA-1280215,-0.30202907486269903,-1.5859393078996582,0.0,0.05380129767057973,0.962,131/477,22.65%,UBB;HMGB1;PPIA;HRAS;VAMP2;RALA;PSMA3;JUN;TRIM35;PSMD7;PSMB3;RPS27A;PSMC6;VRK3;FSCN1;NDN;PSMC1;YES1;CEBPD;LYN;HSPA8;CANX;CDC42;KPNA4;ELOB;TGFB1;EIF4G2;IFNGR2;PSMB6;PELI2;PSMC3;UBA52;UBC;NUP43;POU2F1;PSMA2;PPP2R1A;PSMA7;TRAF6;PTK2B;PSMB7;TNFRSF1A;GSTO1;LRRC14;KPNA3;PSMB1;PSMC5;AKT3;IRS2;SOCS1;TNFRSF9;P4HB;HSP90AA1;PSMB5;IL1RAP;SQSTM1;S100B;B2M;UBE2V1;PPP2CA;YWHAZ;TIFA;PELI3;CSF1R;FBXW11;PSMD11;NUP50;MCL1;AKT1;PSMA4;TYK2;SMAD7;IL16;CD27;PSMF1;RNF7;KPNA1;SOD1;CASP8;UBE2D3;IL1R2;HNRNPA2B1;POMC;NKIRAS2;BCL2;NFKB2;SUMO1;RELA;FOS;MAP2K1;IL12RB2;SEM1;HNRNPDL;TCP1;DUSP6;SLA2;PSMB4;PDE12;IL21R;AURKAIP1;PSMD2;CAMK2B;IFI30;IL17RB;DUSP4;PIAS1;CAPZA1;MAPK3;GSDMD;PRTN3;CRLF1;SH2B3;LAMA5;MYC;IKBKG;IRF1;INPPL1;CRLF2;TNFRSF12A;FOXO1;CDKN1B;IFI35;UBE2N;IFI27;ITGAM;FGF13;IL18;PTPN1;PSMC2;HNRNPF;CNTFR
gsea,Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.4664231224566878,-1.5850871555314583,0.017241379310344827,0.053988994091270316,0.962,5/26,5.23%,UBB;RPS27A;LCT;UBA52;UBC
gsea,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.3692956013884678,-1.5848550400609165,0.008403361344537815,0.0539299508319226,0.963,21/81,16.73%,UBB;YWHAG;TUBA1A;YWHAE;RPS27A;DYNLL1;TUBB4B;TUBA4A;UBA52;UBC;CEP72;PPP2R1A;DCTN1;CEP78;HSP90AA1;FBXW11;SSNA1;TUBB4A;HAUS5;HAUS2;CETN2
gsea,Signaling By Insulin Receptor R-HSA-74752,-0.40130336169559006,-1.5839869265968571,0.016194331983805668,0.054020222436851194,0.963,12/59,9.85%,FGFR2;ATP6V0B;ATP6V1G2;ATP6V0C;HRAS;FGF1;ATP6V1F;ATP6V0E2;ATP6V1A;PDE3B;IRS2;FGF10
gsea,Effects Of PIP2 Hydrolysis R-HSA-114508,0.4915045358431228,1.5823537658161722,0.03359683794466403,0.318159475342311,0.976,6/27,8.05%,DGKG;TRPC3;DGKQ;DGKA;PRKCE;DGKZ
gsea,S Phase R-HSA-69242,-0.3365168212998812,-1.5817468753072266,0.002173913043478261,0.05462936212677951,0.964,44/148,23.93%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;POLD4;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;AKT3;PCNA;PSMB5;POLE4;PSMD11;AKT1;PSMA4;LIN37;POLE3;PSMF1;POLA2;ORC4;SEM1;GINS4;PSMB4;MCM6;PSMD2;CCNE2;GINS2;MYC;CDKN1B;PSMC2;E2F4;ANAPC16;ORC5;GINS1
gsea,Signaling By ALK R-HSA-201556,0.47727929713220446,1.580548808850723,0.017374517374517374,0.30206849738763886,0.976,12/25,22.57%,EP300;SHC1;PIK3R2;HDAC3;JAK3;ALK;PIK3CA;CD274;PTPN6;PTPRZ1;SRC;PLCG1
gsea,Glycogen Metabolism R-HSA-8982491,-0.5026034572878297,-1.5751820328695705,0.02594810379241517,0.05712577802910382,0.969,5/21,5.23%,CALM1;UBB;RPS27A;UBA52;UBC
gsea,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.3942017907951476,-1.5712004398390658,0.016597510373443983,0.05857356591463679,0.971,21/54,20.37%,UBB;RPS27A;XRCC6;POLR2K;UBA52;POLR3H;UBC;AIM2;POLR3E;POLR1D;POLR2F;POLR3A;TLR3;NKIRAS2;NFKB2;TRIM32;RELA;POLR3K;CGAS;POLR2E;IKBKG
gsea,Cellular Response To Heat Stress R-HSA-3371556,-0.37107110770403195,-1.570503482498785,0.002044989775051125,0.058668257970141864,0.972,17/88,10.71%,UBB;EEF1A1;HSP90AB1;HSPA2;GSK3B;YWHAE;MLST8;HSBP1;HSPA8;HSPH1;BAG4;CRYAB;NUP43;HSPA5;PTGES3;HSP90AA1;MRPL18
gsea,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.4445570066374358,-1.5700376821596962,0.016227180527383367,0.058683863639432524,0.972,13/32,21.89%,CCT5;GNG7;CCT3;CCT7;CCT8;CCT6A;CCT2;CSNK2B;CCT4;TCP1;GNG3;GNA15;GNB2
gsea,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.3935190246126019,-1.56746625928924,0.006060606060606061,0.05965344640670761,0.974,22/59,25.60%,RPS7;NOP10;TRMT112;RPS2;SNU13;WDR46;RRP9;PDCD11;RPS6;UTP3;THUMPD1;TSR3;RRP7A;RPS9;RPS14;TBL3;UTP11;SPPL2A;NHP2;FCF1;MPHOSPH10;RCL1
gsea,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.4158507616379536,-1.5670134635975639,0.007827788649706457,0.059634540875539495,0.974,16/44,22.37%,UBB;HRAS;RPS27A;NRG3;UBA52;UBC;ELMO2;RHOA;GPNMB;AKT1;NRG4;BCAR1;DOCK1;EGFR;CDKN1B;PTPN1
gsea,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.32322930655124726,-1.5667906822946387,0.002070393374741201,0.05955878468334818,0.974,64/227,22.78%,CALM1;FGFR2;UBB;HRAS;FGF1;NEFL;LAMTOR2;PSMA3;PSMD7;PSMB3;RPS27A;YWHAB;PSMC6;LAMTOR3;PSMC1;PEBP1;TEK;NRG3;ABHD17A;PSMB6;PSMC3;UBA52;UBC;CNKSR2;PSMA2;PPP2R1A;PSMA7;RASAL2;GFRA4;PSMB7;PSMB1;PSMC5;IRS2;PDGFRA;GOLGA7;FGF10;TGFA;PSMB5;PPP2CA;PSMD11;PSMA4;FGFR3;TYK2;PSMF1;NRG4;MAP2K1;SEM1;RNMT;DUSP6;KBTBD7;PSMB4;SPRED1;PSMD2;CAMK2B;DUSP4;MAPK3;EGFR;FGF7;IL17RD;FGF13;RASGRP4;PPP2R5B;PSMC2;DUSP12
gsea,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.4486081837694774,-1.565700731265571,0.03162055335968379,0.05978811564632974,0.974,6/28,12.18%,SLC25A4;SLC25A5;ARL2BP;SLC35A1;SLCO1C1;PDZD11
gsea,VLDLR Internalisation And Degradation R-HSA-8866427,-0.5522638058169534,-1.5652877975503166,0.03048780487804878,0.059763811179966,0.974,6/16,11.16%,UBB;RPS27A;CLTA;UBA52;UBC;AP2M1
gsea,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.4276330117818394,1.5648285625442235,0.017786561264822136,0.319430264822618,0.982,13/36,11.19%,TNRC6B;TNRC6A;KDM3A;EP300;MOV10;AGO4;ABCA1;NCOR1;NCOA1;HDAC3;ABCG1;RXRA;TNRC6C
gsea,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.3793246620189811,-1.5645271993395446,0.011061946902654867,0.05988328131544169,0.975,26/65,28.44%,FSCN1;NDN;CEBPD;HSPA8;TGFB1;POU2F1;SOCS1;HSP90AA1;MCL1;AKT1;TYK2;POMC;BCL2;FOS;LAMA5;MYC;FOXO1;ITGAM;FGF13;IL18;ITGB1;VIM;IL4;ALOX5;FOXO3;RHOU
gsea,RAF/MAP Kinase Cascade R-HSA-5673001,-0.32296309664939465,-1.5638560047835486,0.004132231404958678,0.059930403670953564,0.975,38/224,9.89%,CALM1;FGFR2;UBB;HRAS;FGF1;NEFL;LAMTOR2;PSMA3;PSMD7;PSMB3;RPS27A;YWHAB;PSMC6;LAMTOR3;PSMC1;PEBP1;TEK;NRG3;ABHD17A;PSMB6;PSMC3;UBA52;UBC;CNKSR2;PSMA2;PPP2R1A;PSMA7;RASAL2;GFRA4;PSMB7;PSMB1;PSMC5;IRS2;PDGFRA;GOLGA7;FGF10;TGFA;PSMB5
gsea,Signaling By FGFR R-HSA-190236,-0.3676229376183688,-1.5638195960126564,0.009823182711198428,0.059752990019864935,0.975,23/72,23.43%,FGFR2;UBB;HRAS;FGF1;RPS27A;FLRT2;POLR2K;UBA52;UBC;PPP2R1A;FGF10;POLR2G;PPP2CA;FGFR3;POLR2F;SPRED1;MAPK3;POLR2E;FGF7;FGF13;HNRNPF;GTF2F2;FGFBP3
gsea,RHO GTPase Effectors R-HSA-195258,-0.3242731482249182,-1.5625755711358575,0.006396588486140725,0.06007454088136269,0.975,52/219,18.13%,CALM1;YWHAG;DYNLL2;RPS27;ARPC3;YWHAE;ACTG1;MYL6;YWHAB;DYNLL1;H2AZ1;WIPF3;NCK1;ARPC1B;ITGB3BP;RHOB;CDC42;CTNNA1;PFN2;YWHAH;BTK;H2AJ;NUP43;PPP2R1A;ARPC2;H2BC4;NUDC;PFN1;WASL;ARPC5;NDEL1;RHOA;CYBA;CENPP;NCF1;LIN7B;ACTR3;ABI2;PPP2CA;YWHAZ;MIS12;BUB3;MYL9;DIAPH2;ABI1;ACTR2;BAIAP2;BRK1;H2AZ2;H2BC21;WASF1;CDC25C
gsea,Peroxisomal Protein Import R-HSA-9033241,-0.3913939896721774,-1.560607075067012,0.017167381974248927,0.06080419196395168,0.976,22/54,24.48%,UBB;RPS27A;SYCP2;UBA52;UBC;NUDT19;TYSND1;CROT;GNPAT;AGPS;UBE2D3;ZFAND6;PIPOX;ACOT2;PEX7;PEX26;PEX10;ACOX1;IDH1;AMACR;PECR;ACOX2
gsea,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.46943722669957855,-1.5577180091280043,0.0205761316872428,0.061867379025016954,0.977,9/26,13.98%,UBB;RPS27A;TGFB1;UBA52;UBC;PPP1CA;SMAD7;SMAD2;SRFBP1
gsea,PKMTs Methylate Histone Lysines R-HSA-3214841,0.4162467346694278,1.556223274137433,0.030828516377649325,0.3212492208395404,0.985,19/43,23.06%,EHMT1;KMT2D;SETD2;KMT2C;ASH1L;SMYD3;NSD1;NSD3;KMT2E;NSD2;RBBP4;SETD1B;KMT2A;DOT1L;EED;SETD1A;RBBP7;NFKB1;KMT2B
gsea,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.4208058844452277,-1.5544523893675126,0.022916666666666665,0.0632357680807297,0.98,16/43,21.42%,UBB;RPS27A;UBE2A;RRAGA;UBA52;UBC;H2BC4;SELENOS;PCNA;UBE2B;TMEM129;UBE2D3;SKIC8;PEX10;UBE2J2;UBE2N
gsea,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.5416750791684913,1.5535871512749162,0.04259259259259259,0.31026139987934176,0.986,6/19,13.19%,GUCY1A2;PDE2A;PDE9A;PDE10A;PDE11A;KCNMA1
gsea,Signaling By FGFR2 In Disease R-HSA-5655253,-0.429507676428471,-1.5525595627864295,0.01293103448275862,0.06400867502497196,0.98,15/35,29.56%,FGFR2;HRAS;FGF1;POLR2K;FGF10;POLR2G;POLR2F;POLR2E;FGF7;FGF13;GTF2F2;NCBP2;FGF18;POLR2J;FGF9
gsea,Dual Incision In GG-NER R-HSA-5696400,-0.41570091082920935,-1.5522858901188081,0.009237875288683603,0.0639317485575533,0.98,10/41,13.30%,UBB;RPS27A;POLD4;UBA52;UBC;ERCC3;PCNA;GTF2H5;POLE4;POLE3
gsea,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.37512810291605403,-1.547821367165134,0.014462809917355372,0.0657043785308805,0.98,10/67,6.69%,UBB;BEX3;YWHAE;RPS27A;MAGED1;ITGB3BP;ARHGEF4;UBA52;UBC;TRAF6
gsea,HDMs Demethylate Histones R-HSA-3214842,0.5004123087105545,1.5472973491897237,0.04296875,0.3088753604613906,0.987,8/19,16.04%,KDM3A;ARID5B;KDM2A;PHF8;KDM6B;KDM5B;KDM4A;KDM4B
gsea,Signaling By ERBB2 R-HSA-1227986,-0.4049824352413339,-1.544292209643585,0.021912350597609563,0.06717275927473956,0.98,12/45,14.16%,UBB;HRAS;RPS27A;YES1;NRG3;UBA52;UBC;AKT3;HSP90AA1;RHOA;AKT1;NRG4
gsea,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.4188757955264206,-1.534683025499287,0.030710172744721688,0.07152444053323732,0.984,17/36,28.51%,UBB;RPS27A;UBA52;UBC;COPS5;INO80B;COPS6;CETN2;COPS8;RUVBL1;INO80D;COPS7A;DDB2;TFPT;INO80C;RAD23B;RAD23A
gsea,Retinoid Metabolism And Transport R-HSA-975634,-0.44086705755511874,-1.532976648929069,0.03289473684210526,0.07217061303427688,0.984,10/29,21.83%,TTR;APOE;APOA1;LDLR;GPC4;RETSAT;SDC4;RBP4;AKR1B10;AGRN
gsea,Pyruvate Metabolism R-HSA-70268,-0.46489597348854733,-1.5318009287069785,0.022267206477732792,0.07250267911658263,0.984,9/25,14.60%,VDAC1;GLO1;BSG;MPC2;HAGH;SLC16A1;PLPP6;PDP2;LDHB
gsea,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.4750247263094707,-1.529531580867323,0.038910505836575876,0.0733969792489205,0.984,6/21,14.34%,VDAC1;SMDT1;STOML2;VDAC2;SLC8B1;MAIP1
gsea,Negative Regulation Of MET Activity R-HSA-6807004,-0.47996107760469336,-1.527389087632483,0.03359683794466403,0.07424662519787034,0.986,6/21,10.19%,UBB;RPS27A;UBA52;SH3GL1;UBC;STAM2
gsea,Insulin Receptor Recycling R-HSA-77387,-0.503979120426818,-1.5230135976388617,0.057539682539682536,0.07627119792060984,0.986,6/20,4.50%,ATP6V0B;ATP6V1G2;ATP6V0C;ATP6V1F;ATP6V0E2;ATP6V1A
gsea,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.5068286469085195,-1.5204468270699647,0.059880239520958084,0.07747144339100197,0.988,3/19,1.62%,CALM1;HRAS;NEFL
gsea,RHOU GTPase Cycle R-HSA-9013420,0.42365918215514414,1.5197712673758714,0.0412573673870334,0.3560398543276049,0.99,14/38,14.34%,SPTAN1;USP9X;DST;IQGAP1;CLTC;GIT1;PIK3R2;GRB2;ITSN2;VANGL1;MYO6;SRGAP2;SPTBN1;GIT2
gsea,COPII-mediated Vesicle Transport R-HSA-204005,-0.38028517416332874,-1.5197218961263241,0.025477707006369428,0.07760773498108463,0.988,18/59,14.91%,CNIH2;CNIH1;TMED2;PREB;SAR1B;CTSZ;LMAN1;TRAPPC6A;BET1;TGFA;TRAPPC2L;CTSC;NSF;TRAPPC4;PPP6C;TRAPPC6B;MCFD2;TRAPPC2
gsea,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.3561424469188848,-1.5190831380615013,0.013944223107569721,0.07772869931091561,0.988,25/84,20.93%,UBB;VAMP2;RPS27A;CLTB;CLTA;NECAP1;NEDD8;UBA52;SH3GL1;UBC;LDLR;REPS2;COPS5;TGFA;STAM2;AP2M1;COPS6;VAMP3;TFRC;COPS8;TOR1A;SCARB2;AP2B1;EGFR;COPS7A
gsea,"Cell Cycle, Mitotic R-HSA-69278",-0.2863494007310191,-1.517652834001482,0.0,0.07812833657752438,0.99,104/439,20.33%,UBB;YWHAG;TUBB2A;TUBA1A;HSP90AB1;DYNLL2;RPS27;NME7;GSK3B;YWHAE;PSMA3;RAN;SET;PSMD7;PSMB3;RPS27A;DYNLL1;PSMC6;H2AZ1;PSMC1;POLD4;TUBB2B;TUBB4B;LYN;ITGB3BP;TUBA4A;PSMB6;PSMC3;UBA52;UBC;CEP72;H2AJ;NUP43;PSMA2;PPP2R1A;RAB2A;PSMA7;H2BC4;TUBB3;BANF1;NUDC;PSMB7;NCAPH;TUBA1B;PSMB1;PSMC5;AKT3;DCTN1;CEP78;RBL1;PCNA;NDEL1;CCND3;CHMP2A;HSP90AA1;PSMB5;CENPP;CHMP4B;POLE4;TUBG2;PPP2CA;MIS12;NCAPD2;FBXW11;PSMD11;SSNA1;NUP50;AKT1;PSMA4;BUB3;ARPP19;LIN37;POLE3;TUBB4A;CSNK2B;PSMF1;POLA2;ORC4;CDKN2D;LCMT1;NEK7;GORASP2;HAUS5;SUMO1;HAUS2;CETN2;H2AZ2;CHMP4C;SEM1;GINS4;TUBB6;H2BC21;CDC25C;PSMB4;MCM6;KNTC1;PSMD2;CCNE2;GINS2;EMD;MAPK3;H2AX;DCTN3;MYC
gsea,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.4224101807617527,1.5172530482131528,0.0325497287522604,0.3452124447090489,0.991,20/36,27.22%,THBS2;ADAMTSL3;ADAMTS19;B3GLCT;ADAMTS20;ADAMTS2;ADAMTS5;ADAMTSL5;THSD4;ADAMTS14;ADAMTS17;ADAMTSL1;ADAMTS10;ADAMTS15;THBS1;SEMA5B;SBSPON;ADAMTSL4;ADAMTS16;ADAMTS8
gsea,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.4070117744146855,-1.5133238121299248,0.022774327122153208,0.0803554132824072,0.99,12/43,13.98%,UBB;FKBP1A;RPS27A;NEDD8;TGFB1;UBA52;UBC;ITGA8;PPP1CA;SMAD7;SMAD2;SRFBP1
gsea,Asparagine N-linked Glycosylation R-HSA-446203,-0.30462117188780985,-1.5113748527964714,0.006224066390041493,0.0811756449809405,0.99,96/257,30.09%,UBB;DYNLL2;DPM1;NAGK;CNIH2;CALR;RPS27A;DYNLL1;DPM2;CNIH1;ALG11;PSMC1;CHGA;DAD1;TMED2;TMED7;DOLK;DPM3;CANX;PREB;UBA52;TMED9;UBC;B4GALT4;CAPZA2;SAR1B;FUCA1;ALG5;CTSZ;PMM1;LMAN1;DCTN1;MGAT4B;SLC35A1;EGFL7;TRAPPC6A;BET1;TGFA;TRAPPC2L;CTSC;NSF;TRAPPC4;PPP6C;RPN2;TRAPPC6B;RNF139;COG5;MCFD2;COPE;TRAPPC2;BET1L;ACTR10;GMDS;COG1;DCTN4;LMAN2;ALG12;ARF5;ALG13;EDEM1;CAPZA1;DCTN3;MLEC;ALG2;MANEA;B4GALT5;ARF4;NANP;RNF185;SCFD1;KDELR1;GOSR2;GORASP1;NGLY1;CMAS;COG2;FUOM;SLC35C1;YKT6;NAPG;TRAPPC3;NANS;RFT1;COG8;RNF5;PTGES2;RAD23B;DERL2;MPDU1;DERL1;GFPT2;TRIM13;SRD5A3;B4GALT3;ST3GAL5;SEC16B
gsea,HIV Life Cycle R-HSA-162587,-0.32068379689826715,-1.511033008086267,0.005952380952380952,0.08114118958443688,0.99,49/137,28.78%,UBB;PPIA;RAN;RPS27A;XRCC6;POLR2K;ELOB;UBA52;TAF13;UBC;NUP43;BANF1;ERCC3;TAF11;CHMP2A;CHMP5;GTF2H5;POLR2G;CHMP4B;MVB12B;NUP50;GTF2B;POLR2F;RANBP1;KPNA1;TCEA1;CCNK;TAF7L;CHMP4C;VPS37C;RNMT;CXCR4;POLR2E;GTF2E2;VPS4A;NUP35;GTF2F2;TAF10;GTF2A1;CTDP1;MVB12A;LRIG1;PSIP1;TAF12;LIG4;NCBP2;NELFA;POLR2J;FURIN
gsea,Signaling By NOTCH2 R-HSA-1980145,-0.4411264319937369,-1.510736440121858,0.03807615230460922,0.0809879531847493,0.99,8/28,18.86%,UBB;RPS27A;UBA52;UBC;MAML3;JAG1;MAML2;PSENEN
gsea,DARPP-32 Events R-HSA-180024,-0.4698171699950738,-1.5097912759341192,0.04950495049504951,0.08130541586535596,0.99,6/23,11.16%,CALM1;PPP3R1;PPP2R1A;PPP3CA;PPP1CA;PPP2CA
gsea,Intracellular Signaling By Second Messengers R-HSA-9006925,-0.2991744499557478,-1.5065746124318171,0.008333333333333333,0.08278956560563122,0.99,53/269,14.16%,CALM1;FGFR2;UBB;FGF1;GSK3B;LAMTOR2;PSMA3;JUN;PSMD7;PSMB3;RPS27A;MLST8;PSMC6;LAMTOR3;PSMC1;CHD3;CNOT6L;NRG3;PSMB6;RRAGA;PSMC3;UBA52;UBC;AHCYL1;PSMA2;PPP2R1A;PSMA7;TRAF6;PIP4K2A;PSMB7;LAMTOR1;RHEB;PSMB1;PSMC5;AKT3;IRS2;PDGFRA;RPS6KB2;FGF10;TGFA;PSMB5;IL1RAP;PPP2CA;PSMD11;AKT1;PSMA4;FGFR3;IER3;NR4A1;CBX4;CSNK2B;PSMF1;NRG4
gsea,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.3788205154292467,-1.506479873545492,0.028513238289205704,0.08259505533101755,0.99,23/53,27.29%,VRK3;VGF;EGR4;PPP2R1A;JUND;ID3;CDK5R2;TCF12;PPP2CA;F3;ID2;FOS;DUSP6;LYL1;DUSP4;MAPK3;NAB1;DUSP7;ID1;ASCL1;EGR1;TRIB1;PPP2R1B
gsea,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.5237227748371968,-1.5054019828467937,0.05128205128205128,0.08294254728451726,0.99,3/17,5.47%,CALM1;HRAS;AHCYL1
gsea,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.3158561317204483,-1.5031870633195308,0.004048582995951417,0.08397728233573931,0.991,44/156,20.39%,UBB;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;H2AZ1;PSMC1;PSMB6;PSMC3;UBA52;UBC;H2AJ;PSMA2;PSMA7;H2BC4;GPAM;PSMB7;PSMB1;PSMC5;CCND3;PSMB5;TCF12;PSMD11;PSMA4;MYL9;CBX4;CSNK2B;CBFB;PSMF1;ELOF1;YAF2;CLDN5;CTSL;H2AZ2;SEM1;H2BC21;RBBP5;PSMB4;LMO1;YAP1;PSMD2;H2AX;SMARCB1
gsea,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.48655561550914816,-1.5025708466382457,0.04338842975206612,0.08409890873633094,0.991,12/19,33.71%,FGFR2;FGF1;POLR2K;POLR2G;POLR2F;POLR2E;FGF13;GTF2F2;NCBP2;POLR2J;POLR2L;POLR2H
gsea,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.5227197686890559,1.5017809033925371,0.056112224448897796,0.3679490345782839,0.996,5/15,8.93%,PIKFYVE;PI4KA;VAC14;OCRL;PI4K2B
gsea,Signaling By FGFR2 R-HSA-5654738,-0.36706715237877213,-1.4993592589538693,0.023952095808383235,0.08573481616719071,0.991,12/61,11.16%,FGFR2;UBB;HRAS;FGF1;RPS27A;POLR2K;UBA52;UBC;PPP2R1A;FGF10;POLR2G;PPP2CA
gsea,RNA Polymerase III Transcription Termination R-HSA-73980,-0.46879212143870375,-1.4982825754492939,0.06542056074766354,0.08608761588880286,0.991,10/21,23.45%,POLR2K;POLR3H;POLR3E;POLR1D;POLR2F;POLR3A;NFIA;POLR3K;POLR2E;POLR3D
gsea,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.5547922572561371,-1.4965942822846934,0.052123552123552123,0.08676275116054924,0.992,5/17,4.09%,RAB3A;VAMP2;CPLX1;HSPA8;RIMS1
gsea,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.42101637107554074,-1.495521647306475,0.05056179775280899,0.08724449877718532,0.992,12/33,20.33%,DYNLL2;DYNLL1;CAPZA2;RAB6A;DCTN1;RAB18;RAB6B;ACTR10;DCTN4;CAPZA1;DCTN3;GALNT2
gsea,Interleukin-2 Family Signaling R-HSA-451927,0.4392224721277578,1.4942157082761707,0.041176470588235294,0.37013712812515626,0.997,14/32,22.41%,STAT1;SHC1;PIK3R2;GRB2;LGALS9;JAK3;CLSTN1;JAK2;STAT5B;PIK3CA;PTPN6;SOS2;IL15RA;JAK1
gsea,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.38350334286408355,-1.492843762163369,0.02702702702702703,0.08858040776613232,0.994,17/49,21.09%,UBB;JUN;RPS27A;H2AZ1;UBA52;UBC;CEBPB;H2AJ;H2BC4;CDKN2D;RELA;FOS;H2AZ2;H2BC21;MAPK3;H2AX;CDKN1B
gsea,Fanconi Anemia Pathway R-HSA-6783310,-0.40905684433383155,-1.4898385932709117,0.029345372460496615,0.08999585777105205,0.994,5/33,5.23%,UBB;RPS27A;USP1;UBA52;UBC
gsea,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.40618835611248316,-1.4889594427548372,0.02976190476190476,0.09022130747627391,0.994,14/36,21.19%,GSK3B;H2AZ1;POLR2K;H2AJ;H2BC4;POLR1D;POLR2F;SMARCA5;POLR1H;H2AZ2;H2BC21;H2AX;POLR2E;POLR1G
gsea,RAB Geranylgeranylation R-HSA-8873719,-0.3824818579050026,-1.4869747240608533,0.0465587044534413,0.09121736374690666,0.995,19/51,24.98%,RAB3A;RAB11A;RAB5B;RAB6A;RAB2A;RAB18;RAB38;RAB6B;RAB14;RAB36;RAB40B;RAB5A;RAB2B;RAB35;RAB29;RABGGTB;RAB8B;RAB22A;RAB33B
gsea,Signaling By VEGF R-HSA-194138,-0.3557331659794231,-1.4840347531232365,0.024844720496894408,0.09261303413689669,0.995,25/90,17.96%,CALM1;HRAS;MLST8;NCK1;CDC42;CTNNA1;AHCYL1;PGF;PTK2B;AKT3;ELMO2;HSP90AA1;RHOA;CYBA;NCF1;ABI2;AKT1;VEGFB;BCAR1;ABI1;BAIAP2;BRK1;VEGFC;DOCK1;WASF1
gsea,MAP Kinase Activation R-HSA-450294,-0.36907008308792094,-1.4834375740778027,0.0297029702970297,0.09270188994951924,0.995,18/58,21.42%,UBB;JUN;RPS27A;VRK3;UBA52;UBC;PPP2R1A;TRAF6;UBE2V1;PPP2CA;FBXW11;FOS;MAP2K1;DUSP6;DUSP4;MAPK3;IKBKG;UBE2N
gsea,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.3959785733822344,-1.4819687148498077,0.040697674418604654,0.09333816729089757,0.995,11/47,12.69%,CALM1;YWHAG;VAMP2;YWHAE;RALA;YWHAB;RAB11A;YWHAH;YWHAZ;RAB14;AKT1
gsea,EPH-Ephrin Signaling R-HSA-2682334,-0.3602512091564918,-1.4817109227735326,0.030612244897959183,0.09326641050074573,0.995,31/82,24.61%,HRAS;ARPC3;ACTG1;MYL6;CLTB;CLTA;YES1;ARPC1B;LYN;EPHA7;CDC42;ARPC2;WASL;ARPC5;RHOA;ACTR3;AP2M1;EFNB2;EPHA4;MYL9;ACTR2;EPHA5;PSENEN;SDCBP;AP2B1;EPHA6;AP2S1;MYL12A;MYH14;EPHA3;EFNA3
gsea,Diseases Of Programmed Cell Death R-HSA-9645723,-0.3873170318227163,-1.4806564063742342,0.038539553752535496,0.09364081999922799,0.995,15/45,20.01%,YWHAE;JUN;GSDME;H2AZ1;C1QBP;H2AJ;H2BC4;PRDX2;POLA2;CASP8;FADD;H2AZ2;H2BC21;CDC25C;H2AX
gsea,IRS-mediated Signaling R-HSA-112399,-0.4078651370017583,-1.4800321585332328,0.028397565922920892,0.09375718636892164,0.995,7/35,13.06%,FGFR2;HRAS;FGF1;PDE3B;IRS2;FGF10;FGFR3
gsea,Cell Cycle Checkpoints R-HSA-69620,-0.2957207520438316,-1.4776865551251432,0.006564551422319475,0.09490264519034006,0.995,41/222,14.02%,UBB;YWHAG;DYNLL2;RPS27;YWHAE;PSMA3;PSMD7;PSMB3;RPS27A;YWHAB;DYNLL1;PSMC6;PSMC1;ITGB3BP;PSMB6;PSMC3;UBA52;UBC;YWHAH;NUP43;PSMA2;PPP2R1A;PSMA7;H2BC4;NUDC;PSMB7;PSMB1;PSMC5;NDEL1;RAD9B;PSMB5;BABAM2;CENPP;PPP2CA;YWHAZ;MIS12;PSMD11;PSMA4;BUB3;PSMF1;ORC4
gsea,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.5067587008337257,1.4767312117999531,0.05660377358490566,0.39798500925114777,0.998,6/16,13.84%,PIKFYVE;VAC14;PI4K2B;MTM1;MTMR2;INPP4A
gsea,Transferrin Endocytosis And Recycling R-HSA-917977,-0.4704047434022112,-1.4763963305718268,0.07465618860510806,0.09538089559492999,0.995,6/24,4.50%,ATP6V0B;ATP6V1G2;ATP6V0C;ATP6V1F;ATP6V0E2;ATP6V1A
gsea,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.3738569100052853,-1.4720714805389525,0.03373015873015873,0.09785986854600717,0.995,12/55,15.92%,UBB;GSK3B;RPS27A;DAD1;CANX;UBA52;UBC;MGAT4B;GOLGA7;RPN2;PARP10;SUMO1
gsea,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.46030879388906243,-1.4716068520152314,0.057971014492753624,0.09792759662668511,0.995,9/24,19.52%,UBB;RPS27A;UBA52;UBC;HSP90AA1;CASP8;FADD;STUB1;SDCBP
gsea,Metalloprotease DUBs R-HSA-5689901,-0.4541599368350371,-1.4713976827094242,0.053388090349075976,0.09780015177579018,0.995,5/22,10.03%,UBB;RPS27A;UBA52;UBC;BABAM2
gsea,Meiotic Synapsis R-HSA-1221632,-0.4041060016967745,-1.4712624999731634,0.0371900826446281,0.09761160948251077,0.995,6/33,6.21%,HSPA2;SYCP3;H2AZ1;SYCP2;H2AJ;H2BC4
gsea,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.39726138926817045,-1.4692671242481028,0.033203125,0.09852475311456228,0.995,7/37,13.06%,FGFR2;HRAS;FGF1;PDE3B;IRS2;FGF10;FGFR3
gsea,RNA Polymerase III Chain Elongation R-HSA-73780,-0.49661169378260067,-1.467330289076011,0.07587548638132295,0.09956454853209801,0.995,9/17,23.45%,POLR2K;POLR3H;POLR3E;POLR1D;POLR2F;POLR3A;POLR3K;POLR2E;POLR3D
gsea,Interleukin-17 Signaling R-HSA-448424,-0.3583502155320752,-1.465566061505427,0.029940119760479042,0.10039282239615531,0.995,19/61,21.42%,UBB;JUN;RPS27A;VRK3;UBA52;UBC;PPP2R1A;TRAF6;UBE2V1;PPP2CA;FBXW11;FOS;MAP2K1;DUSP6;IL17RB;DUSP4;MAPK3;IKBKG;UBE2N
gsea,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.3430524872194863,1.4648363226070058,0.033663366336633666,0.4137336698043304,0.998,26/95,13.43%,KIF1B;DOCK3;KIFC2;DOCK7;DOCK9;KIF5A;KIF5B;MFN1;KIF21A;KIF3C;VPS45;CARMIL1;IRF2;KIF16B;PRKCA;KIF13B;PRKAR1B;KIF11;KIF1A;KIF3A;KIFC1;DOCK5;JAK2;KLC4;DOCK11;CABLES1
gsea,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.44584219711076095,-1.463259691975211,0.06828193832599119,0.10170117754126043,0.996,7/22,13.38%,MOV10L1;POLR2K;MYBL1;HSP90AA1;POLR2G;HENMT1;POLR2F
gsea,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.4442522933924243,-1.4621560428854827,0.056910569105691054,0.10216198830901013,0.996,9/26,19.52%,UBB;RPS27A;UBA52;UBC;HSP90AA1;CASP8;FADD;STUB1;SDCBP
gsea,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.4713767870257719,1.4586901562793166,0.0691699604743083,0.4144457978359592,0.999,8/18,19.25%,ANAPC1;ANAPC5;CDC14A;CDC23;ANAPC11;CDC27;ANAPC15;UBE2S
gsea,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.42340943975251116,-1.4580291758034996,0.048728813559322036,0.10450915062446173,0.996,12/31,17.76%,TUBB2A;TUBA1A;TTLL8;TUBB2B;TUBB4B;TUBB3;TUBA1B;VASH1;TPGS1;TUBB4A;AGBL5;TUBB6
gsea,MAP2K And MAPK Activation R-HSA-5674135,-0.4215685191191583,-1.4577293965044273,0.05714285714285714,0.104370839446254,0.996,6/31,5.79%,HRAS;LAMTOR2;YWHAB;LAMTOR3;PEBP1;CNKSR2
gsea,FLT3 Signaling In Disease R-HSA-9682385,-0.43752082838293327,-1.4571150867625786,0.050880626223091974,0.10443625533584064,0.996,5/25,5.23%,UBB;HRAS;RPS27A;UBA52;UBC
gsea,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.3527539989712218,-1.4562353248882192,0.02028397565922921,0.10478556755214856,0.997,10/71,6.05%,UBB;HSPA2;GSK3B;YWHAE;HSBP1;HSPA8;HSPH1;BAG4;NUP43;HSPA5
gsea,RET Signaling R-HSA-8853659,0.41291977062112767,1.4535376891162415,0.06300813008130081,0.4124130083864903,0.999,11/33,14.28%,DOK5;SHC1;SHC3;PIK3R2;GRB2;PRKCA;CLSTN1;SHANK3;RAP1GAP;PIK3CA;NRTN
gsea,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.49307530003447364,-1.4494230218401762,0.07272727272727272,0.10925635400675593,0.997,7/16,20.37%,UBB;RPS27A;UBA52;UBC;FBXW11;MAP2K1;IKBKG
gsea,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.4522428496425283,-1.449358074260039,0.06048387096774194,0.10900818578872533,0.997,9/23,17.44%,BBIP1;CCT5;ARL6;CCT3;BBS5;CCT8;CCT2;CCT4;TCP1
gsea,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.4191778155677617,-1.4466309757841622,0.05010893246187364,0.11066240427372451,0.997,8/29,21.20%,UBB;RPS27A;UBA52;UBC;UBE2K;UBE2D3;ATG12;MAVS
gsea,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.500309787849355,-1.4461069725925941,0.07509881422924901,0.11076115454087612,0.997,5/16,4.09%,RAB3A;VAMP2;CPLX1;PPFIA2;RIMS1
gsea,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.4408256091661046,-1.445774977739053,0.07066381156316917,0.1107234036789487,0.997,8/22,21.40%,H2AZ1;H2AJ;H2BC4;MPG;H2AZ2;H2BC21;H2AX;TDG
gsea,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.40274615543156517,-1.4452508398436699,0.06153846153846154,0.11081722501740067,0.997,10/33,21.83%,TTR;APOE;APOA1;LDLR;GPC4;RETSAT;SDC4;RBP4;AKR1B10;AGRN
gsea,MTOR Signaling R-HSA-165159,-0.39642059507820004,-1.443148680942906,0.04233870967741935,0.11184459180498839,0.997,11/40,12.69%,FKBP1A;LAMTOR2;MLST8;YWHAB;LAMTOR3;RRAGA;LAMTOR1;RHEB;CAB39L;RPS6;AKT1
gsea,MAPK Family Signaling Cascades R-HSA-5683057,-0.29440725589486266,-1.4391711970980552,0.012345679012345678,0.11417742454470203,0.997,71/259,22.78%,CALM1;FGFR2;UBB;HRAS;FGF1;NEFL;LAMTOR2;PSMA3;JUN;PSMD7;PSMB3;RPS27A;YWHAB;PSMC6;LAMTOR3;PSMC1;PEBP1;TEK;CDC42;NRG3;ABHD17A;PSMB6;PSMC3;UBA52;UBC;CNKSR2;PSMA2;PPP2R1A;PSMA7;RASAL2;GFRA4;PSMB7;PSMB1;PSMC5;IRS2;PDGFRA;CCND3;GOLGA7;FGF10;TGFA;PSMB5;CDC42EP3;PPP2CA;PSMD11;PSMA4;FGFR3;TYK2;PSMF1;NRG4;MAP2K1;SEM1;RNMT;DUSP6;KBTBD7;PSMB4;SPRED1;PSMD2;CAMK2B;DUSP4;MAPK3;ETV4;MYC;EGFR;FGF7;FOXO1;IL17RD;FGF13;RASGRP4;PPP2R5B;PSMC2;DUSP12
gsea,NGF-stimulated Transcription R-HSA-9031628,-0.40469469419207665,-1.4381311643678327,0.05776892430278884,0.11455982358103768,0.997,15/32,25.65%,VGF;EGR4;JUND;ID3;CDK5R2;TCF12;F3;ID2;FOS;LYL1;NAB1;ID1;ASCL1;EGR1;TRIB1
gsea,RHOV GTPase Cycle R-HSA-9013424,0.4145744012557515,1.4373803833069205,0.058823529411764705,0.44022588498687926,0.999,12/34,15.14%,SPTAN1;USP9X;DST;IQGAP1;CLTC;MYO9A;GIT1;VANGL1;TPM3;SPTBN1;GIT2;PARD6B
gsea,Cleavage Of Damaged Purine R-HSA-110331,-0.48157100025999217,-1.4367745464266248,0.06768558951965066,0.1152798249265053,0.997,7/16,20.01%,H2AZ1;H2AJ;H2BC4;MPG;H2AZ2;H2BC21;H2AX
gsea,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.43126826187565137,1.4338968489710642,0.08484848484848485,0.43489531725849934,0.999,11/30,13.83%,EPB41L1;GRIA4;PRKCG;PRKCB;CACNG2;MDM2;CAMK2D;PRKCA;MYO6;CAMK2A;AP2A1
gsea,Heme Signaling R-HSA-9707616,0.3954712618261329,1.4327893458483127,0.0547945205479452,0.4238181165010737,0.999,11/37,9.45%,NPAS2;EP300;CREBBP;NCOA6;NCOR1;NCOA1;CARM1;RORA;BRIP1;HDAC3;RXRA
gsea,PI-3K cascade:FGFR2 R-HSA-5654695,-0.48450950693665007,-1.4316953715028404,0.09240246406570841,0.1187894994977991,0.997,2/16,1.07%,FGFR2;FGF1
gsea,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.32983925519184626,-1.429451235252914,0.03966597077244259,0.12024533192836082,0.997,22/84,22.31%,FGFR2;FGF1;NRG3;PPP2R1A;TRAF6;PIP4K2A;IRS2;PDGFRA;FGF10;TGFA;IL1RAP;PPP2CA;AKT1;FGFR3;IER3;NRG4;RNMT;MAPK3;EGFR;FGF7;FGF13;PPP2R5B
gsea,Basigin Interactions R-HSA-210991,-0.4331768922913469,-1.4278795034927032,0.07024793388429752,0.12116521572922262,0.997,8/22,17.84%,ATP1B1;PPIA;BSG;SLC7A5;ATP1B2;SLC16A1;SLC3A2;ATP1B3
gsea,Transcriptional Regulation By TP53 R-HSA-3700989,-0.27810922969257174,-1.4278362364049706,0.002364066193853428,0.12089781734440674,0.997,64/313,14.50%,UBB;YWHAG;COX6C;COX8A;COX7C;COX4I1;COX19;PRDX5;LAMTOR2;YWHAE;JUN;RPS27A;MLST8;YWHAB;COX7B;LAMTOR3;COX5B;POLR2K;CHD3;CYCS;CNOT6L;ELOB;DDIT4;COX6A1;RRAGA;UBA52;TAF13;CNOT8;UBC;YWHAH;COX7A2L;COX6B1;TRIAP1;PPP2R1A;COX14;PIP4K2A;ERCC3;LAMTOR1;RHEB;AKT3;PIP4P1;RBL1;PCNA;BNIP3L;TAF11;TXN2;COX20;MLH1;GTF2H5;RAD9B;POLR2G;PPP2CA;YWHAZ;NPM1;NLRC4;RRM2B;AKT1;PRDX2;POLR2F;ING3;CSNK2B;TXNRD1;TCEA1;CCNK
gsea,Signaling By NOTCH R-HSA-157118,-0.2982459459906658,-1.4258377209068167,0.02178217821782178,0.12197258261616493,0.997,45/166,20.98%,UBB;PSMA3;JUN;PSMD7;PSMB3;RPS27A;PSMC6;H2AZ1;PSMC1;TMED2;PSMB6;PSMC3;UBA52;UBC;RAB6A;HDAC11;H2AJ;PSMA2;PSMA7;H2BC4;ACTA2;PSMB7;MAML3;PSMB1;PSMC5;SNW1;PSMB5;YWHAZ;PSMD11;AKT1;PSMA4;PSMF1;H2AZ2;JAG1;SEM1;MAML2;H2BC21;PSMB4;PSENEN;PSMD2;H2AX;MYC;EGFR;TBL1XR1;SIRT6
gsea,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.32590278581458354,-1.4255299161431765,0.033264033264033266,0.1218406784237683,0.997,24/90,22.36%,FGFR2;FGF1;NRG3;PPP2R1A;TRAF6;PIP4K2A;AKT3;IRS2;PDGFRA;FGF10;TGFA;IL1RAP;PPP2CA;AKT1;FGFR3;IER3;NRG4;RNMT;MAPK3;EGFR;FGF7;FGF13;PPP2R5B;THEM4
gsea,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.3475773007413349,-1.4229451790008898,0.055441478439425054,0.1233972956858606,0.997,22/82,17.96%,CALM1;HRAS;MLST8;NCK1;CDC42;CTNNA1;AHCYL1;PTK2B;AKT3;ELMO2;HSP90AA1;RHOA;CYBA;NCF1;ABI2;AKT1;BCAR1;ABI1;BAIAP2;BRK1;DOCK1;WASF1
gsea,Chromosome Maintenance R-HSA-73886,-0.3228866975802042,-1.4223726988717071,0.020179372197309416,0.12352106252233784,0.997,25/90,20.04%,H2AZ1;POLD4;NOP10;POLR2K;ITGB3BP;H2AJ;H2BC4;PCNA;POLR2G;CENPP;MIS18BP1;HJURP;NPM1;PPP6C;CENPW;POLR2F;POLA2;SMARCA5;H2AZ2;MIS18A;RUVBL1;TERT;H2BC21;H2AX;POLR2E
gsea,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.45039940847840204,-1.422316764369762,0.07249466950959488,0.12327560383130941,0.997,8/19,30.70%,ALG11;EGFL7;ALG12;ALG13;ALG2;RFT1;MPDU1;B4GALT1
gsea,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.4440488699998755,-1.4222349936090921,0.06342494714587738,0.12303141039126571,0.997,8/21,21.20%,HMGB1;TRAF6;S100B;NKIRAS2;NFKB2;RELA;IKBKG;MAVS
gsea,Dual Incision In TC-NER R-HSA-6782135,-0.34033236614707296,-1.4219453242775038,0.03361344537815126,0.12296366918985359,0.997,16/63,15.12%,UBB;RPS27A;POLD4;POLR2K;UBA52;UBC;ERCC3;HMGN1;PCNA;GTF2H5;POLR2G;POLE4;POLE3;POLR2F;TCEA1;PRPF19
gsea,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.4892624926525758,-1.4198192237883271,0.09278350515463918,0.12427799997922899,0.998,7/15,20.01%,H2AZ1;H2AJ;H2BC4;RRP8;H2AZ2;H2BC21;H2AX
gsea,FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.4833270305689528,-1.4190206495714728,0.09207708779443255,0.1245600717704107,0.998,3/16,9.85%,HRAS;FGF1;FGF10
gsea,PI Metabolism R-HSA-1483255,0.3417923018659915,1.4189421705911538,0.05410821643286573,0.44646326488656923,0.999,25/78,16.35%,PIKFYVE;PLEKHA6;ENPP6;PI4KA;INPP5K;SYNJ1;VAC14;TNFAIP8L3;PIK3R2;PLEKHA1;PIK3C2B;PNPLA6;OCRL;PI4K2B;CLSTN1;INPP5J;MTM1;MTMR2;SYNJ2;PIK3CA;INPP4A;SBF2;PIK3C2G;MTMR14;PIP5K1C
gsea,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.3411599329314175,-1.41839342072506,0.0440251572327044,0.12472749589164854,0.998,16/62,15.12%,UBB;RPS27A;POLD4;POLR2K;UBA52;UBC;ERCC3;HMGN1;PCNA;GTF2H5;POLR2G;POLE4;POLE3;POLR2F;TCEA1;PRPF19
gsea,Protein Ubiquitination R-HSA-8852135,-0.34849499418360513,-1.4181537686550434,0.0430327868852459,0.12461579969116253,0.998,17/61,15.80%,UBB;RPS27A;UBE2A;RRAGA;UBA52;UBC;H2BC4;OTULIN;SELENOS;PCNA;UBE2B;TMEM129;UBE2R2;UBE2K;UBE2D3;SKIC8;UBE2E3
gsea,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.436017049704961,-1.4143359064710788,0.07468123861566485,0.12722397380243558,0.998,8/23,13.73%,HSP90AB1;ACTG1;HSP90AA1;CCT7;TXNL1;CCT6A;CCT2;TWF1
gsea,Neurotransmitter Release Cycle R-HSA-112310,-0.38411835150887563,-1.413621051522749,0.0671785028790787,0.12743955665056475,0.998,11/44,11.76%,RAB3A;VAMP2;LIN7C;CPLX1;PPFIA2;HSPA8;RIMS1;ARL6IP5;LIN7B;SLC1A6;SLC32A1
gsea,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.35953350696248093,-1.4135174220576059,0.04,0.12716576744874405,0.998,17/50,21.19%,GSK3B;H2AZ1;POLR2K;CHD3;H2AJ;CBX3;H2BC4;TTF1;POLR1D;POLR2F;SMARCA5;POLR1H;H2AZ2;H2BC21;H2AX;POLR2E;POLR1G
gsea,RNA Polymerase I Transcription R-HSA-73864,-0.3507596190222741,-1.4133452105132924,0.05714285714285714,0.12667408524443582,0.998,18/54,21.19%,H2AZ1;POLR2K;CHD3;H2AJ;CBX3;H2BC4;ERCC3;GTF2H5;TTF1;POLR1D;POLR2F;POLR1H;H2AZ2;H2BC21;MAPK3;H2AX;POLR2E;POLR1G
gsea,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.3507596190222741,-1.4133452105132924,0.05714285714285714,0.12667408524443582,0.998,18/54,21.19%,H2AZ1;POLR2K;CHD3;H2AJ;CBX3;H2BC4;ERCC3;GTF2H5;TTF1;POLR1D;POLR2F;POLR1H;H2AZ2;H2BC21;MAPK3;H2AX;POLR2E;POLR1G
gsea,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.45040853553651683,1.4130352069846597,0.07450980392156863,0.4492056225382397,1.0,6/19,14.52%,MCCC1;ACACA;AMN;PCCA;MTR;LMBRD1
gsea,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.49402363332734117,-1.4113906840508574,0.09404990403071017,0.12777469210774434,0.998,5/16,4.09%,RAB3A;VAMP2;CPLX1;PPFIA2;RIMS1
gsea,Fatty Acid Metabolism R-HSA-8978868,-0.3020527030758062,-1.4095021605535283,0.02546296296296296,0.12898470259281075,0.998,42/128,26.13%,SYCP2;TECR;HACD4;HPGDS;ACOT13;ACOT12;NUDT19;PTGS1;NDUFAB1;ACSL3;HSD17B12;MCEE;HACD2;PTGES3;FADS2;CROT;ACBD6;HSD17B8;PTGIS;DBI;CBR1;ELOVL6;ACOT2;ELOVL4;PTGDS;GPX1;PRXL2B;MECR;CBR4;ACOX1;CPT2;AMACR;THEM4;ELOVL5;PECR;GPX4;PTGR2;MCAT;ACOX2;ACOT9;ACBD5;CPT1A
gsea,RHO GTPases Activate PAKs R-HSA-5627123,-0.46717381239313766,-1.4093304595471265,0.09243697478991597,0.12881718926058697,0.998,3/20,4.20%,CALM1;MYL6;CDC42
gsea,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.45964644817302,-1.4092181867262252,0.07644628099173553,0.1285677150313177,0.998,7/18,20.01%,SET;H2AZ1;H2AJ;H2BC4;H2AZ2;H2BC21;H2AX
gsea,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.4366198691441897,-1.4082556190803985,0.07535641547861507,0.12904311454144926,0.998,5/21,10.59%,CALR;CANX;SAR1B;HSPA5;B2M
gsea,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.4115842394276161,-1.4074433332679155,0.06944444444444445,0.1293827762832127,0.998,9/28,15.74%,UBB;RPS27A;UBA52;UBC;SNW1;SMAD7;SMAD2;UBE2D3;WWTR1
gsea,IGF1R Signaling Cascade R-HSA-2428924,-0.3749772721172426,-1.406397319673157,0.05232558139534884,0.12949494123667726,0.998,7/38,13.06%,FGFR2;HRAS;FGF1;PDE3B;IRS2;FGF10;FGFR3
gsea,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.3749772721172426,-1.406397319673157,0.05232558139534884,0.12949494123667726,0.998,7/38,13.06%,FGFR2;HRAS;FGF1;PDE3B;IRS2;FGF10;FGFR3
gsea,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.29801612329858257,-1.4056398667429413,0.028169014084507043,0.12978815353063738,0.998,43/155,20.48%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;H2AZ1;PSMC1;PSMB6;PSMC3;UBA52;UBC;H2AJ;PSMA2;PPP2R1A;PSMA7;H2BC4;PSMB7;PSMB1;PSMC5;PSMB5;PPP2CA;YWHAZ;PSMD11;AKT1;PSMA4;CSNK2B;PSMF1;FZD1;H2AZ2;SEM1;RUVBL1;TERT;H2BC21;RBBP5;PSMB4;PSMD2;CTNNBIP1;FRAT1;H2AX;MYC;FZD2
gsea,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.4164096283109559,-1.4035008938159597,0.08187134502923976,0.1310976953752697,0.998,12/26,23.45%,POLR2K;POLR3H;POU2F1;POLR3E;POLR1D;POLR2F;POLR3A;POLR3K;POLR2E;BRF2;SNAPC1;POLR3D
gsea,TNF Signaling R-HSA-75893,-0.3799678033789269,-1.4034744236976178,0.06147540983606557,0.13079653865545396,0.998,9/42,7.19%,UBB;RPS27A;NSMAF;RACK1;BAG4;UBA52;UBC;OTULIN;TNFRSF1A
gsea,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.4238696867367281,-1.402331419740808,0.0860655737704918,0.13133569857457952,0.998,8/23,21.92%,NPY;SIRT3;AGRP;SMAD2;POMC;FOXO4;FOXO1;SIN3A
gsea,Centrosome Maturation R-HSA-380287,-0.33228953933315225,-1.4018561150524302,0.034782608695652174,0.1313477846313207,0.998,18/75,16.73%,YWHAG;TUBA1A;NME7;YWHAE;DYNLL1;TUBB4B;TUBA4A;CEP72;PPP2R1A;DCTN1;CEP78;HSP90AA1;TUBG2;SSNA1;TUBB4A;HAUS5;HAUS2;CETN2
gsea,Neurexins And Neuroligins R-HSA-6794361,0.3615372400842785,1.4012328948362878,0.04838709677419355,0.46918125244515635,1.0,19/55,14.13%,DLGAP1;EPB41L1;DLGAP4;SHANK1;DLGAP2;MPP3;STXBP1;DLGAP3;EPB41;SYT2;APBA1;MPP2;EPB41L2;STX1A;SHANK3;NLGN2;GRIN2D;EPB41L3;GRM5
gsea,Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.4487818774418474,-1.39919063023904,0.09645669291338582,0.13323324829201333,0.998,6/23,4.09%,RAB3A;VAMP2;LIN7C;CPLX1;PPFIA2;RIMS1
gsea,Potential Therapeutics For SARS R-HSA-9679191,-0.3314232534271697,-1.39823618685485,0.041928721174004195,0.133612926260134,0.998,29/83,26.60%,ATP1B1;HSP90AB1;FKBP1A;NCK1;SIGMAR1;CHD3;IFNGR2;NFE2L2;BTK;ATP1A2;ATP1B2;PTGES3;HSP90AA1;AP2M1;TYK2;FXYD1;ATP1B3;AP2B1;FKBP4;SAP18;AP2S1;BLNK;ITGB1;HMG20B;FXYD2;ATP1A3;ITGA4;SAP30;SAP30L
gsea,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.3297467915651115,-1.393805865690059,0.043859649122807015,0.1369998198993904,0.998,18/75,16.73%,YWHAG;TUBA1A;NME7;YWHAE;DYNLL1;TUBB4B;TUBA4A;CEP72;PPP2R1A;DCTN1;CEP78;HSP90AA1;TUBG2;SSNA1;TUBB4A;HAUS5;HAUS2;CETN2
gsea,Defective Pyroptosis R-HSA-9710421,-0.4463766119287809,-1.393082008819086,0.122568093385214,0.13733803935498895,0.998,9/20,24.19%,GSDME;H2AZ1;H2AJ;H2BC4;POLA2;H2AZ2;H2BC21;H2AX;EZH2
gsea,Late Phase Of HIV Life Cycle R-HSA-162599,-0.30039208995091504,-1.392894829351533,0.033797216699801194,0.13720220485918525,0.998,37/125,24.95%,UBB;PPIA;RAN;RPS27A;POLR2K;ELOB;UBA52;TAF13;UBC;NUP43;ERCC3;TAF11;CHMP2A;CHMP5;GTF2H5;POLR2G;CHMP4B;MVB12B;NUP50;GTF2B;POLR2F;RANBP1;TCEA1;CCNK;TAF7L;CHMP4C;VPS37C;RNMT;POLR2E;GTF2E2;VPS4A;NUP35;GTF2F2;TAF10;GTF2A1;CTDP1;MVB12A
gsea,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.3191159353965845,-1.3881612323320616,0.03164556962025317,0.14060933569748482,0.998,22/81,21.42%,UBB;SUMO2;RPS27A;POLD4;UBA52;UBC;ERCC3;PCNA;COPS5;GTF2H5;POLE4;INO80B;COPS6;POLE3;SUMO1;CETN2;COPS8;RUVBL1;INO80D;PIAS1;COPS7A;UBE2N
gsea,RHOJ GTPase Cycle R-HSA-9013409,0.3604769578122274,1.3863954851087685,0.07238095238095238,0.4986003289826171,1.0,15/51,12.50%,TRIO;FNBP1;GIT1;PIK3R2;WIPF2;CDC42BPB;CDC42BPA;OCRL;OPHN1;ARHGAP32;VANGL1;SYDE1;FNBP1L;SCRIB;ARHGAP35
gsea,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.27011326393465135,-1.3858891789077454,0.011013215859030838,0.14221049472787503,0.998,132/427,25.89%,CALM1;FGFR2;ATP6V0B;UBB;ATP6V1G2;ATP6V0C;HRAS;FGF1;APOE;RALA;RPS27A;MLST8;ATP6V1F;YWHAB;VRK3;CLTA;VGF;NCK1;YES1;ATP6V0E2;FLRT2;LYN;POLR2K;CDC42;CTNNA1;NRG3;ATP6V1A;UBA52;EGR4;SH3GL1;UBC;COL4A2;AHCYL1;PPP2R1A;PGF;PTK2B;JUND;ID3;CDK5R2;PDE3B;AKT3;ELMO2;IRS2;COL6A1;SOCS1;PDGFRA;HSP90AA1;RHOA;FGF10;TGFA;CYBA;POLR2G;STAM2;NCF1;S100B;GABRB3;ABI2;TCF12;NTRK3;AP2M1;PPP2CA;GFAP;GABRG2;AKT1;FGFR3;POLR2F;LAMC3;F3;VEGFB;CXCL12;NRG4;PDGFC;LAMB1;BCAR1;ATP6V1G1;ABI1;SPARC;ID2;BAIAP2;BRK1;FOS;MAP2K1;RIT2;THBS3;VEGFC;RNMT;DUSP6;DOCK1;LYL1;WASF1;ATP6V1D;COL9A2;YAP1;PSENEN;SPRED1;GABRB2;STUB1;DUSP4;AP2B1;MAPK3;POLR2E;STMN1;SH2B3;LAMA5;MYC;NAB1;EGFR;FGF7;ITGAV;SIN3A;MXD4;FGF13;THEM4;PTPN1;AP2S1;HNRNPF;ATP6V1E1;GTF2F2;FGFBP3;DUSP7;ID1;ARF6;ITPR2;ITGB1;JUP;ASCL1;EGR1;TRIB1;NCKAP1L;ATP6V1B2;MEMO1;GRB10
gsea,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.3436850855917068,-1.3851998111860817,0.06378600823045268,0.14237417917821263,0.998,19/54,22.12%,H2AZ1;POLR2K;H2AJ;H2BC4;ERCC3;GTF2H5;TTF1;POLR1D;POLR2F;RRP8;SMARCA5;POLR1H;H2AZ2;H2BC21;H2AX;POLR2E;POLR1G;SIN3A;SAP18
gsea,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.34561333364277386,-1.3847647242482686,0.055900621118012424,0.14245029097387008,0.998,16/61,21.89%,CALM1;HRAS;GNG7;AKT3;S1PR3;HSP90AA1;TGFA;AKT1;CAV2;BCL2;FOS;GNG3;MAPK3;EGFR;CDKN1B;GNB2
gsea,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.3364577632268625,1.3836983337411748,0.04356435643564356,0.49316900841812267,1.0,18/69,10.19%,MED13;CDK8;MED24;EP300;NCOA3;MED13L;CREBBP;FAM120B;NCOA6;NCOR1;MED27;NCOA1;MED15;CARM1;HDAC3;MED26;RXRA;MED12
gsea,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.4267407184287758,-1.3834940312698885,0.09202453987730061,0.14310579793129652,0.998,9/22,20.01%,H2AZ1;CHD3;H2AJ;CBX3;H2BC4;TTF1;H2AZ2;H2BC21;H2AX
gsea,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.3919986027786633,-1.3826636100588066,0.086,0.14341267076982522,0.998,7/33,7.19%,UBB;RPS27A;RACK1;UBA52;UBC;OTULIN;TNFRSF1A
gsea,Activation Of SMO R-HSA-5635838,0.47415708245169025,1.382324953479959,0.09551656920077972,0.4842191881565285,1.0,7/16,20.35%,CSNK1A1;IQCE;KIF3A;GRK2;EVC2;ARRB1;PTCH1
gsea,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.38688010480047724,-1.3786999412766636,0.07128309572301425,0.14623972565698903,0.999,12/33,22.73%,UBB;RPS27A;UBA52;UBC;RBL1;SMAD7;SMAD2;CCNK;WWTR1;MAPK3;MYC;E2F4
gsea,RHOBTB1 GTPase Cycle R-HSA-9013422,0.4239028397405709,1.3785307829567581,0.07802874743326489,0.48195409625385294,1.0,9/23,16.47%,SRRM1;RBMX;CPSF7;ROCK1;RNF20;MYO6;ROCK2;RBBP6;COPS2
gsea,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.4147880790474893,-1.3760913041750111,0.09473684210526316,0.1481226790372831,0.999,4/24,9.85%,HRAS;FGF1;FLRT2;FGF10
gsea,Cristae Formation R-HSA-8949613,-0.48214071112401025,-1.3746168462568307,0.11570247933884298,0.14925838548393391,0.999,7/15,20.66%,ATP5PB;MTX1;MICOS10;MICOS13;MTX2;SAMM50;TMEM11
gsea,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.37390523577514945,1.3742554123472948,0.06963249516441006,0.4811327730263968,1.0,10/40,13.19%,SPTAN1;EPB41L1;ATP2B4;CLIC5;PCDH15;CDH23;MYO7A;EPB41L3;SPTBN1;KCNMA1
gsea,Metabolism Of Cofactors R-HSA-8978934,-0.45990988689312307,-1.3739980065860615,0.09900990099009901,0.1495367727893895,0.999,7/17,21.11%,CALM1;COQ2;HSP90AA1;AKT1;COQ9;IDH1;COQ3
gsea,RHO GTPases Activate Formins R-HSA-5663220,-0.30542140105589966,-1.3738796412006709,0.028077753779697623,0.1493090574901317,0.999,18/104,12.96%,DYNLL2;RPS27;ACTG1;DYNLL1;ITGB3BP;RHOB;CDC42;PFN2;NUP43;PPP2R1A;NUDC;PFN1;NDEL1;RHOA;CENPP;PPP2CA;MIS12;BUB3
gsea,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.39628209289980443,-1.3737551127861625,0.09,0.14904907853678825,0.999,10/27,22.27%,APOE;CHGA;KCTD1;TGFA;HSPD1;NPM1;SUMO1;MYC;EGFR;CITED2
gsea,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.26679882110602515,-1.3726500393761913,0.01680672268907563,0.14958092407820134,0.999,82/328,21.43%,UBE3A;UBB;HMGB1;PSMA3;PSMD7;SEC61G;CALR;PSMB3;RPS27A;FBXL16;PSMC6;PSMC1;CANX;RNF114;ELOB;PSMB6;UBE2A;PSMC3;UBA52;RNF138;UBC;ANAPC13;BTK;SAR1B;FBXL14;PSMA2;HSPA5;PSMA7;ASB14;PSMB7;PSMB1;PSMC5;PJA1;SOCS1;UBE2B;LRRC41;PSMB5;CYBA;NCF1;B2M;UBE2V1;FBXL22;SEC61B;FBXW11;PSMD11;FBXO9;PSMA4;VAMP3;UBE2R2;UBE2K;PSMF1;RNF7;RNF115;RLIM;FBXL8;UBE2D3;NDUFA2;UBE2E3;TRIM32;FBXO15;FBXO27;CTSL;SEM1;FBXW2;KBTBD7;ASB13;FBXW4;PSMB4;STUB1;PSMD2;ZNRF2;RNF182;CTSS;RNF34;BTBD1;KLHL25;UBE2J2;IKBKG;MKRN1;ITGAV;UBE2N;HECW2
gsea,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.34537416600659226,-1.372425677720641,0.07039337474120083,0.14942472613498406,0.999,18/51,22.12%,H2AZ1;POLR2K;H2AJ;H2BC4;ERCC3;GTF2H5;TTF1;POLR1D;POLR2F;SMARCA5;POLR1H;H2AZ2;H2BC21;H2AX;POLR2E;POLR1G;SIN3A;SAP18
gsea,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.456980941670078,-1.3721211308413057,0.09090909090909091,0.14934279915178778,0.999,9/17,25.92%,HSP90AB1;TXN2;NFKB2;RELA;ENTPD1;GSDMD;PYCARD;IL18;PSTPIP1
gsea,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.42409796419513984,-1.3717313189653766,0.10344827586206896,0.14927959543464947,0.999,6/23,12.69%,CALM1;MLST8;CTNNA1;AKT3;HSP90AA1;AKT1
gsea,CTLA4 Inhibitory Signaling R-HSA-389513,-0.4442615023985812,-1.3713607906963388,0.10187110187110188,0.1492679281585091,0.999,6/21,12.69%,YES1;LYN;PPP2R1A;AKT3;PPP2CA;AKT1
gsea,Signaling By WNT R-HSA-195721,-0.2780882329526263,-1.3707944934625034,0.030612244897959183,0.14937317506477527,0.999,64/238,20.48%,CALM1;UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;CLTB;H2AZ1;CLTA;PSMC1;SNX3;PARD6A;PSMB6;PSMC3;UBA52;UBC;GNG7;H2AJ;PPP3R1;PSMA2;PPP2R1A;PSMA7;H2BC4;PPP3CA;PFN1;PSMB7;PSMB1;PSMC5;TLE5;RHOA;PSMB5;AP2M1;PPP2CA;PLCB1;YWHAZ;PSMD11;AKT1;PSMA4;VANGL2;CSNK2B;PSMF1;TMED5;FZD1;PRKG1;VPS29;H2AZ2;SEM1;RUVBL1;TERT;H2BC21;RBBP5;CTBP2;PSMB4;FZD9;PSMD2;CTNNBIP1;FRAT1;AP2B1;GNG3;H2AX;MYC;FZD2
gsea,Meiotic Recombination R-HSA-912446,-0.39570777673848867,-1.370201855781865,0.08768267223382047,0.14954352094870077,0.999,10/29,20.01%,H2AZ1;PSMC3IP;H2AJ;H2BC4;RAD51C;MLH1;RAD51;H2AZ2;H2BC21;H2AX
gsea,FLT3 Signaling R-HSA-9607240,-0.3855030105962,-1.3646832237382267,0.07157464212678936,0.15399164076639585,0.999,6/34,7.82%,UBB;HRAS;RPS27A;UBA52;UBC;AKT3
gsea,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.32797096484198063,-1.3639003570965316,0.057569296375266525,0.15439363525887345,0.999,16/66,16.73%,YWHAG;TUBA1A;YWHAE;DYNLL1;TUBB4B;TUBA4A;CEP72;PPP2R1A;DCTN1;CEP78;HSP90AA1;SSNA1;TUBB4A;HAUS5;HAUS2;CETN2
gsea,GPCR Ligand Binding R-HSA-500792,-0.2725490877366153,-1.362515328210217,0.007936507936507936,0.15538723429850268,0.999,58/215,27.49%,GLP2R;P2RY14;P2RY12;PLPPR4;CX3CR1;CHGA;RAMP1;PTRH2;PLPPR5;PTGER4;NTSR2;GNG7;NPY;HTR4;PROK2;S1PR3;GRM1;NMUR1;SSTR2;HEBP1;OPN4;GPNMB;CORT;P2RY1;RXFP3;GNAS;FZD1;CXCL12;PNOC;POMC;CALCB;PTHLH;NPFFR1;ACKR3;PENK;HTR5A;FZD9;CXCR4;LPAR1;GNG3;FZD2;CALCA;GNB2;P2RY13;SSTR4;ADGRE1;NPFF;MRLN;CCL25;NTSR1;WNT2B;ADRA1D;ADRA2C;GNG10;EDNRA;CCR9;CX3CL1;MC1R
gsea,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.4394000593679329,-1.3587279749495604,0.11623246492985972,0.1583366967388916,0.999,4/20,5.23%,UBB;RPS27A;UBA52;UBC
gsea,Base Excision Repair R-HSA-73884,-0.3436749112941463,-1.358612693696555,0.07399577167019028,0.15806689284824246,0.999,14/50,23.41%,H2AZ1;POLD4;H2AJ;H2BC4;MPG;PCNA;PNKP;POLE4;POLE3;H2AZ2;H2BC21;H2AX;TDG;ADPRS
gsea,Metabolism Of Nucleotides R-HSA-15869,-0.3164953126278883,-1.3584496649482487,0.05454545454545454,0.15785581530246265,0.999,24/77,22.90%,NME2;UCKL1;NUDT5;TK2;DTYMK;NME4;AK6;TXN2;DUT;DGUOK;NUDT16;RRM2B;AK1;TXNRD1;APRT;GLRX;ENTPD1;SCO2;NUDT9;ADK;DCK;NUDT18;PAICS;AK7
gsea,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.4040452673265784,-1.35821172197765,0.1022964509394572,0.15771740866838907,0.999,7/28,7.55%,LAMTOR2;MLST8;LAMTOR3;RRAGA;LAMTOR1;RHEB;CAB39L
gsea,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.3399457373508302,-1.3560119429831956,0.06912442396313365,0.1592611440851268,0.999,16/55,26.46%,GLP2R;RAMP1;PTRH2;GNG7;GNAS;FZD1;CALCB;PTHLH;FZD9;GNG3;FZD2;CALCA;GNB2;ADGRE1;WNT2B;GNG10
gsea,Ub-specific Processing Proteases R-HSA-5689880,-0.28738200143316783,-1.3542986215353414,0.03655913978494624,0.1603552905926176,0.999,42/150,20.83%,UBB;VDAC1;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;SNX3;PTRH2;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;H2BC4;TRAF6;PSMB7;OTUB1;PSMB1;PSMC5;VDAC2;PSMB5;FKBP8;STAM2;TOMM20;PSMD11;PSMA4;SMAD7;SMAD2;PSMF1;TADA3;SEM1;RUVBL1;H2BC21;PSMB4;PSMD2;USP2;MYC;IKBKG;FOXO4
gsea,CDC42 GTPase Cycle R-HSA-9013148,0.3099811988195212,1.3536680178258653,0.06505576208178439,0.5277439052623196,1.0,48/137,20.97%,TRIO;MYO9B;IQGAP1;FNBP1;SHKBP1;DOCK7;DOCK9;GIT1;FAM13B;ARHGEF15;PIK3R2;WIPF2;CDC42BPB;CDC42BPA;OPHN1;WDR81;ARHGAP32;WIPF1;ARHGEF11;GMIP;SRGAP1;VANGL1;PLEKHG1;ARHGAP42;SRGAP2;SYDE1;FNBP1L;PLEKHG4;SCRIB;ARHGAP35;DOCK11;CDC42EP5;MCF2L;DNMBP;GIT2;ARHGAP17;ARHGAP21;DLC1;ARAP1;ARHGEF10;ARHGAP33;RASGRF2;REPS1;ITSN1;ECT2;CDC42EP2;ARAP3;DAAM1
gsea,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.3869550183937477,-1.3534072220346445,0.10721649484536082,0.16069301848173428,0.999,5/34,5.79%,CALM1;HRAS;YWHAB;PEBP1;CNKSR2
gsea,AURKA Activation By TPX2 R-HSA-8854518,-0.3261703589515859,-1.3532573417877816,0.06493506493506493,0.16045709731651642,0.999,16/67,16.73%,YWHAG;TUBA1A;YWHAE;DYNLL1;TUBB4B;TUBA4A;CEP72;PPP2R1A;DCTN1;CEP78;HSP90AA1;SSNA1;TUBB4A;HAUS5;HAUS2;CETN2
gsea,ESR-mediated Signaling R-HSA-8939211,-0.2879094615073475,-1.3495478273044483,0.05220883534136546,0.1632431519144517,0.999,39/144,21.09%,CALM1;DDX5;HSP90AB1;HRAS;JUN;H2AZ1;POLR2K;GNG7;H2AJ;POU2F1;H2BC4;GPAM;JUND;AKT3;FKBP5;S1PR3;PTGES3;HSP90AA1;TGFA;POLR2G;USF1;AKT1;PPID;CAV2;POLR2F;CBFB;CXCL12;BCL2;FOS;H2AZ2;H2BC21;GNG3;MAPK3;H2AX;POLR2E;MYC;EGFR;FKBP4;CDKN1B
gsea,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.43168087515071174,-1.3494271944581542,0.11328125,0.16298136510756628,0.999,7/20,16.52%,TECR;HACD4;ACSL3;HSD17B12;HACD2;ELOVL6;ELOVL4
gsea,mRNA Splicing - Minor Pathway R-HSA-72165,-0.33988694745329984,-1.3478881619871668,0.05263157894736842,0.16398444403946127,0.999,13/49,15.70%,SNRPF;SNRPG;POLR2K;TXNL4A;SRSF2;SF3B6;SNRPD2;ZCRB1;POLR2G;SF3B5;POLR2F;SNRNP35;SNRPD3
gsea,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.4535495404190125,1.3467164128539943,0.12619502868068833,0.5349579281584756,1.0,4/17,3.44%,TNRC6B;TNRC6A;MOV10;AGO4
gsea,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.4118251860048193,-1.3466029878079908,0.12981744421906694,0.16488796967912228,0.999,3/26,1.62%,CALM1;HRAS;NEFL
gsea,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.37121362519003426,-1.3439452206660596,0.09594882729211088,0.16697178530668264,0.999,11/32,24.61%,ACOT13;ACOT12;NDUFAB1;MCEE;ACBD6;DBI;ACOT2;MECR;THEM4;MCAT;ACOT9
gsea,MET Promotes Cell Motility R-HSA-8875878,0.3962996835528794,1.3438479507326098,0.10556621880998081,0.5306271245471109,1.0,9/26,14.47%,DOCK7;ITGA3;PTK2;GRB2;LAMC2;LAMA4;LMNB2;CRKL;CRK
gsea,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.30898640693158475,-1.3435480103129482,0.06553911205073996,0.16699860855055443,0.999,22/85,22.04%,FGFR2;FGF1;GSK3B;MLST8;NRG3;AKT3;IRS2;PDGFRA;RPS6KB2;FGF10;TGFA;AKT1;FGFR3;NR4A1;NRG4;RNMT;EGFR;FOXO4;FGF7;FOXO1;CDKN1B;FGF13
gsea,Phase I - Functionalization Of Compounds R-HSA-211945,-0.33823968359451273,-1.3418755551414199,0.07764705882352942,0.16826385965101426,0.999,16/48,25.32%,HSP90AB1;CYP7B1;PTGS1;FDX1;PTGES3;VDAC2;FDXR;PTGIS;POMC;FDX2;CYB5B;AURKAIP1;NQO2;AHRR;BPHL;CMBL
gsea,Signaling By Hedgehog R-HSA-5358351,-0.2920954001107004,-1.3414081213010967,0.059063136456211814,0.1683261198827789,0.999,24/125,13.87%,UBB;GSK3B;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;PSMB7;PSMB1;PSMC5;P4HB;PSMB5;GNAS;PSMD11;PSMA4;NOTUM;PSMF1
gsea,Tie2 Signaling R-HSA-210993,-0.45684706753598747,-1.3408738349909035,0.13673469387755102,0.16846822324773356,0.999,3/15,3.93%,HRAS;ANGPT2;TEK
gsea,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.3552882725482055,-1.3402618837189397,0.08196721311475409,0.16872440146636453,0.999,7/42,9.56%,UBB;SUMO2;RPS27A;UBA52;UBC;ERCC3;GTF2H5
gsea,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.31387270530915984,-1.3397914443447436,0.059574468085106386,0.1687575004778585,0.999,18/75,15.12%,UBB;RPS27A;POLD4;POLR2K;UBA52;UBC;ERCC3;HMGN1;PCNA;COPS5;GTF2H5;POLR2G;POLE4;COPS6;POLE3;POLR2F;TCEA1;PRPF19
gsea,Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.45652241872290966,-1.338814710759859,0.1392156862745098,0.16942719112799223,0.999,5/18,4.09%,RAB3A;VAMP2;CPLX1;PPFIA2;RIMS1
gsea,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.4187221637373156,-1.3381106625681753,0.1278825995807128,0.16978319522742444,0.999,7/20,21.40%,H2AZ1;H2AJ;H2BC4;H2AZ2;H2BC21;H2AX;TDG
gsea,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.398948603643199,-1.3375682347131364,0.09205020920502092,0.16997571406658926,0.999,10/26,20.04%,H2AZ1;POLR2K;H2AJ;H2BC4;POLR2G;POLR2F;H2AZ2;H2BC21;H2AX;POLR2E
gsea,Processing Of SMDT1 R-HSA-8949664,-0.456070972912375,-1.335599490624247,0.1262135922330097,0.1713913267596197,0.999,8/15,37.86%,SMDT1;STOML2;MAIP1;SPG7;PHB2;AFG3L2;PARL;PMPCA
gsea,Signaling By FGFR3 In Disease R-HSA-5655332,-0.4444642711688777,-1.3346125415023062,0.14770459081836326,0.17198776819335376,0.999,2/16,1.07%,HRAS;FGF1
gsea,Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.43387437847998345,-1.3320759241784599,0.1298449612403101,0.1741562831442206,0.999,7/22,11.67%,RAB3A;VAMP2;CPLX1;PPFIA2;RIMS1;ARL6IP5;SLC1A6
gsea,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.2742224833833174,-1.3314832145159823,0.0234375,0.17440944884546145,0.999,42/151,28.10%,P2RY14;P2RY12;PLPPR4;CX3CR1;CHGA;PLPPR5;PTGER4;NTSR2;NPY;HTR4;PROK2;S1PR3;NMUR1;SSTR2;HEBP1;OPN4;GPNMB;CORT;P2RY1;RXFP3;CXCL12;PNOC;POMC;NPFFR1;ACKR3;PENK;HTR5A;CXCR4;LPAR1;P2RY13;SSTR4;NPFF;MRLN;CCL25;NTSR1;ADRA1D;ADRA2C;EDNRA;CCR9;CX3CL1;MC1R;ACKR4
gsea,RAF Activation R-HSA-5673000,-0.39698856449849845,-1.3313191256113497,0.1115702479338843,0.17418434562932442,0.999,4/30,6.07%,CALM1;HRAS;YWHAB;PPP2R1A
gsea,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.3833321014335528,-1.3307012468788275,0.10743801652892562,0.1743683422709726,0.999,4/30,5.23%,UBB;RPS27A;UBA52;UBC
gsea,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.3424344624794071,-1.3245070083052413,0.08113590263691683,0.18003937674351034,0.999,15/50,17.01%,UBB;RPS27A;POLR2K;UBA52;UBC;ERCC3;HMGN1;COPS5;GTF2H5;POLR2G;COPS6;POLR2F;TCEA1;PRPF19;COPS8
gsea,P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.30371630330350086,-1.3241771686454662,0.07157464212678936,0.17995946941173302,0.999,13/88,11.41%,UBB;BEX3;YWHAE;RPS27A;MAGED1;ITGB3BP;ARHGEF4;UBA52;UBC;TRAF6;RHOA;SQSTM1;SMPD2
gsea,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.4156306562391778,-1.3220579549719407,0.1026694045174538,0.18166082505515874,0.999,5/20,25.47%,ABCD3;PEX26;PEX19;FIS1;ACBD5
gsea,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.311330094885869,-1.3202393633752476,0.0851063829787234,0.1831155168937545,0.999,20/83,16.86%,RAB3A;YWHAE;SBF1;RAB5B;RAB6A;DENND1A;HPS4;AKT3;RAB18;TRAPPC6A;RAB38;TRAPPC2L;RAB6B;TRAPPC4;RAB14;AKT1;TRAPPC6B;TRAPPC2;DENND2A;RAB5A
gsea,tRNA Processing In Nucleus R-HSA-6784531,-0.32973374853139603,-1.3198342235063147,0.09561752988047809,0.18306660254537532,0.999,9/51,13.27%,POP5;RAN;RPP21;TSEN15;POP7;NUP43;RPP38;NUP50;RPP25
gsea,Meiosis R-HSA-1500620,-0.3251949147528117,-1.319381104683271,0.07474747474747474,0.18317907370465508,0.999,10/54,11.50%,HSPA2;SYCP3;H2AZ1;SYCP2;PSMC3IP;H2AJ;H2BC4;RAD51C;MLH1;RAD51
gsea,EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.45811587215431104,-1.3183020041990912,0.12704918032786885,0.18399473330040164,0.999,5/15,13.19%,MYL6;YES1;LYN;RHOA;MYL9
gsea,Apoptotic Execution Phase R-HSA-75153,0.36320766554227735,1.31763678693674,0.11281070745697896,0.5999900762881044,1.0,9/39,9.86%,SPTAN1;MAPT;FNTA;PTK2;SATB1;ACIN1;ROCK1;ADD1;GAS2
gsea,Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.44965730823064565,-1.3168694323801344,0.12058212058212059,0.18504769854421974,0.999,3/17,4.83%,CHST9;CHST15;CSPG5
gsea,Nucleotide Excision Repair R-HSA-5696398,-0.28836199668492596,-1.3168388495473287,0.06995884773662552,0.1846914911661083,0.999,29/105,21.42%,UBB;SUMO2;RPS27A;POLD4;POLR2K;UBA52;UBC;ERCC3;HMGN1;PCNA;COPS5;GTF2H5;POLR2G;POLE4;INO80B;COPS6;POLE3;POLR2F;TCEA1;PRPF19;SUMO1;CETN2;COPS8;RUVBL1;INO80D;PIAS1;POLR2E;COPS7A;UBE2N
gsea,Clathrin-mediated Endocytosis R-HSA-8856828,-0.2900306748698214,-1.3159523088940281,0.04483430799220273,0.1851958334065722,0.999,34/121,20.93%,UBB;VAMP2;ARPC3;RPS27A;CLTB;CLTA;NECAP1;NEDD8;HSPA8;RAB5B;UBA52;SH3GL1;UBC;ARPC2;WASL;LDLR;REPS2;ARPC5;COPS5;TGFA;STAM2;ACTR3;AP2M1;COPS6;VAMP3;TFRC;ACTR2;RAB5A;COPS8;TOR1A;SCARB2;AP2B1;EGFR;COPS7A
gsea,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.46058551679857923,-1.3156149433667201,0.13078470824949698,0.18513652771812844,0.999,4/15,12.69%,CALM1;WASL;HSP90AA1;AKT1
gsea,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.32486834367587336,-1.3139446841752462,0.06666666666666667,0.18638718389591558,0.999,13/58,22.04%,FGFR2;FGF1;NRG3;IRS2;PDGFRA;FGF10;TGFA;FGFR3;NRG4;RNMT;EGFR;FGF7;FGF13
gsea,Cholesterol Biosynthesis R-HSA-191273,-0.4128794078823108,-1.313615310109144,0.15547024952015356,0.18635872675617507,0.999,11/23,31.39%,FDFT1;MSMO1;SREBF2;PLPP6;HMGCR;HMGCS1;SQLE;SC5D;ARV1;DHCR7;IDI1
gsea,Phosphorylation Of APC/C R-HSA-176412,0.4384111293497386,1.313519209603261,0.15204678362573099,0.599653189293015,1.0,8/17,22.99%,ANAPC1;ANAPC5;CDC23;ANAPC11;CDC27;ANAPC15;UBE2S;ANAPC2
gsea,Metabolism Of Steroids R-HSA-8957322,-0.2959562889842255,-1.3131212840526159,0.06935123042505593,0.1864921820426676,0.999,33/108,24.48%,SUMO2;RAN;FDFT1;CYP7B1;SYCP2;CHGA;MSMO1;INSIG2;SREBF2;SAR1B;STARD4;FDX1;GPAM;HSD17B12;NFYA;PLPP6;FDXR;PTGIS;HSD11B1;POMC;FDX2;ELOVL6;HMGCR;PPARA;HMGCS1;CH25H;SLC10A1;TBL1XR1;SQLE;AMACR;STARD3NL;INSIG1;ACOX2
gsea,Other Interleukin Signaling R-HSA-449836,-0.42114902690937883,-1.3094388443071112,0.13513513513513514,0.1899102479848253,0.999,6/18,23.77%,VAMP2;CSF1R;TYK2;IL16;PRTN3;IL34
gsea,Regulation Of Complement Cascade R-HSA-977606,-0.4378148497398615,-1.3088034621825877,0.15337423312883436,0.19004564585717,0.999,10/20,25.41%,CD81;C1QB;PSMA7;CLU;C1QC;CPNE2;SERPING1;CR2;C1QA;CFH
gsea,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.37866675281906415,1.3047790163196,0.14583333333333334,0.6147056105932485,1.0,11/29,12.26%,TNRC6B;TNRC6A;MOV10;AGO4;NCOR1;CAMK2D;PRKCA;HDAC3;TNRC6C;CAMK2A;MECP2
gsea,Glucagon-type Ligand Receptors R-HSA-420092,-0.41353318769148495,-1.3040303094217631,0.12916666666666668,0.19464647747623662,0.999,6/21,26.46%,GLP2R;GNG7;GNAS;GNG3;GNB2;GNG10
gsea,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.4008191058493795,-1.2979446985883039,0.12581344902386118,0.2005938167897541,0.999,4/21,13.30%,POLD4;PCNA;POLE4;POLE3
gsea,PI3K Cascade R-HSA-109704,-0.36484665881072675,-1.2963636485451835,0.13617886178861788,0.2016965153095205,0.999,9/32,22.36%,FGFR2;FGF1;PDE3B;IRS2;FGF10;FGFR3;FGF7;FGF13;THEM4
gsea,Nuclear Envelope Breakdown R-HSA-2980766,0.3390310443797211,1.2945236986993152,0.10993657505285412,0.6360414363811162,1.0,15/46,19.10%,VRK2;NUP214;NUP205;RANBP2;PRKCB;NEK9;PRKCA;LPIN1;NUP188;NUP155;LEMD3;NUP88;NUP98;NUP133;LMNB1
gsea,PPARA Activates Gene Expression R-HSA-1989781,0.29437639082974965,1.2939931567821708,0.07770961145194274,0.6240946128422317,1.0,25/102,11.82%,MED13;NPAS2;CDK8;MED24;ARNT2;EP300;NCOA3;MED13L;CREBBP;ABCA1;FAM120B;NCOA6;NCOR1;MED27;NCOA1;MED15;CARM1;RORA;HDAC3;MED26;RXRA;PCDHB16;MED12;NFYC;NRF1
gsea,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.30521159293067435,-1.2937687673930576,0.09375,0.2041023975330045,0.999,29/74,35.13%,DPM1;NAGK;DPM2;ALG11;DOLK;DPM3;ALG5;PMM1;SLC35A1;EGFL7;GMDS;ALG12;ALG13;ALG2;NANP;CMAS;FUOM;SLC35C1;NANS;RFT1;MPDU1;GFPT2;SRD5A3;ST3GAL5;GFPT1;ST6GALNAC2;ST3GAL6;ST3GAL2;GMPPB
gsea,PERK Regulates Gene Expression R-HSA-381042,-0.382370864608358,-1.29102452070868,0.11713665943600868,0.20653419833736825,1.0,14/26,36.25%,CEBPB;HSPA5;NFYA;ATF4;EXOSC7;ATF6;EXOSC5;EIF2S2;ASNS;DDIT3;NFYB;HERPUD1;EXOSC8;EXOSC4
gsea,Interleukin-6 Family Signaling R-HSA-6783589,0.4460049963845908,1.2900869451310375,0.14092664092664092,0.6239066544676223,1.0,5/15,11.15%,STAT1;IL31RA;CCM2;CBL;JAK2
gsea,Mitotic Prometaphase R-HSA-68877,-0.26807877883170766,-1.2872057635223513,0.05194805194805195,0.21031685492970717,1.0,32/165,16.73%,YWHAG;TUBA1A;DYNLL2;RPS27;NME7;YWHAE;DYNLL1;TUBB4B;ITGB3BP;TUBA4A;CEP72;NUP43;PPP2R1A;NUDC;NCAPH;DCTN1;CEP78;NDEL1;HSP90AA1;CENPP;TUBG2;PPP2CA;MIS12;NCAPD2;SSNA1;BUB3;TUBB4A;CSNK2B;NEK7;HAUS5;HAUS2;CETN2
gsea,Apoptotic Factor-Mediated Response R-HSA-111471,-0.4189339986549818,-1.287059904901884,0.15513626834381553,0.21004881630961883,1.0,5/18,20.00%,GSDME;CYCS;C1QBP;MAPK3;GSDMD
gsea,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.31181785504478776,1.2837133371937868,0.10392156862745099,0.6326169645311623,1.0,16/68,11.60%,KIF1B;KIFC2;KIF5A;KIF5B;KIF21A;ZW10;KIF3C;KIF16B;KIF13B;NBAS;KIF11;KIF1A;KIF3A;ARCN1;KIFC1;KLC4
gsea,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.3646992238291916,-1.2834809499187794,0.1396761133603239,0.21377651550379811,1.0,11/30,28.78%,DPH3;DHPS;DNAJC24;ARSJ;EEF2;FN3K;EIF5A2;DPH6;ARSB;FN3KRP;FURIN
gsea,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.4161098860706429,1.2831954014025573,0.1553784860557769,0.6214465128080705,1.0,8/19,19.25%,ANAPC1;ANAPC5;BUB1B;CDC23;ANAPC11;CDC27;ANAPC15;UBE2S
gsea,MHC Class II Antigen Presentation R-HSA-2132295,-0.3017031825349368,-1.2829068646574575,0.10216110019646366,0.21403836086760328,1.0,24/81,20.19%,ACTR1B;DYNLL2;DYNLL1;CLTA;CTSB;CANX;CAPZA2;SAR1B;KIF22;AP1S1;DCTN1;CTSC;AP2M1;AP1S3;KIF15;ACTR10;DCTN4;CTSL;IFI30;CTSS;AP2B1;CAPZA1;AP1S2;DCTN3
gsea,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.4049547277202624,-1.2828835485109589,0.13305613305613306,0.21363231597670812,1.0,8/21,26.46%,GNG7;AKT3;RHOA;AKT1;PIK3CG;GNG3;GNB2;GNG10
gsea,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.26431205545912795,-1.2826253878232268,0.06423982869379015,0.21347867636476622,1.0,46/203,22.37%,CALM1;TMSB4X;TTR;PPIA;P2RY12;LYN;MANF;RHOB;APOA1;TUBA4A;CDC42;TGFB1;TIMP3;GNG7;OLA1;HSPA5;PFN1;PCDH7;CAP1;RHOA;CLU;P2RY1;YWHAZ;ENDOD1;AKT1;PCYOX1L;VTI1B;CD63;VEGFB;SOD1;BCAR1;SPARC;CLEC3B;FAM3C;VEGFC;PIK3CG;APLP2;FERMT3;GNG3;MAPK3;STXBP3;LHFPL2;GNA15;GNB2;SERPING1;PTPN1
gsea,Arachidonic Acid Metabolism R-HSA-2142753,-0.3775986787127087,-1.2781350668223723,0.14416475972540047,0.21798737513115474,1.0,13/29,28.84%,HPGDS;PTGS1;PTGES3;PTGIS;CBR1;PTGDS;GPX1;PRXL2B;GPX4;PTGR2;ALOX5;PTGES2;HPGD
gsea,Glucose Metabolism R-HSA-70326,-0.3042410080100481,-1.2780782044680736,0.10590631364562118,0.21762063931485945,1.0,18/74,17.08%,TPI1;MDH2;ENO2;NUP43;PPP2R1A;ALDOC;GAPDHS;PKM;MDH1;PPP2CA;PGP;NUP50;PGK1;PGAM2;SLC25A11;BPGM;PFKL;PFKFB1
gsea,Drug ADME R-HSA-9748784,-0.345855945846722,-1.2778106456335943,0.11956521739130435,0.2175397730503992,1.0,7/33,12.90%,NME2;ACY1;CNDP2;BSG;TPMT;SLC16A1;SLC38A3
gsea,Visual Phototransduction R-HSA-2187338,-0.3094805532752537,-1.2772762694983322,0.10648148148148148,0.21775580665753466,1.0,12/59,16.39%,CALM1;TTR;APOE;APOA1;NAPEPLD;LDLR;GPC4;RETSAT;SDC4;RNF7;RBP4;SLC24A1
gsea,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.38799378086242314,-1.2762887547055315,0.15757575757575756,0.2183974369144677,1.0,7/27,16.16%,CALM1;HSP90AB1;VAMP2;HSP90AA1;TXNRD1;EEF2;MAP2K1
gsea,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.32404051781580767,1.2744344524313802,0.125,0.6383354100252744,1.0,16/56,13.19%,SPTAN1;PCLO;EPB41L1;ATP2B4;CLIC5;PCDH15;CDH23;CACNA2D2;SYN1;STX1A;MYO7A;OTOF;BSN;EPB41L3;SPTBN1;KCNMA1
gsea,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.3993831296672908,-1.2729171411481393,0.16114790286975716,0.2218124865901503,1.0,11/22,32.68%,MAGED1;CASP8;NDUFA2;FADD;DCC;LY96;TLR4;TRADD;TICAM1;TNFRSF10B;TANK
gsea,Phospholipid Metabolism R-HSA-1483257,0.2717964052597298,1.2720494800151065,0.09270216962524655,0.6339481365850379,1.0,45/180,16.35%,SLC44A2;PIKFYVE;PLEKHA6;MIGA1;CPNE1;MIGA2;ENPP6;PI4KA;INPP5K;SYNJ1;VAC14;TNFAIP8L3;CHEK2;PIK3R2;PLEKHA1;PLD2;PIK3C2B;PNPLA6;OCRL;TMEM86B;DDHD1;LPIN1;OSBPL10;PI4K2B;STARD10;CLSTN1;INPP5J;MTM1;CPNE7;PLA2G4E;CHKA;MTMR2;SYNJ2;PIK3CA;PEMT;INPP4A;HADHB;SBF2;PITPNM3;PIK3C2G;GPAT3;GPAT4;PLA2G4A;MTMR14;PIP5K1C
gsea,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.3643453774652039,-1.270345853258045,0.1545253863134658,0.2244119068537002,1.0,9/31,20.33%,H2AZ1;CEBPB;H2AJ;H2BC4;CBFB;H2AZ2;H2BC21;H2AX;MYC
gsea,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.36689988462232614,-1.2702978224278014,0.14087301587301587,0.22400510454884992,1.0,4/29,5.47%,CALM1;YES1;LYN;AHCYL1
gsea,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.2882110867202425,1.2702053513047573,0.09146341463414634,0.6280336529525379,1.0,25/104,11.82%,MED13;NPAS2;CDK8;MED24;ARNT2;EP300;NCOA3;MED13L;CREBBP;ABCA1;FAM120B;NCOA6;NCOR1;MED27;NCOA1;MED15;CARM1;RORA;HDAC3;MED26;RXRA;PCDHB16;MED12;NFYC;NRF1
gsea,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.31324275261303536,-1.2693348225644805,0.1271551724137931,0.22470494645227707,1.0,9/60,9.49%,DPM1;NAGK;DPM2;DOLK;DPM3;ALG5;PMM1;SLC35A1;EGFL7
gsea,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.24730810950188545,-1.2687618029256884,0.05979381443298969,0.2249797806367772,1.0,86/378,21.20%,CALM1;FGFR2;UBB;HRAS;FGF1;FKBP1A;GSK3B;PSMA3;EEF1G;PSMD7;PSMB3;RPS27A;MLST8;YWHAB;PSMC6;PSMC1;YES1;PEBP1;LYN;POLR2K;TGFB1;NRG3;PSMB6;PSMC3;BAG4;UBA52;UBC;CEBPB;HDAC11;CNKSR2;PSMA2;PPP2R1A;PSMA7;PSMB7;MAML3;PSMB1;PSMC5;AKT3;DCTN1;IRS2;PDGFRA;HSP90AA1;SNW1;RPS6KB2;FGF10;TGFA;PSMB5;POLR2G;SQSTM1;BIN2;PPP2CA;NPM1;PSMD11;RPS6;AKT1;PSMA4;FGFR3;NR4A1;POLR2F;SMAD2;PSMF1;NRG4;MAP2K1;AGTRAP;JAG1;SEM1;RNMT;DUSP6;MAML2;CTBP2;PSMB4;PSENEN;SPRED1;PSMD2;CAMK2B;MAPK3;POLR2E;FIP1L1;MYC;EGFR;TBL1XR1;FOXO4;FGF7;FOXO1;CDKN1B;QKI
gsea,ER To Golgi Anterograde Transport R-HSA-199977,-0.28108875812683953,-1.2669836029324977,0.09430255402750491,0.22653655419515864,1.0,32/120,17.87%,DYNLL2;CNIH2;DYNLL1;CNIH1;TMED2;TMED7;PREB;TMED9;CAPZA2;SAR1B;CTSZ;LMAN1;DCTN1;TRAPPC6A;BET1;TGFA;TRAPPC2L;CTSC;NSF;TRAPPC4;PPP6C;TRAPPC6B;COG5;MCFD2;COPE;TRAPPC2;BET1L;ACTR10;COG1;DCTN4;LMAN2;ARF5
gsea,Insulin Processing R-HSA-264876,0.37860752006692683,1.266966432840263,0.15833333333333333,0.627446471239127,1.0,7/24,10.83%,MYO5A;KIF5A;KIF5B;EXOC1;MYRIP;EXOC7;STX1A
gsea,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.3434609490289921,-1.2666841392596233,0.12845849802371542,0.22643633538041275,1.0,15/38,23.45%,POLR2K;POLR3H;POU2F1;POLR3E;POLR1D;POLR2F;POLR3A;NFIA;GTF3A;POLR3K;GTF3C6;POLR2E;BRF2;SNAPC1;POLR3D
gsea,Insulin Receptor Signaling Cascade R-HSA-74751,-0.33769913671260643,-1.2637296771644222,0.13793103448275862,0.22952827723809427,1.0,11/40,22.36%,FGFR2;HRAS;FGF1;PDE3B;IRS2;FGF10;FGFR3;MAPK3;FGF7;FGF13;THEM4
gsea,Signaling By TGFB Family Members R-HSA-9006936,-0.28382823136950275,-1.2628180079138385,0.09873949579831932,0.23019781922084512,1.0,23/109,15.74%,UBB;FKBP1A;RPS27A;NEDD8;PARD6A;TGFB1;UBA52;UBC;ITGA8;FST;INHBA;RBL1;SNW1;RHOA;BMPR1B;PPP1CA;BMPR1A;SMAD7;SMAD2;SRFBP1;CCNK;UBE2D3;WWTR1
gsea,Signaling By Hippo R-HSA-2028269,-0.3934591621811627,-1.2624618329852648,0.15212981744421908,0.2301190643154805,1.0,5/20,18.85%,YWHAE;YWHAB;WWTR1;YAP1;MOB1A
gsea,DNA Double Strand Break Response R-HSA-5693606,-0.3276417158000254,-1.2612040705447858,0.13078470824949698,0.23105882837218145,1.0,13/43,21.42%,UBB;RPS27A;EYA1;UBA52;UBC;H2BC4;BABAM2;SMARCA5;SUMO1;H2BC21;APBB1;H2AX;UBE2N
gsea,RND2 GTPase Cycle R-HSA-9696270,0.3466169509361511,1.2598617250691164,0.1402061855670103,0.6397274543996453,1.0,19/38,25.38%,DST;FNBP1;RBMX;ANKRD26;PIK3R2;PLXND1;VANGL1;SCRIB;ARHGAP35;LEMD3;GOLGA3;PRAG1;KIDINS220;CKAP4;PKP4;KTN1;WDR6;DLG5;RND2
gsea,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.4249849753778161,1.2588791241415156,0.19246031746031747,0.6313325648076441,1.0,7/19,12.47%,PTPRS;PPFIA3;SLITRK1;PPFIA1;PTPRF;PTPRD;IL1RAPL2
gsea,Recycling Pathway Of L1 R-HSA-437239,0.3763030484261055,1.258798603437026,0.17137096774193547,0.6204523231781097,1.0,9/25,13.83%,CLTC;DNM2;DNM1;L1CAM;RPS6KA2;DNM3;RPS6KA4;RPS6KA6;AP2A1
gsea,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.3016874090468791,-1.2578602554093181,0.11063829787234042,0.23465508551371012,1.0,11/61,13.30%,UBB;RPS27A;POLD4;UBA52;UBC;PCNA;RAD51C;RAD9B;POLE4;RAD51;POLE3
gsea,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.38420314698848834,-1.2575321905289318,0.1735357917570499,0.2345649687277763,1.0,12/22,36.25%,CEBPB;NFYA;ATF4;EXOSC7;ATF6;EXOSC5;ASNS;DDIT3;NFYB;HERPUD1;EXOSC8;EXOSC4
gsea,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.33026390375918524,-1.2572939337700355,0.1310483870967742,0.23441948413808758,1.0,13/42,21.42%,UBB;RPS27A;EYA1;UBA52;UBC;H2BC4;BABAM2;SMARCA5;SUMO1;H2BC21;APBB1;H2AX;UBE2N
gsea,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.39008053607919896,-1.2552948175687357,0.18962075848303392,0.23637852406415352,1.0,4/23,5.23%,UBB;RPS27A;UBA52;UBC
gsea,RNA Polymerase III Transcription Initiation R-HSA-76046,-0.34868478233752104,-1.2552671948765948,0.1596806387225549,0.23594331167327587,1.0,14/34,23.45%,POLR2K;POLR3H;POU2F1;POLR3E;POLR1D;POLR2F;POLR3A;GTF3A;POLR3K;GTF3C6;POLR2E;BRF2;SNAPC1;POLR3D
gsea,tRNA Processing R-HSA-72306,-0.2787790119596654,-1.2531071986076325,0.10408163265306122,0.23799334273064077,1.0,16/96,13.27%,POP5;RAN;RPP21;TSEN15;NSUN6;POP7;TRMT112;NUP43;TRMT61A;TRMT9B;TRMT12;LAGE3;METTL1;RPP38;NUP50;RPP25
gsea,Nephrin Family Interactions R-HSA-373753,0.4284592359264374,1.2499715383248093,0.20489977728285078,0.6377672849191952,1.0,7/18,16.27%,SPTAN1;IQGAP1;PIK3R2;ACTN4;SPTBN1;PIK3CA;FYN
gsea,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.2807713775586884,-1.2483744738415845,0.10044642857142858,0.24331584249113833,1.0,10/99,5.47%,CALM1;GLP2R;CHGA;YES1;LYN;RAMP1;PTRH2;PTGER4;GNG7;AHCYL1
gsea,G Alpha (I) Signaling Events R-HSA-418594,-0.262516442056574,-1.2477311563736226,0.08369098712446352,0.24354110527639258,1.0,50/172,28.10%,CALM1;P2RY14;P2RY12;RGS4;CX3CR1;GNG7;AHCYL1;NPY;PPP3R1;PPP2R1A;PPP3CA;S1PR3;NMUR1;SSTR2;HEBP1;CORT;PPP1CA;PPP2CA;RXFP3;PLCB1;GNAS;CXCL12;PNOC;POMC;RGS10;PPP1R1B;ACKR3;PENK;HTR5A;CAMK2B;CXCR4;LPAR1;GNG3;GNA15;RGS8;GNB2;P2RY13;SSTR4;ITPR2;CCL25;ADRA2C;PLCB2;GNG10;CCR9;PRKX;PPP2R1B;CX3CL1;ADCY9;PRKAR1A;ACKR4
gsea,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.3297081739383002,1.2418475511411289,0.16417910447761194,0.6533302452749395,1.0,24/49,24.21%,SPTBN4;SPTAN1;CNTN2;PTK2;GRB2;CACNB4;SPTBN2;COL6A2;SPTBN1;COL6A3;NRTN;COL6A5;CACNA1H;FYN;ST8SIA4;CACNA1C;SPTB;CACNA1G;RPS6KA5;SRC;CACNB1;CREB1;ST8SIA2;NCAM1
gsea,PRC2 Methylates Histones And DNA R-HSA-212300,-0.4065752211699695,-1.2404837912997737,0.1925343811394892,0.2518461394792678,1.0,8/19,24.19%,H2AZ1;H2AJ;H2BC4;JARID2;H2AZ2;H2BC21;H2AX;EZH2
gsea,RND3 GTPase Cycle R-HSA-9696264,0.34347718660864196,1.2383937209568725,0.16468253968253968,0.6535332470263285,1.0,20/38,25.22%,CCDC88A;DST;RBMX;ANKRD26;PIK3R2;ROCK1;VANGL1;SCRIB;ARHGAP35;TMOD3;LEMD3;ARHGAP21;SEMA4F;CKAP4;PKP4;PLEKHG5;KTN1;DDX4;WDR6;DLG5
gsea,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.3195677251643662,1.2381899859689103,0.141804788213628,0.6435659457808259,1.0,21/52,23.56%,THBS2;ADAMTSL3;ADAMTS19;B3GLCT;ADAMTS20;ADAMTS2;ADAMTS5;ADAMTSL5;THSD4;ADAMTS14;POMT1;ADAMTS17;DAG1;ADAMTSL1;GALNT12;ADAMTS10;C1GALT1;ADAMTS15;THBS1;SEMA5B;SBSPON
gsea,Triglyceride Metabolism R-HSA-8979227,-0.39101070295100493,-1.2379702070268035,0.19483101391650098,0.25444521934168085,1.0,6/21,16.75%,FABP3;GPAM;PLIN3;PPP1CA;AGMO;DGAT2
gsea,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.3194389486653069,-1.2374067938267743,0.16204690831556504,0.25471788209012486,1.0,13/45,21.70%,HSP90AB1;AIM2;TRAF6;TXN2;UBE2V1;NLRC4;CASP8;BCL2;NFKB2;RELA;IKBKG;UBE2N;PYCARD
gsea,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.3948560387587322,-1.2373259451396257,0.18604651162790697,0.2543749996502557,1.0,8/21,21.09%,AKT3;TGFA;AKT1;BCL2;FOS;MAPK3;EGFR;CDKN1B
gsea,Nucleotide Salvage R-HSA-8956321,-0.40380716564614244,-1.2358646367997494,0.19703389830508475,0.2557337276042422,1.0,9/17,28.41%,UCKL1;TK2;DGUOK;APRT;SCO2;ADK;DCK;GMPR;UCK1
gsea,RHO GTPases Activate CIT R-HSA-5625900,-0.41207854220211837,-1.2338856988724078,0.21810699588477367,0.25778123010000287,1.0,8/17,32.28%,MYL6;RHOB;RHOA;MYL9;CDKN1B;MYH14;MYL12B;MYH11
gsea,Ion Channel Transport R-HSA-983712,-0.2731080748520828,-1.2332500269908282,0.11238532110091744,0.2580030998460234,1.0,19/131,10.08%,CALM1;ATP6V0B;UBB;ATP1B1;ATP6V1G2;ATP6V0C;RPS27A;ATP6V1F;ATP6V0E2;ATP6V1A;UBA52;UBC;OSTM1;TRPM1;ATP1A2;SRI;ATP1B2;TTYH3;TRPC4
gsea,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.2602764675463762,-1.232654395914828,0.08240534521158129,0.2582422377384682,1.0,37/146,24.37%,CALM1;TTR;APOE;COQ2;APOA1;THTPA;NAXE;GSTO1;LDLR;HSP90AA1;SLC19A2;GPC4;RETSAT;SLC25A16;PDZD11;AKT1;PTGIS;SDC4;CD38;PARP10;RFK;RBP4;GPHN;COQ9;MTHFD2;NAXD;AKR1B10;IDH1;MTHFD1;COQ3;PDXK;AGRN;AASDHPPT;PNPO;MOCOS;SP8;SLC23A1
gsea,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.34036322823970655,-1.2323274464619898,0.16226415094339622,0.2581038220186484,1.0,6/33,14.09%,SLC25A4;SLC25A5;NUP43;BANF1;NUP50;KPNA1
gsea,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.26472292254142227,-1.2306930328458674,0.1203155818540434,0.259595962547516,1.0,35/146,17.03%,DYNLL2;CNIH2;DYNLL1;CNIH1;CHGA;TMED2;TMED7;PREB;TMED9;B4GALT4;CAPZA2;SAR1B;FUCA1;CTSZ;LMAN1;DCTN1;MGAT4B;TRAPPC6A;BET1;TGFA;TRAPPC2L;CTSC;NSF;TRAPPC4;PPP6C;TRAPPC6B;COG5;MCFD2;COPE;TRAPPC2;BET1L;ACTR10;COG1;DCTN4;LMAN2
gsea,FGFR1 Mutant Receptor Activation R-HSA-1839124,0.36753739369598604,1.2298562354187146,0.19622641509433963,0.6600749388081186,1.0,8/24,13.68%,STAT1;ZMYM2;GRB2;MYO18A;CUX1;LRRFIP1;STAT5B;PIK3CA
gsea,Glycolysis R-HSA-70171,-0.3016319076059236,-1.228415749299092,0.14990138067061143,0.26202199604855225,1.0,15/60,17.08%,TPI1;ENO2;NUP43;PPP2R1A;ALDOC;GAPDHS;PKM;PPP2CA;PGP;NUP50;PGK1;PGAM2;BPGM;PFKL;PFKFB1
gsea,Sensory Processing Of Sound R-HSA-9659379,0.30904845475364723,1.2249256659703263,0.15643564356435644,0.6655103503582851,1.0,16/60,13.19%,SPTAN1;PCLO;EPB41L1;ATP2B4;CLIC5;PCDH15;CDH23;CACNA2D2;SYN1;STX1A;MYO7A;OTOF;BSN;EPB41L3;SPTBN1;KCNMA1
gsea,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.3519687091188683,1.2248842575903,0.17227722772277226,0.6552651845228945,1.0,14/35,17.06%,SHC1;PIK3R2;GRB2;PRKCA;JAK3;CLSTN1;CBL;JAK2;CRKL;STAT5B;PIK3CA;CRK;FYN;PTPN6
gsea,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.4043929887401575,-1.2247808359441668,0.20711297071129708,0.26620953294264893,1.0,6/16,26.46%,GNG7;PLCB1;GNG3;GNB2;PLCB2;GNG10
gsea,Chromatin Modifying Enzymes R-HSA-3247509,0.2571263851553428,1.2238543697530435,0.12781954887218044,0.6482537078318408,1.0,49/199,16.04%,EHMT1;HDAC8;KMT2D;TRRAP;KDM3A;SETD2;EP400;EP300;KMT2C;OGT;ASH1L;SMYD3;CREBBP;BRPF3;ARID5B;NCOR1;CHD4;NCOA1;NSD1;NSD3;ARID2;ELP3;DNMT3A;ATXN7;CARM1;KMT2E;KDM2A;PHF20;HDAC3;PBRM1;PHF8;SMARCA2;GATAD2B;BRWD1;KDM6B;MTA1;ZZZ3;JAK2;NSD2;RBBP4;KDM5B;MSL1;KDM4A;ARID4B;SETD1B;RCOR1;KMT2A;MTA2;KDM4B
gsea,Unfolded Protein Response (UPR) R-HSA-381119,-0.28537677777553694,-1.2231023104039451,0.1399548532731377,0.26791118588704776,1.0,34/79,34.76%,CALR;SRPRB;PREB;CEBPB;HSPA5;SERP1;DCTN1;EXTL2;NFYA;SSR1;ATF4;DNAJB9;EXOSC7;ATF6;DNAJC3;EXOSC5;CTDSP2;YIF1A;EIF2S2;EDEM1;ASNS;PPP2R5B;GOSR2;DDIT3;TLN1;DNAJB11;CREB3L1;NFYB;GFPT1;HERPUD1;ARFGAP1;TSPYL2;HYOU1;EXOSC8
gsea,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.27463531092459603,-1.2210046853022567,0.13865546218487396,0.2701227969280488,1.0,19/94,16.73%,YWHAG;TUBA1A;YWHAE;DYNLL1;TUBB4B;TUBA4A;RAB11A;CEP72;PPP2R1A;KIF24;DCTN1;CEP78;TMEM216;HSP90AA1;SSNA1;TUBB4A;HAUS5;HAUS2;CETN2
gsea,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.27695267241912586,-1.2207228163415191,0.11952191235059761,0.26996361040959993,1.0,33/102,25.65%,HRAS;RALA;YWHAB;VRK3;CLTA;VGF;EGR4;PPP2R1A;JUND;ID3;CDK5R2;IRS2;RHOA;TCF12;AP2M1;PPP2CA;F3;ID2;FOS;MAP2K1;RIT2;DUSP6;LYL1;DUSP4;AP2B1;MAPK3;NAB1;AP2S1;DUSP7;ID1;ASCL1;EGR1;TRIB1
gsea,Post NMDA Receptor Activation Events R-HSA-438064,-0.3191272778364662,-1.2203043518828312,0.18811881188118812,0.26999533048451174,1.0,4/57,1.62%,NRGN;CALM1;HRAS;NEFL
gsea,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.3926139806915687,-1.2189963277169151,0.21074380165289255,0.27129724168402647,1.0,2/18,1.07%,HRAS;FGF1
gsea,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.39210703688181786,1.21602835303222,0.22874493927125505,0.6632718290692521,1.0,7/19,19.25%,ANAPC1;ANAPC5;CDC23;ANAPC11;CDC27;ANAPC15;UBE2S
gsea,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.29497496107505267,-1.2151064305684787,0.14623655913978495,0.2757493123832603,1.0,8/59,10.03%,UBB;SUMO2;RPS27A;UBA52;UBC;H2BC4;RAD9B;BABAM2
gsea,Signaling By Nuclear Receptors R-HSA-9006931,-0.24653972154582557,-1.2132450142624551,0.102,0.27765067401128496,1.0,45/191,21.09%,CALM1;DDX5;HSP90AB1;HRAS;APOE;JUN;H2AZ1;POLR2K;PLTP;GNG7;H2AJ;POU2F1;H2BC4;GPAM;JUND;GPS2;AKT3;FKBP5;S1PR3;PTGES3;HSP90AA1;TGFA;POLR2G;RXRB;USF1;AKT1;PPID;CAV2;POLR2F;CBFB;CXCL12;BCL2;FOS;H2AZ2;H2BC21;ARL4C;GNG3;MAPK3;H2AX;POLR2E;MYC;EGFR;TBL1XR1;FKBP4;CDKN1B
gsea,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.40191110352813875,-1.2129861731416223,0.2202020202020202,0.27745829125400945,1.0,4/17,5.23%,UBB;RPS27A;UBA52;UBC
gsea,Nicotinamide Salvaging R-HSA-197264,-0.4127678839436624,-1.2122484903214024,0.21304347826086956,0.2779500833386536,1.0,4/15,18.09%,NAXE;PTGIS;PARP10;NAXD
gsea,Signaling By RAF1 Mutants R-HSA-9656223,-0.35196202739344296,-1.211375451997148,0.20910973084886128,0.27865470572311635,1.0,4/32,5.79%,CALM1;HRAS;YWHAB;CNKSR2
gsea,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.3749944778643552,-1.20968500778766,0.21304347826086956,0.28036050067799334,1.0,12/21,36.09%,POLR2K;POLR2G;POLR2F;POLR2E;GTF2F2;CTDP1;NCBP2;NELFA;POLR2J;POLR2L;POLR2H;GTF2F1
gsea,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.34759758030768384,-1.209426028034441,0.1894093686354379,0.2801791794758621,1.0,11/30,22.03%,APOE;NRG3;S100B;GFAP;CXCL12;NRG4;SPARC;YAP1;PSENEN;STMN1;MXD4
gsea,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,0.3618624568312461,1.2090328782487951,0.19886363636363635,0.6758297346511567,1.0,5/26,5.56%,DHTKD1;BCKDHB;GNMT;HAO1;AMT
gsea,Signaling By FGFR In Disease R-HSA-1226099,-0.3044139559194619,-1.2082425365245821,0.1704781704781705,0.2811682095653477,1.0,9/52,13.38%,FGFR2;HRAS;FGF1;POLR2K;BAG4;FGF10;POLR2G;FGFR3;POLR2F
gsea,Rab Regulation Of Trafficking R-HSA-9007101,-0.2683557928806211,-1.2036534660638956,0.12526096033402923,0.28665149881906155,1.0,21/113,12.73%,RAB3A;YWHAE;SBF1;GABARAP;GABARAPL2;RAB11A;RAB5B;MAP1LC3B;RAB6A;DENND1A;HPS4;AKT3;RAB18;TRAPPC6A;RAB38;TRAPPC2L;RAB6B;TRAPPC4;RAB14;AKT1;TRAPPC6B
gsea,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.24127536019328416,-1.2019501405264073,0.1127348643006263,0.2884378490031064,1.0,65/275,21.43%,UBE3A;UBB;PSMA3;PSMD7;PSMB3;RPS27A;FBXL16;PSMC6;PSMC1;RNF114;ELOB;PSMB6;UBE2A;PSMC3;UBA52;RNF138;UBC;ANAPC13;FBXL14;PSMA2;PSMA7;ASB14;PSMB7;PSMB1;PSMC5;PJA1;SOCS1;UBE2B;LRRC41;PSMB5;UBE2V1;FBXL22;FBXW11;PSMD11;FBXO9;PSMA4;UBE2R2;UBE2K;PSMF1;RNF7;RNF115;RLIM;FBXL8;UBE2D3;UBE2E3;TRIM32;FBXO15;FBXO27;SEM1;FBXW2;KBTBD7;ASB13;FBXW4;PSMB4;STUB1;PSMD2;ZNRF2;RNF182;RNF34;BTBD1;KLHL25;UBE2J2;MKRN1;UBE2N;HECW2
gsea,Signaling By KIT In Disease R-HSA-9669938,-0.3908167447680051,-1.2007608490359203,0.2237354085603113,0.2894469948939171,1.0,3/18,3.59%,HRAS;YES1;LYN
gsea,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.3902788210404534,1.2006897718285445,0.23449612403100775,0.6923767829145686,1.0,6/21,9.45%,NPAS2;CREBBP;NCOA6;NCOA1;CARM1;RXRA
gsea,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.3214727669998374,1.2002662358698588,0.1840607210626186,0.6837525493299934,1.0,7/40,3.44%,TNRC6B;TNRC6A;KMT2D;EP300;MOV10;KMT2C;AGO4
gsea,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.404366203629182,-1.1977776877657629,0.234,0.2927978927603243,1.0,6/17,31.59%,P2RY12;GNG7;GNG3;GNB2;GNG10;GNAI1
gsea,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.33107337882028676,-1.1977599323073043,0.17543859649122806,0.29227999810512223,1.0,12/36,19.36%,CCT5;GAPDHS;CCT3;CCT7;CCT8;CCT6A;CCT2;CCT4;FBXW2;TCP1;FBXW4;CCNE2
gsea,Peroxisomal Lipid Metabolism R-HSA-390918,-0.35056796810879903,-1.197663866589729,0.19017094017094016,0.2918652201800387,1.0,12/26,37.56%,SYCP2;NUDT19;CROT;ACOX1;AMACR;PECR;ACOX2;ACBD5;ACOX3;MLYCD;ACOT6;ECI2
gsea,Death Receptor Signaling R-HSA-73887,-0.268527710683291,-1.1974816919403595,0.14912280701754385,0.2915962993142569,1.0,15/125,7.19%,UBB;BEX3;YWHAE;RPS27A;NSMAF;MAGED1;ITGB3BP;ARHGEF4;RACK1;BAG4;UBA52;UBC;OTULIN;TRAF6;TNFRSF1A
gsea,IRE1alpha Activates Chaperones R-HSA-381070,-0.3129514463057794,-1.197188834030002,0.20346320346320346,0.29144362320756023,1.0,20/46,34.30%,SRPRB;PREB;HSPA5;SERP1;DCTN1;EXTL2;SSR1;DNAJB9;DNAJC3;CTDSP2;YIF1A;EDEM1;PPP2R5B;GOSR2;TLN1;DNAJB11;GFPT1;ARFGAP1;TSPYL2;HYOU1
gsea,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.3440104846294037,-1.1963341734015769,0.20608899297423888,0.29215443379859946,1.0,12/30,28.73%,CD81;ICAM5;B2M;CD247;NPDC1;TYROBP;TREM2;CD200;ITGB1;LAIR1;ITGA4;FCGR2B
gsea,Interleukin-37 Signaling R-HSA-9008059,0.4077589087584852,1.1959733445719751,0.23653846153846153,0.6878661929218202,1.0,7/17,24.91%,PTPN23;PTPN5;PTPN2;PTPN14;PTPN6;PTPN9;PTPN4
gsea,Transcriptional Regulation By MECP2 R-HSA-8986944,0.2954097004830885,1.1953049553516186,0.18908382066276802,0.6804411282850091,1.0,14/58,12.26%,TNRC6B;TNRC6A;TRPC3;RBFOX1;MOV10;AGO4;NCOR1;CAMK2D;PRKCA;HDAC3;OPRK1;TNRC6C;CAMK2A;MECP2
gsea,Metabolism Of Carbohydrates R-HSA-71387,-0.23650269359033824,-1.1948473009695009,0.11283185840707964,0.2937498793019651,1.0,49/233,20.14%,CALM1;UBB;CHST9;NDST4;RPS27A;TPI1;B4GAT1;CHST15;MDH2;ENO2;CSPG5;UBA52;UBC;B4GALT4;NUP43;PPP2R1A;PAPSS2;PHGDH;ALDOC;GAPDHS;PKM;AKR1A1;MDH1;GPC4;PPP2CA;PGP;B3GALT5;NUP50;B3GALT2;HYAL2;PGK1;PGAM2;B3GALT1;SDC4;OGN;SLC25A11;BPGM;GLYCTK;PFKL;PFKFB1;NHLRC1;CHST2;HS2ST1;SGSH;GNS;SHPK;CHORDC1;UST;B3GAT1
gsea,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.31495155103398476,-1.1916688455544509,0.20444444444444446,0.2975951271058259,1.0,19/44,34.30%,SRPRB;PREB;SERP1;DCTN1;EXTL2;SSR1;DNAJB9;DNAJC3;CTDSP2;YIF1A;EDEM1;PPP2R5B;GOSR2;TLN1;DNAJB11;GFPT1;ARFGAP1;TSPYL2;HYOU1
gsea,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.2863887334285914,-1.1914566667916162,0.16853932584269662,0.29732115139671794,1.0,12/66,12.06%,FTH1;VAMP2;CLTB;CLTA;NECAP1;HSPA8;CTSZ;AP1S1;CHMP2A;BLOC1S4;TBC1D8B;AP1S3
gsea,Deubiquitination R-HSA-5688426,-0.241319444342287,-1.1894808101251506,0.11464968152866242,0.2995411983587702,1.0,40/220,14.17%,UBB;VDAC1;PSMA3;PSMD7;PSMB3;RPS27A;PSMC6;PSMC1;MBD5;NEDD8;SNX3;PTRH2;TGFB1;PSMB6;PSMC3;UBA52;UBC;PSMA2;PSMA7;H2BC4;TRAF6;PSMB7;OTUB1;PSMB1;PSMC5;VDAC2;RHOA;PSMB5;FKBP8;BABAM2;STAM2;TOMM20;SENP8;INO80B;PSMD11;PSMA4;SMAD7;SMAD2;PSMF1;JOSD1
gsea,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.4023634896063472,-1.1893167716544761,0.22869955156950672,0.29923620230114417,1.0,6/16,25.34%,C1QBP;PRCP;F3;PRTN3;SERPING1;SERPINC1
gsea,RND1 GTPase Cycle R-HSA-9696273,0.32345498918423926,1.1872411566685592,0.21772639691714837,0.6969595455979415,1.0,11/37,15.91%,CCDC88A;DST;RBMX;ANKRD26;PIK3R2;VANGL1;ARHGAP35;RRAS2;LEMD3;RND1;FAM135A
gsea,Peptide Ligand-Binding Receptors R-HSA-375276,-0.2743798078431827,-1.187238176957054,0.16517857142857142,0.30154158519600066,1.0,28/80,29.00%,CX3CR1;NTSR2;NPY;PROK2;NMUR1;SSTR2;HEBP1;GPNMB;CORT;RXFP3;CXCL12;PNOC;POMC;NPFFR1;ACKR3;PENK;CXCR4;SSTR4;NPFF;MRLN;CCL25;NTSR1;EDNRA;CCR9;CX3CL1;MC1R;ACKR4;SST
gsea,Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.279138856342645,-1.1872202549679498,0.16631578947368422,0.3010182302339375,1.0,25/86,22.73%,UBB;FKBP1A;RPS27A;NEDD8;PARD6A;TGFB1;UBA52;UBC;ITGA8;RBL1;SNW1;RHOA;PPP1CA;SMAD7;SMAD2;SRFBP1;CCNK;UBE2D3;WWTR1;STUB1;MAPK3;MYC;ITGAV;LTBP1;E2F4
gsea,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.3221021635931005,-1.1868181982465478,0.2229580573951435,0.30105246187504736,1.0,11/39,22.04%,TTR;TGFB1;TRAPPC4;SDC4;LAMC3;LAMB1;LAMA5;NRXN1;ITGAV;AGRN;FGF13
gsea,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.28130459033954935,-1.186021888196003,0.17849462365591398,0.3015960096369808,1.0,14/80,14.31%,ATP1B1;PPIA;HRAS;ANGPT2;YES1;LYN;TEK;TGFB1;BSG;SLC7A5;ATP1B2;SLC16A1;SDC4;SLC3A2
gsea,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.3435000840703293,-1.1845830131760506,0.22950819672131148,0.3030105966097207,1.0,10/29,22.76%,TECR;HACD4;ACSL3;HSD17B12;HACD2;HSD17B8;ELOVL6;ELOVL4;CBR4;ELOVL5
gsea,Tight Junction Interactions R-HSA-420029,-0.41442826611100303,-1.1831858288675963,0.25100401606425704,0.304473732149263,1.0,6/15,30.23%,PARD6A;CLDN5;PARD6G;PALS1;PRKCI;CLDN18
gsea,Intra-Golgi Traffic R-HSA-6811438,0.33387939167237257,1.1831829623816694,0.2297029702970297,0.7009311074085829,1.0,8/35,7.39%,MAN2A2;VTI1A;MAN2A1;TRIP11;VPS45;CUX1;COG6;RAB30
gsea,Estrogen-dependent Gene Expression R-HSA-9018519,-0.27155817897810125,-1.1826265705288468,0.17038539553752535,0.30470708756886616,1.0,26/87,21.05%,DDX5;HSP90AB1;JUN;H2AZ1;POLR2K;H2AJ;POU2F1;H2BC4;GPAM;JUND;PTGES3;HSP90AA1;TGFA;POLR2G;USF1;POLR2F;CBFB;CXCL12;BCL2;FOS;H2AZ2;H2BC21;H2AX;POLR2E;MYC;FKBP4
gsea,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.3718191220328095,-1.1793255118175778,0.25925925925925924,0.308882242986919,1.0,2/19,1.07%,HRAS;FGF1
gsea,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.3280318024351294,-1.1761546876489983,0.2390852390852391,0.3129332175780565,1.0,9/33,12.69%,UBB;RPS27A;MLST8;UBA52;UBC;PPP2R1A;AKT3;PPP2CA;AKT1
gsea,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.29769530651301523,-1.1742309881579822,0.2,0.3151301391813391,1.0,8/54,7.33%,LAMTOR2;JUN;MLST8;LAMTOR3;CHD3;RRAGA;LAMTOR1;RHEB
gsea,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.3380967668820529,-1.17372077943777,0.23279352226720648,0.31532069180753214,1.0,13/27,36.09%,POLR2K;ELOB;POLR2G;POLR2F;TCEA1;POLR2E;GTF2F2;CTDP1;NELFA;POLR2J;POLR2L;POLR2H;GTF2F1
gsea,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.3919456545971346,-1.1733908902765018,0.24025974025974026,0.31522595766708134,1.0,9/16,39.05%,CCND3;CCNE2;CDKN1B;CCND2;CDK4;TFDP2;RB1;CCNE1;CCND1
gsea,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.31267703459927043,-1.1712889239134294,0.23668639053254437,0.3176022480800128,1.0,16/42,26.34%,CLTB;CLTA;YES1;LYN;EPHA7;AP2M1;EFNB2;EPHA4;EPHA5;PSENEN;AP2B1;EPHA6;AP2S1;EPHA3;EFNA3;TIAM1
gsea,Regulation Of TP53 Degradation R-HSA-6804757,-0.3301212993589625,-1.1712168356597061,0.2182952182952183,0.31716461524820155,1.0,9/32,12.69%,UBB;RPS27A;MLST8;UBA52;UBC;PPP2R1A;AKT3;PPP2CA;AKT1
gsea,Telomere Maintenance R-HSA-157579,-0.28122913954321643,-1.1701056898561972,0.183585313174946,0.3182662479330485,1.0,17/65,20.04%,H2AZ1;POLD4;NOP10;POLR2K;H2AJ;H2BC4;PCNA;POLR2G;PPP6C;POLR2F;POLA2;H2AZ2;RUVBL1;TERT;H2BC21;H2AX;POLR2E
gsea,Ion Homeostasis R-HSA-5578775,-0.3205850575545779,-1.1693443680132525,0.22482435597189696,0.31877938191591787,1.0,7/42,9.06%,CALM1;ATP1B1;AHCYL1;ATP1A2;ORAI2;SRI;ATP1B2
gsea,ERK/MAPK Targets R-HSA-198753,-0.3634621243885636,-1.1680589490534203,0.26156941649899396,0.3201343555972933,1.0,8/21,27.29%,VRK3;PPP2R1A;PPP2CA;DUSP6;DUSP4;MAPK3;DUSP7;PPP2R1B
gsea,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.38107719695098874,-1.167510115612164,0.2712871287128713,0.32036632875256155,1.0,2/21,1.62%,CALM1;NEFL
gsea,RAC1 GTPase Cycle R-HSA-9013149,0.2661607979810505,1.1668690284779184,0.22053231939163498,0.7450876162262574,1.0,49/163,20.56%,TRIO;DOCK3;MYO9B;IQGAP1;VRK2;DOCK7;DOCK9;GIT1;FAM13B;TAOK3;ARHGEF15;PIK3R2;KALRN;WIPF2;PLD2;CDC42BPA;OPHN1;ARHGAP23;ARHGAP32;WIPF1;ARHGEF11;GMIP;SRGAP1;VANGL1;PLEKHG1;ALS2;ARHGAP42;DOCK5;SRGAP2;PLEKHG4;ARHGAP35;DOCK11;PIK3CA;MCF2L;LEMD3;GIT2;ARHGAP17;ARHGAP21;DLC1;ARAP1;ARHGEF10;DHDDS;ARHGAP33;RASGRF2;SOS2;REPS1;ECT2;ARHGEF18;ARAP3
gsea,Complement Cascade R-HSA-166658,-0.3724153683336766,-1.1665972140974328,0.25157232704402516,0.3211267203032428,1.0,11/24,25.41%,CD81;C1QB;PSMA7;CLU;MASP2;C1QC;CPNE2;SERPING1;CR2;C1QA;CFH
gsea,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.3671823761563498,-1.1662147481038059,0.26506024096385544,0.32108926031224866,1.0,15/24,41.94%,GSK3B;PPP2R1A;PPP2CA;FZD1;FRAT1;FZD2;PPP2R5B;PPP2R1B;FRAT2;CAV1;LRP5;CTNNB1;PPP2CB;AXIN1;AMER1
gsea,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.3800003508601254,-1.1602881727320908,0.2832980972515856,0.3292924122837727,1.0,9/18,32.62%,TYK2;MAP2K1;DUSP6;DUSP4;MAPK3;DUSP12;DUSP7;MAP2K2;PTPN11
gsea,Collagen Chain Trimerization R-HSA-8948216,0.3342934112843067,1.1600971175692938,0.24288107202680068,0.7580420286714586,1.0,14/36,18.74%,COL24A1;COL7A1;COL20A1;COL16A1;COL6A2;COL14A1;COL1A2;COL6A3;COL12A1;COL8A1;COL6A5;COL19A1;COL28A1;COL5A2
gsea,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.3631998099354815,1.1592532799529354,0.26587301587301587,0.7510043156426719,1.0,4/21,5.20%,DOCK3;SHC1;NTRK2;GRB2
gsea,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.3451716051930685,-1.1576739377342808,0.2597701149425287,0.33234224132870044,1.0,9/23,24.30%,HMGB1;BTK;TLR3;NDUFA2;NFKB2;RELA;IKBKG;LY96;TLR4
gsea,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.29156030138877737,1.1561559631863527,0.22764227642276422,0.7515344917374429,1.0,13/52,13.68%,BIRC6;CLTC;KIF5B;SHC1;RANBP2;TFG;SEC31A;GRB2;EIF2AK3;ALK;MECP2;TPM3;PIK3CA
gsea,FCERI Mediated MAPK Activation R-HSA-2871796,-0.3428976815591044,-1.1502958127949485,0.2578616352201258,0.3429229050415715,1.0,3/26,3.59%,HRAS;JUN;LYN
gsea,Reproduction R-HSA-1474165,-0.27402835251900576,-1.1490179727774439,0.22268907563025211,0.3441515833371736,1.0,10/66,11.50%,HSPA2;SYCP3;H2AZ1;SYCP2;PSMC3IP;H2AJ;H2BC4;RAD51C;MLH1;RAD51
gsea,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.33447866550641964,-1.1487407150812785,0.2581967213114754,0.3439875226857817,1.0,8/25,32.76%,POLD4;PCNA;POLE4;POLE3;ADPRS;LRIG1;RFC5;POLD2
gsea,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.25583529536898886,-1.1463054282358636,0.1935483870967742,0.3469802484589599,1.0,13/91,11.50%,UBB;SUMO2;RPS27A;POLD4;UBA52;UBC;H2BC4;PCNA;RAD51C;RAD9B;BABAM2;POLE4;RAD51
gsea,RNA Polymerase I Transcription Termination R-HSA-73863,-0.32712314078769045,-1.1457163106026436,0.27800829875518673,0.34732026908181046,1.0,9/29,21.19%,POLR2K;ERCC3;GTF2H5;TTF1;POLR1D;POLR2F;POLR1H;POLR2E;POLR1G
gsea,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.2893165009194731,-1.144815569033008,0.2237354085603113,0.34818290854339634,1.0,5/69,2.19%,NRGN;CALM1;HRAS;NEFL;LIN7C
gsea,Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.38504835584323915,-1.1406894696163123,0.2751540041067762,0.35377839214518164,1.0,4/15,15.99%,PAPSS2;SULT4A1;PODXL2;BPNT1
gsea,Stimuli-sensing Channels R-HSA-2672351,-0.267377709800391,-1.13730207529545,0.2311212814645309,0.3583838125563588,1.0,10/72,10.08%,CALM1;UBB;RPS27A;UBA52;UBC;OSTM1;TRPM1;SRI;TTYH3;TRPC4
gsea,Netrin-1 Signaling R-HSA-373752,0.29970839936783084,1.1370185538005162,0.2837301587301587,0.8064258637598293,1.0,22/45,24.18%,TRIO;DSCAML1;TRPC3;ABLIM1;PTK2;ABLIM2;UNC5B;MAPK14;ABLIM3;AGAP2;FYN;MAPK8;NTN1;TRPC5;SRC;PITPNA;PLCG1;MAPK11;EZR;NTN4;TRPC1;UNC5A
gsea,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.28639785591340877,-1.1360721726311689,0.24366471734892786,0.3596471008816911,1.0,9/52,12.06%,FTH1;VAMP2;CLTA;NECAP1;HSPA8;AP1S1;BLOC1S4;TBC1D8B;AP1S3
gsea,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.3860254069003814,1.135631317599962,0.28688524590163933,0.8010769596893492,1.0,5/16,14.30%,PTPRS;SHC1;GRB2;PIK3CA;PTPRU
gsea,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.31299610775925285,1.1348821229974826,0.2700587084148728,0.7935909640640598,1.0,11/35,18.46%,NUP214;NUP205;RANBP2;MDM2;NUP188;PIAS4;NUP155;NUP88;PIAS2;NUP98;NUP133
gsea,Endogenous Sterols R-HSA-211976,-0.37238608360308034,-1.1331912265054398,0.2771618625277162,0.36358536080755893,1.0,6/18,15.43%,CYP7B1;FDX1;FDXR;PTGIS;POMC;FDX2
gsea,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.2947433249229967,-1.1329821756191654,0.246,0.36326675417248405,1.0,20/47,31.75%,BBIP1;RAB11A;CCT5;NUDT19;ARL6;CCT3;BBS5;CCT8;CCT2;CCT4;TCP1;EXOC3;ARF4;EXOC4;INPP5E;EXOC8;PTGES2;BBS10;TTC8;CYS1
gsea,Ca-dependent Events R-HSA-111996,0.3312218985258591,1.1327343221398256,0.2700587084148728,0.7912713129724622,1.0,15/33,20.63%,ADCY8;PRKCG;CAMK2D;PRKCA;PRKAR1B;ADCY1;CAMK2A;GRK2;NBEA;ADCY6;PLA2G4A;PRKAR2A;ADCY2;ADCY7;ADCY5
gsea,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.33714964580091455,-1.1316226374548382,0.28484848484848485,0.364840385616626,1.0,4/27,5.79%,HRAS;YWHAB;PEBP1;CNKSR2
gsea,HIV Elongation Arrest And Recovery R-HSA-167287,-0.3246150791890022,-1.1312419626013257,0.27720739219712526,0.36481304531390524,1.0,14/29,36.09%,POLR2K;ELOB;POLR2G;POLR2F;TCEA1;CCNK;POLR2E;GTF2F2;CTDP1;NELFA;POLR2J;POLR2L;POLR2H;GTF2F1
gsea,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.30798196904885966,-1.129900039003939,0.26522593320235754,0.3662743365377755,1.0,11/40,21.92%,DDX5;SUMO2;PARK7;NPM1;CBX4;ING3;SUMO1;TRIM28;TOPORS;PIAS1;SIN3A
gsea,Diseases Of Metabolism R-HSA-5668914,-0.2259919203410756,-1.1285119849684,0.171875,0.3679632254089336,1.0,37/183,20.65%,UBB;DPM1;RPS27A;CYP7B1;DPM2;PRNP;ALG11;B4GAT1;DOLK;DPM3;MUC15;LCT;CSPG5;UBA52;UBC;PAPSS2;FDX1;ACY1;TPMT;SEMA5A;EGFL7;ADAMTS1;GPC4;FDXR;SDC4;APRT;OGN;POMC;FDX2;NHLRC1;ALG12;ALG13;SGSH;C1GALT1C1;GNS;ALG2;IDH1
gsea,Oncogene Induced Senescence R-HSA-2559585,-0.3264706446341281,-1.1255467839458626,0.28016359918200406,0.3720691665227313,1.0,5/29,5.88%,UBB;RPS27A;UBA52;UBC;ETS2
gsea,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.32475110845342414,-1.12499681926723,0.3026052104208417,0.37231487992669415,1.0,9/28,23.68%,JUN;VRK3;PPP2R1A;PPP2CA;FOS;DUSP6;DUSP4;MAPK3;DUSP7
gsea,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.32625961313761165,1.1248102547047902,0.275,0.8086422692101861,1.0,8/28,18.46%,NUP214;NUP205;RANBP2;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.29115556762282363,-1.1234035825424702,0.2879684418145957,0.37423776230865746,1.0,17/44,28.50%,RAB6A;PLIN3;NAA38;NSF;RAB6B;SYS1;VAMP3;COG5;STX16;COG1;ARFIP2;AKR1B10;NAA30;COG2;NAPG;COG8;M6PR
gsea,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.3165090278822912,1.1232043439319905,0.2836438923395445,0.8042719445846461,1.0,9/31,18.46%,NUP214;NUP205;RANBP2;NXF1;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,Lysosome Vesicle Biogenesis R-HSA-432720,-0.31709996378984145,-1.1230909711190549,0.27893738140417457,0.37407814430373,1.0,8/32,12.06%,VAMP2;CLTB;CLTA;HSPA8;CTSZ;AP1S1;CHMP2A;AP1S3
gsea,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.3775820667078863,-1.1227085421949903,0.3136456211812627,0.3740860332517123,1.0,5/16,26.46%,CDC42;GNG7;GNG3;GNB2;GNG10
gsea,Integrin Signaling R-HSA-354192,0.3516562687355529,1.1226106601656534,0.2991967871485944,0.7966261554674376,1.0,9/23,22.50%,RAPGEF4;SHC1;PTK2;GRB2;CRK;RAPGEF3;FN1;SRC;PDPK1
gsea,Activation Of HOX Genes During Differentiation R-HSA-5619507,0.28013433983996416,1.12220788019268,0.2688588007736944,0.7885773844924767,1.0,14/52,11.69%,KMT2D;CNOT6;EP300;NCOA3;KMT2C;CREBBP;NCOA6;NCOR1;POLR2A;HDAC3;RXRA;PKNOX1;POLR2B;RBBP4
gsea,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.326984459765084,-1.1206978290209477,0.28823529411764703,0.37663929228192733,1.0,11/27,23.45%,POLR2K;POLR3H;POLR3E;POLR1D;POLR2F;POLR3A;GTF3A;POLR3K;GTF3C6;POLR2E;POLR3D
gsea,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.2576576195207789,-1.119370224464997,0.25,0.3781432767132294,1.0,12/80,12.96%,DYNLL2;RPS27;DYNLL1;ITGB3BP;NUP43;PPP2R1A;NUDC;NDEL1;CENPP;PPP2CA;MIS12;BUB3
gsea,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.36910135401713157,-1.1162218848513337,0.3312883435582822,0.3825457441463199,1.0,2/21,1.62%,CALM1;NEFL
gsea,Neuronal System R-HSA-112316,0.23061680822837496,1.1160150447703203,0.2475633528265107,0.8002981765308607,1.0,83/329,14.90%,PTPRS;DLGAP1;EPB41L1;GRIA4;GABBR2;PPFIA3;MAPT;DLGAP4;GRIK4;SHANK1;CACNA1B;CACNA1A;NCALD;GABRG3;UNC13B;NRG1;ADCY8;TSPOAP1;RPS6KA2;PRKCG;GIT1;DLGAP2;GRIK5;MPP3;STXBP1;PRKCB;CACNB4;CACNG2;KCNB2;LRFN2;MDM2;DLGAP3;CACNA2D2;CAMK2D;SLITRK1;PPFIA1;EPB41;PRKCA;SLC6A1;SLC1A1;SYT2;SYN1;APBA1;PRKAR1B;LRFN1;KCNH5;RTN3;PTPRF;KCNN3;MPP2;CHRNB3;PRKAG1;EPB41L2;PTPRD;ADCY1;MYO6;STX1A;SHANK3;KCNK4;HCN3;NLGN2;RPS6KA6;PRKAA2;CAMK2A;KCNA6;IL1RAPL2;GRIN2D;EPB41L3;CHRNA3;SLC5A7;GRIK3;KCNG1;KIF17;KCNMA1;AP2A1;GRIK1;GRM5;NBEA;KCNAB3;KCNB1;KCNQ2;RASGRF1;KCNH3
gsea,Nicotinate Metabolism R-HSA-196807,-0.3320850829088343,-1.1137395907721943,0.29718004338394793,0.3860700413200402,1.0,11/24,39.38%,NAXE;PTGIS;CD38;PARP10;NAXD;NADSYN1;NNMT;NMRK1;NMNAT1;PARP14;NADK
gsea,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.35120622080677777,-1.1122623103864133,0.3191489361702128,0.387727005680156,1.0,4/19,14.16%,HRAS;NRG3;HSP90AA1;NRG4
gsea,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.25352703632618934,-1.1093715263174724,0.2548262548262548,0.39176898268817334,1.0,24/88,22.12%,GSK3B;H2AZ1;POLR2K;CHD3;H2AJ;CBX3;H2BC4;JARID2;ERCC3;GTF2H5;TTF1;POLR1D;POLR2F;RRP8;SMARCA5;POLR1H;H2AZ2;H2BC21;H2AX;POLR2E;POLR1G;TDG;SIN3A;SAP18
gsea,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.32818991614994286,-1.1090895428454572,0.3090909090909091,0.39161131482703976,1.0,7/24,15.43%,CYP7B1;FDX1;VDAC2;FDXR;PTGIS;POMC;FDX2
gsea,mRNA 3-End Processing R-HSA-72187,0.2757150855903961,1.1084311556418796,0.2834008097165992,0.8166696544788411,1.0,12/57,14.76%,SRSF5;SRRM1;SRSF1;CPSF3;CSTF2;PABPN1;CPSF7;CASC3;UPF3B;PAPOLA;SRSF6;SRSF4
gsea,Transcription Of HIV Genome R-HSA-167172,-0.26793654995805416,-1.1078334821608753,0.29006085192697767,0.3931384711004643,1.0,23/64,28.76%,POLR2K;ELOB;TAF13;ERCC3;TAF11;GTF2H5;POLR2G;GTF2B;POLR2F;TCEA1;CCNK;TAF7L;RNMT;POLR2E;GTF2E2;GTF2F2;TAF10;GTF2A1;CTDP1;TAF12;NCBP2;NELFA;POLR2J
gsea,GPVI-mediated Activation Cascade R-HSA-114604,-0.3306157320018748,-1.1070081566128034,0.33557046979865773,0.39377022074135953,1.0,4/28,9.68%,LYN;RHOB;CDC42;RHOA
gsea,Costimulation By CD28 Family R-HSA-388841,-0.29700931854801865,-1.1046714957159058,0.2760084925690021,0.3968685084858067,1.0,9/45,12.69%,MLST8;YES1;LYN;CDC42;PPP2R1A;AKT3;PPP2CA;CD247;AKT1
gsea,HCMV Infection R-HSA-9609646,-0.2505155268610011,-1.1045754028345056,0.28484848484848485,0.3963781907418827,1.0,25/90,24.95%,DYNLL2;DYNLL1;CEBPD;NUP43;H2BC4;GPS2;TXN2;CHMP2A;CHMP4B;MVB12B;DUT;NUP50;TRIM28;CHMP4C;VPS37C;H2BC21;CHMP1A;EGFR;TBL1XR1;H2AC25;VPS4A;NUP35;EZH2;ITGB1;MVB12A
gsea,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.3500368008340029,1.1043222831478767,0.3333333333333333,0.8212262194821142,1.0,5/19,7.51%,NRG1;SHC1;GRB2;PRKCE;PRKCA
gsea,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.3471209807026055,-1.1036677320203405,0.3111111111111111,0.39727433639559684,1.0,8/20,29.54%,YWHAE;JUN;C1QBP;PRDX2;CDC25C;FOXO3;PRDX1;CDK5R1
gsea,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.21873159758739796,-1.098365347658433,0.2388663967611336,0.4054695913834673,1.0,51/246,20.87%,CALM1;YWHAG;TUBA1A;DYNLL2;YWHAE;DYNLL1;TUBB4B;CYCS;ATP5PB;TUBA4A;BBIP1;RAB11A;MTX1;CCT5;NUDT19;CEP72;MICOS10;IFT20;PPP2R1A;SIRT3;MICOS13;KIF24;DCTN1;CEP78;TMEM216;ARL6;HSP90AA1;CCT3;BBS5;CCT8;MTX2;SSNA1;DYNLT2B;SSBP1;CCT2;TUBB4A;CCT4;HAUS5;HAUS2;PPARA;CETN2;SAMM50;TCP1;GABPA;DYNLRB1;EXOC3;DCTN3;IFT22;TMEM11;TBL1XR1;IFT46
gsea,Signaling By NOTCH3 R-HSA-9012852,-0.2892109254993096,-1.0969365990965025,0.3008298755186722,0.4072957971781989,1.0,10/44,20.62%,UBB;RPS27A;UBA52;UBC;MAML3;SNW1;JAG1;MAML2;PSENEN;EGFR
gsea,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.26343654169433156,1.0967906213157297,0.30387931034482757,0.8380327962872297,1.0,14/68,15.03%,SRSF5;SRRM1;SRSF1;NUP214;NUP205;RANBP2;NXF1;NUP188;CASC3;NUP155;UPF3B;SRSF6;SRSF4;NUP88
gsea,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.2311510004944178,1.0934238364957187,0.27565392354124746,0.8402570318909938,1.0,29/160,10.60%,KIF1B;DYNC1H1;MAN2A2;VTI1A;KIFC2;KIF5A;KIF5B;MAN2A1;RAB3GAP2;KIF21A;ZW10;GOLGA4;KIF3C;DYNC1LI1;TRIP11;VPS45;RAB43;CUX1;VPS54;COG6;RAB30;KIF16B;KIF13B;NBAS;KIF11;KIF1A;KIF3A;ARCN1;KIFC1
gsea,Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.3526867040845835,-1.091680991638569,0.3452631578947368,0.4155539717817316,1.0,6/17,26.46%,GNG7;PLCB1;GNG3;GNB2;PLCB2;GNG10
gsea,CaM Pathway R-HSA-111997,0.32152612585071416,1.0915891026789382,0.32086614173228345,0.8371448325609305,1.0,14/31,20.63%,ADCY8;PRKCG;CAMK2D;PRKCA;PRKAR1B;ADCY1;CAMK2A;GRK2;NBEA;ADCY6;PRKAR2A;ADCY2;ADCY7;ADCY5
gsea,RHOH GTPase Cycle R-HSA-9013407,-0.30034143226219745,-1.0910400323205949,0.33608247422680415,0.4160000401280915,1.0,6/33,15.00%,TMEM59;LAMTOR1;TUBA1B;ARHGDIG;VAMP3;TFRC
gsea,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.3375169794226988,-1.0908135434056452,0.326271186440678,0.4157436853656771,1.0,6/25,20.38%,SREBF2;LAMB1;WWTR1;HMGCR;YAP1;NAB1
gsea,Collagen Formation R-HSA-1474290,0.2697688249426001,1.0866709960527692,0.30564784053156147,0.8450553124183927,1.0,34/75,26.17%,DST;COL24A1;ADAMTS2;PCOLCE2;LAMC2;COL7A1;COL20A1;MMP28;LAMA4;COL16A1;COL6A2;COL14A1;COL1A2;ADAMTS14;COL6A3;COL12A1;COL8A1;COL6A5;COL19A1;COL28A1;P4HA3;COL5A2;BMP1;COLGALT2;MMP9;TLL2;P3H3;PXDN;PLOD3;COL5A1;COL13A1;COLGALT1;COL9A3;PLEC
gsea,ISG15 Antiviral Mechanism R-HSA-1169408,-0.26140867016208175,-1.0848370428596958,0.30648330058939094,0.4251031690535708,1.0,8/64,7.49%,UBB;RPS27A;KPNA4;EIF4G2;UBA52;UBC;NUP43;KPNA3
gsea,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.2738447255613573,-1.0847520643660273,0.31983805668016196,0.4245580350454959,1.0,13/50,20.04%,RAN;H2AZ1;POLR2K;H2AJ;NUP43;H2BC4;POLR2G;NUP50;POLR2F;H2AZ2;H2BC21;H2AX;POLR2E
gsea,G-protein Activation R-HSA-202040,-0.34212696227309497,-1.0842424487500508,0.34808853118712274,0.42482251248914776,1.0,7/20,30.19%,GNG7;POMC;GNG3;GNA15;GNB2;GNG10;GNA11
gsea,mRNA Splicing - Major Pathway R-HSA-72163,0.22303746152383103,1.0839504018665198,0.29918032786885246,0.8452844876073732,1.0,27/180,7.06%,FUS;SRRM2;SRSF5;RBM5;SRRM1;HNRNPR;SRSF1;CPSF3;HNRNPH1;DHX9;RBMX;PRCC;HNRNPL;DDX42;CSTF2;PABPN1;HNRNPD;HNRNPM;HNRNPU;POLR2A;CWC25;SUGP1;EFTUD2;CPSF7;GCFC2;DHX15;DDX46
gsea,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.30039315839833375,1.0828966872357466,0.3136456211812627,0.8400243592083194,1.0,9/32,18.46%,NUP214;NUP205;RANBP2;NXF1;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,Homology Directed Repair R-HSA-5693538,-0.2398696735484178,-1.0822571259661973,0.2894168466522678,0.4275902568351779,1.0,13/96,11.50%,UBB;SUMO2;RPS27A;POLD4;UBA52;UBC;H2BC4;PCNA;RAD51C;RAD9B;BABAM2;POLE4;RAD51
gsea,Signaling By PDGFR In Disease R-HSA-9671555,0.35336520554868106,1.0807478146057758,0.3485148514851485,0.8385773400539852,1.0,5/19,5.20%,STAT1;GOLGA4;ETV6;PIK3R2;GRB2
gsea,Processing Of Intronless Pre-mRNAs R-HSA-77595,0.34199462497235245,1.0763484007325097,0.34970530451866405,0.8450413639284874,1.0,4/20,6.53%,CPSF3;CSTF2;PABPN1;CPSF7
gsea,Gene Silencing By RNA R-HSA-211000,-0.24964706148587876,-1.0761796337272072,0.3157894736842105,0.437905559633397,1.0,21/74,23.10%,RAN;H2AZ1;MOV10L1;TSNAX;POLR2K;MYBL1;H2AJ;NUP43;H2BC4;HSP90AA1;POLR2G;NUP50;HENMT1;POLR2F;H2AZ2;H2BC21;H2AX;POLR2E;TSN;ELAC2;NUP35
gsea,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.3048695517103589,1.0753227549227728,0.34285714285714286,0.8397439575406654,1.0,9/30,18.46%,NUP214;NUP205;RANBP2;NEK9;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.28158690088615324,-1.0733162529881908,0.32914046121593293,0.44215933229549326,1.0,11/47,15.74%,UBB;RPS27A;UBA52;UBC;RBL1;SNW1;SMAD7;SMAD2;CCNK;UBE2D3;WWTR1
gsea,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.2979682191808501,-1.0729545379795868,0.34460887949260044,0.4421135198028446,1.0,9/30,21.09%,H2AZ1;H2AJ;H2BC4;ASF1A;H2AZ2;H2BC21;CCNE2;H2AX;CDKN1B
gsea,DNA Strand Elongation R-HSA-69190,-0.3091022000200437,-1.0710439295375453,0.3642241379310345,0.4446678345104953,1.0,10/29,32.76%,POLD4;PCNA;POLA2;GINS4;MCM6;GINS2;GINS1;LRIG1;RFC5;POLD2
gsea,Regulation Of Signaling By CBL R-HSA-912631,0.35513952676688576,1.070553996496759,0.3627450980392157,0.8471754828839874,1.0,8/18,16.27%,PIK3R2;GRB2;CLSTN1;CBL;CRKL;PIK3CA;CRK;FYN
gsea,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.34651450877617285,-1.0695942457943297,0.36058700209643607,0.446413882810187,1.0,9/18,34.82%,PPP2R1A;PPP2CA;POLA2;ORC4;ORC5;PPP2R1B;TFDP2;ORC6;RB1
gsea,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.2879948548902021,-1.0687522993183995,0.35714285714285715,0.4471476029561682,1.0,6/37,13.30%,POLD4;MPG;PCNA;PNKP;POLE4;POLE3
gsea,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.2523104909230322,-1.0686007943414801,0.34415584415584416,0.44671434169385554,1.0,15/81,16.39%,CALM1;SLC24A5;SLC16A10;SLC15A2;AHCYL2;SRI;SLC7A5;SLC8B1;SLC1A6;SLC32A1;SLC38A3;SLC12A6;SLC3A2;SLC9A3;SLC24A1
gsea,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.3385810894719507,-1.0674535193638823,0.36699029126213595,0.4480948822307711,1.0,10/22,23.81%,AP1S1;B2M;AP2M1;AP1S3;CD247;DOCK2;AP2B1;AP1S2;AP2S1;AP1M1
gsea,Cell-Cell Communication R-HSA-1500931,0.25217449724177043,1.0662315245061584,0.33081285444234404,0.8532756224692077,1.0,22/92,15.14%,SPTAN1;DST;IQGAP1;FLNA;AFDN;PTK2;CDH4;PIK3R2;GRB2;CDH13;LAMC2;NECTIN4;LAMA4;SDK2;CDH12;CADM3;ACTN4;SPTBN1;CDH19;PIK3CA;CDH10;PARD6B
gsea,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.24804854969464502,1.0660134194396578,0.3389473684210526,0.8455150546456689,1.0,15/77,15.03%,SRSF5;SRRM1;SRSF1;CPSF3;NUP214;NUP205;RANBP2;NXF1;NUP188;CASC3;NUP155;UPF3B;SRSF6;SRSF4;NUP88
gsea,Plasma Lipoprotein Remodeling R-HSA-8963899,-0.3384345874673617,-1.063244023236418,0.3663594470046083,0.4548870086573838,1.0,4/19,9.35%,APOE;PLTP;APOA1;P4HB
gsea,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.3108076289371534,1.0627687062030222,0.3723608445297505,0.8479974770613729,1.0,7/31,11.48%,HEXB;ST3GAL3;ACAN;SDC2;DCN;SLC26A2;VCAN
gsea,RHO GTPase Cycle R-HSA-9012999,0.21512321593051345,1.0611561595936212,0.312015503875969,0.8450356204326441,1.0,115/403,20.68%,TRIO;CCDC88A;SPTAN1;USP9X;DOCK3;DST;SRRM1;MYO9B;IQGAP1;FNBP1;SHKBP1;VRK2;CLTC;DOCK7;MYO9A;ATP6AP1;DOCK9;RBMX;ANKRD26;MSI2;NCOA3;ARHGEF10L;GIT1;FAM13B;TAOK3;ARHGEF15;PIK3R2;GRB2;KALRN;WIPF2;PLXND1;CDC42BPB;PLD2;FAM169A;CDC42BPA;OCRL;CPSF7;OPHN1;MOSPD2;WDR81;ARHGAP23;ARHGAP32;ROCK1;RNF20;WIPF1;ITSN2;ARHGEF11;GMIP;SRGAP1;VANGL1;ARHGEF2;PLEKHG1;ALS2;ARHGAP42;DOCK5;MYO6;SRGAP2;SYDE1;FNBP1L;PLEKHG4;SCRIB;MTR;RALGAPA1;ARHGAP35;DOCK11;TPM3;ROCK2;SPTBN1;SENP1;GFOD1;CDC42EP5;RRAS2;PIK3CA;MCF2L;SHMT2;TMOD3;LEMD3;EFHD2;DNMBP;GIT2;ANLN;ANKFY1;RND1;PARD6B;RBBP6;GOLGA3;FAM135A;COPS2;DIAPH1;ARHGAP17;ARHGAP21;DLC1;ARAP1;ARHGEF10;SEMA4F;DHDDS;ARHGAP33;WDR11;LMNB1;RASGRF2;SOS2;PRAG1;ARHGEF28;REPS1;CCDC187;ITSN1;KIDINS220;RHOH;ECT2;CDC42EP2;ANKLE2;ARHGEF18;CKAP4;ARAP3;SRC
gsea,Mismatch Repair R-HSA-5358508,-0.36786964537811473,-1.060177766578785,0.3765432098765432,0.4597576510203598,1.0,7/15,32.76%,POLD4;PCNA;MLH1;LRIG1;MSH2;EXO1;POLD2
gsea,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.28326758017135545,1.0549695182822476,0.3866943866943867,0.857341900691418,1.0,10/38,18.46%,CPSF3;NUP214;NUP205;RANBP2;NXF1;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,Signaling To RAS R-HSA-167044,-0.3606428366862578,-1.0545798490199207,0.39539748953974896,0.4694933764625214,1.0,2/16,1.75%,HRAS;RALA
gsea,RHOB GTPase Cycle R-HSA-9013026,0.262851683163328,1.0543638495356924,0.3770833333333333,0.8513256951111741,1.0,22/64,20.97%,MYO9B;MYO9A;ARHGEF10L;PIK3R2;OPHN1;ARHGAP32;ROCK1;ARHGEF11;VANGL1;ARHGEF2;ARHGAP35;ROCK2;MCF2L;ANLN;DIAPH1;ARHGAP21;DLC1;ARHGEF10;DHDDS;ARHGEF28;ECT2;DAAM1
gsea,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.2721506474914299,1.0543151186343478,0.37333333333333335,0.8433878700822932,1.0,27/59,25.63%,COL24A1;ADAMTS2;PCOLCE2;COL7A1;COL20A1;COL16A1;COL6A2;COL14A1;COL1A2;ADAMTS14;COL6A3;COL12A1;COL8A1;COL6A5;COL19A1;COL28A1;P4HA3;COL5A2;BMP1;COLGALT2;TLL2;P3H3;PLOD3;COL5A1;COL13A1;COLGALT1;COL9A3
gsea,CD28 Co-Stimulation R-HSA-389356,-0.31150457099593887,-1.0540835991938675,0.3559322033898305,0.4697012862468524,1.0,5/29,7.82%,MLST8;YES1;LYN;CDC42;AKT3
gsea,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.2763380688489617,-1.0534047546305743,0.34714003944773175,0.4702144877187076,1.0,7/46,9.61%,UBB;RPS27A;UBA52;UBC;HDAC11;MAML3;SNW1
gsea,Regulation Of TP53 Activity R-HSA-5633007,0.23046232099006764,1.052797890660751,0.32514177693761814,0.8403875687021825,1.0,35/134,16.33%,MTOR;USP7;EHMT1;TAF1;RICTOR;EP300;RFFL;ATM;BRPF3;CHEK2;CHD4;JMY;BANP;MDM2;RAD9A;AKT2;PHF20;BRIP1;PPP2R5C;TBP;MAPK14;GATAD2B;PRKAG1;RBBP8;RBBP4;DNA2;PRKAA2;PPP1R13L;L3MBTL1;RAD50;CHEK1;TAF4;TAF15;MTA2;TOP3A
gsea,Cilium Assembly R-HSA-5617833,-0.2187231232998404,-1.0502490915152782,0.31896551724137934,0.4753806729990059,1.0,49/177,26.76%,YWHAG;TUBA1A;DYNLL2;YWHAE;DYNLL1;TUBB4B;TUBA4A;BBIP1;RAB11A;CCT5;NUDT19;CEP72;IFT20;PPP2R1A;KIF24;DCTN1;CEP78;TMEM216;ARL6;HSP90AA1;CCT3;BBS5;CCT8;SSNA1;DYNLT2B;CCT2;TUBB4A;CCT4;HAUS5;HAUS2;CETN2;TCP1;DYNLRB1;EXOC3;DCTN3;IFT22;IFT46;HSPB11;ARF4;EXOC4;PAFAH1B1;HAUS3;TTC30B;TCTN1;INPP5E;EXOC8;B9D1;CEP135;CC2D2A
gsea,mRNA Splicing R-HSA-72172,0.21471895398795487,1.0493947006755973,0.3582995951417004,0.8433502072972675,1.0,27/188,7.06%,FUS;SRRM2;SRSF5;RBM5;SRRM1;HNRNPR;SRSF1;CPSF3;HNRNPH1;DHX9;RBMX;PRCC;HNRNPL;DDX42;CSTF2;PABPN1;HNRNPD;HNRNPM;HNRNPU;POLR2A;CWC25;SUGP1;EFTUD2;CPSF7;GCFC2;DHX15;DDX46
gsea,DNA Double-Strand Break Repair R-HSA-5693532,-0.22456264757766797,-1.0488821055597182,0.34513274336283184,0.4770032405574139,1.0,25/125,21.42%,UBB;SUMO2;RPS27A;XRCC6;EYA1;POLD4;UBA52;UBC;H2BC4;PCNA;RAD51C;RAD9B;BABAM2;POLE4;RAD51;POLE3;SMARCA5;SUMO1;SEM1;H2BC21;RAD51B;APBB1;H2AX;SIRT6;UBE2N
gsea,SLC-mediated Transmembrane Transport R-HSA-425407,-0.22393720240405662,-1.0486209574300307,0.33406593406593404,0.47672628220202384,1.0,56/165,33.15%,CALM1;SLC25A4;SLC25A5;SLC24A5;SLC16A10;SLC15A2;AHCYL2;BSG;ARL2BP;SRI;SLC7A5;SLC35A1;SLCO1C1;SLC8B1;SLC1A6;SLC32A1;SLC30A5;SLC16A7;SLC16A1;PDZD11;SLC38A3;SLC12A6;SLC3A2;SLC9A3;SLC24A1;SLC40A1;SLC44A1;SLC12A1;SLC24A3;SLC25A26;SLC39A3;SLC18A2;SLC41A1;SLC39A10;ARL2;SLC7A10;SLC35A3;SLC35C1;SLC50A1;SLC30A6;SLC30A10;SLC27A1;SLC31A1;SLC4A10;SLC11A2;SLC13A1;SLC2A12;SLC2A13;SLC9A9;SLC16A2;CTNS;SLC6A15;SLC16A3;SLC8A2;SLC7A1;SLC38A2
gsea,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.3200827753981256,-1.046770149218143,0.38703339882121807,0.47931600815474806,1.0,4/22,14.16%,HRAS;NRG3;HSP90AA1;NRG4
gsea,Gap Junction Trafficking And Regulation R-HSA-157858,-0.3541005808950607,-1.0466473414746014,0.38762886597938145,0.4787949429985462,1.0,5/16,14.25%,CLTB;CLTA;GJA1;AP2M1;GJD2
gsea,O-linked Glycosylation R-HSA-5173105,0.24855297846871854,1.0456714402836473,0.3697632058287796,0.8476631634199332,1.0,27/79,23.56%,THBS2;ADAMTSL3;ST3GAL3;ADAMTS19;B3GLCT;ADAMTS20;GALNT9;ADAMTS2;ADAMTS5;GALNT18;ADAMTSL5;THSD4;ADAMTS14;GALNT14;POMT1;ADAMTS17;ST6GAL1;DAG1;ADAMTSL1;GALNT12;ADAMTS10;C1GALT1;ADAMTS15;THBS1;SEMA5B;ST3GAL4;SBSPON
gsea,Transmission Across Chemical Synapses R-HSA-112315,0.2219046627393717,1.045423164810522,0.3584158415841584,0.8406481014795295,1.0,49/206,13.86%,EPB41L1;GRIA4;GABBR2;PPFIA3;MAPT;GRIK4;CACNA1B;CACNA1A;NCALD;GABRG3;UNC13B;NRG1;ADCY8;TSPOAP1;RPS6KA2;PRKCG;GIT1;GRIK5;MPP3;STXBP1;PRKCB;CACNB4;CACNG2;MDM2;CACNA2D2;CAMK2D;PPFIA1;PRKCA;SLC6A1;SLC1A1;SYN1;APBA1;PRKAR1B;MPP2;CHRNB3;PRKAG1;ADCY1;MYO6;STX1A;RPS6KA6;PRKAA2;CAMK2A;GRIN2D;CHRNA3;SLC5A7;GRIK3;KIF17;AP2A1;GRIK1
gsea,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.3258461820603709,1.0447683307371984,0.40471512770137524,0.8352213734262989,1.0,8/24,14.20%,CHUK;IKBKB;USP25;OTUD7B;USP4;TAB1;MAP3K7;XIAP
gsea,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.28939120366433546,1.042697625044451,0.35685483870967744,0.8343076867912357,1.0,9/31,18.46%,NUP214;NUP205;RANBP2;PBRM1;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,RHOBTB GTPase Cycle R-HSA-9706574,-0.2892474939883815,-1.0424069162594563,0.38992537313432835,0.48605354046512544,1.0,8/35,13.73%,HSP90AB1;ACTG1;HSP90AA1;CCT7;TXNL1;CCT6A;CCT2;TWF1
gsea,RHOQ GTPase Cycle R-HSA-9013406,0.26798783238621904,1.0422334941912208,0.37476099426386233,0.8282732864209872,1.0,20/57,20.45%,IQGAP1;FNBP1;GIT1;CDC42BPB;CDC42BPA;OPHN1;ARHGAP32;VANGL1;SRGAP2;SYDE1;SCRIB;ARHGAP35;GFOD1;GIT2;ARHGAP17;ARHGAP21;DLC1;ARHGAP33;ITSN1;CDC42EP2
gsea,Degradation Of Extracellular Matrix R-HSA-1474228,0.2488252707281251,1.037657073620723,0.4114391143911439,0.8353017382736885,1.0,17/78,11.75%,ACAN;KLKB1;CAPN15;LAMC2;ADAM17;ADAMTS5;ADAM15;MMP16;MMP28;DCN;LAMA4;COL16A1;CAPN2;CD44;NCSTN;COL14A1;CAPN1
gsea,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.23805028247194715,-1.0362339582136242,0.39914163090128757,0.496657683068318,1.0,13/84,14.65%,DYNLL2;RPS27;DYNLL1;ITGB3BP;NUP43;PPP2R1A;NUDC;NDEL1;CENPP;PPP2CA;MIS12;BUB3;NEK7
gsea,Transcriptional Regulation By E2F6 R-HSA-8953750,0.2929801843554376,1.036221046119414,0.37473684210526315,0.8323010090173306,1.0,12/32,21.64%,EHMT1;MGA;PCGF6;RYBP;RBBP8;RBBP4;CHEK1;MAX;EED;UXT;L3MBTL2;RBBP7
gsea,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.34035839736916224,1.0361198396291824,0.4074074074074074,0.8254245715994231,1.0,4/20,7.77%,MTOR;RICTOR;PIK3R2;AKT2
gsea,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.31147060635588425,-1.033764865988121,0.4140625,0.5004036285849018,1.0,4/23,14.16%,HRAS;NRG3;HSP90AA1;NRG4
gsea,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.295799863342386,1.031401108823708,0.4081237911025145,0.833007664999559,1.0,6/29,7.45%,SCN8A;SCN1A;SCN2A;CACNA2D2;CAMK2D;CACNG7
gsea,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.20499692300245206,1.0307791084637687,0.38289205702647655,0.8278335768820699,1.0,31/235,7.24%,FUS;SRRM2;SRSF5;RBM5;SRRM1;HNRNPR;SRSF1;CPSF3;HNRNPH1;DHX9;RBMX;PRCC;HNRNPL;NUP214;NUP205;DDX42;CSTF2;PABPN1;HNRNPD;HNRNPM;RANBP2;HNRNPU;POLR2A;CWC25;SUGP1;EFTUD2;CPSF7;GCFC2;DHX15;DDX46;NXF1
gsea,VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.34546225522138424,1.0304062364568989,0.4329501915708812,0.8220095701139567,1.0,5/18,11.73%,EXOC1;ASAP1;PKD1;EXOC7;RAB11FIP3
gsea,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.30662263828397224,-1.0297673381131536,0.4088176352705411,0.5071791512680178,1.0,10/26,23.45%,POLR2K;POLR3H;POLR3E;POLR1D;POLR2F;POLR3A;POLR3K;GTF3C6;POLR2E;POLR3D
gsea,Opioid Signaling R-HSA-111885,-0.24500421041571624,-1.026127376606827,0.3723849372384937,0.5134447594878876,1.0,22/81,27.79%,CALM1;GNG7;AHCYL1;PPP3R1;PPP2R1A;PPP3CA;PPP1CA;PPP2CA;PLCB1;POMC;PPP1R1B;CAMK2B;GNG3;GNA15;GNB2;ITPR2;PLCB2;GNG10;PRKX;PPP2R1B;ADCY9;PRKAR1A
gsea,DNA Repair R-HSA-73894,-0.1981844636218132,-1.0230157548218495,0.4199134199134199,0.5187049260684232,1.0,75/271,29.01%,UBB;SUMO2;RPS27A;XRCC6;H2AZ1;EYA1;POLD4;USP1;POLR2K;UBA52;UBC;H2AJ;H2BC4;MPG;SPRTN;ERCC3;HMGN1;PCNA;RAD51C;UBE2B;COPS5;PNKP;MLH1;GTF2H5;RAD9B;POLR2G;BABAM2;POLE4;RAD51;INO80B;COPS6;POLE3;POLR2F;TCEA1;SMARCA5;PRPF19;FTO;SUMO1;CETN2;H2AZ2;COPS8;SEM1;RUVBL1;H2BC21;RAD51B;APBB1;INO80D;PIAS1;H2AX;POLR2E;COPS7A;SIRT6;TDG;UBE2N;FANCE;XAB2;SPIDR;ADPRS;DDB2;LRIG1;RMI1;MSH2;RAD18;TFPT;LIG4;TDP2;TINF2;RNF168;INO80C;RAD23B;EXO1;RMI2;RAD23A;POLR2J;BABAM1
gsea,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.24127915551489965,-1.0228544731126452,0.4105461393596987,0.518276025045494,1.0,8/68,7.49%,UBB;RPS27A;KPNA4;EIF4G2;UBA52;UBC;NUP43;KPNA3
gsea,NRAGE Signals Death Thru JNK R-HSA-193648,0.2717882884447223,1.0225089971720203,0.4052532833020638,0.8392386749137112,1.0,16/50,22.65%,TRIO;ARHGEF10L;ARHGEF15;KALRN;ARHGEF11;ARHGEF2;MCF2L;MAPK8;ARHGEF10;RASGRF2;SOS2;ITSN1;ECT2;ARHGEF18;FGD4;PLEKHG5
gsea,Platelet Aggregation (Plug Formation) R-HSA-76009,0.3045043080338847,1.0224990384715313,0.4196078431372549,0.8322747760678949,1.0,9/27,22.50%,RAPGEF4;SHC1;PTK2;GRB2;CRK;RAPGEF3;FN1;SRC;PDPK1
gsea,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.2714996241342927,1.0223949348001669,0.42008196721311475,0.8257174026780458,1.0,10/39,18.46%,CPSF3;NUP214;NUP205;RANBP2;NXF1;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,0.359030679368775,1.0223332342820743,0.4246575342465753,0.8191431341223182,1.0,3/15,3.38%,DHX9;CHUK;IKBKB
gsea,Synthesis Of PC R-HSA-1483191,0.30973321826088684,1.0217903667405681,0.42350746268656714,0.8142035207951652,1.0,5/23,13.70%,SLC44A2;LPIN1;STARD10;CHKA;PEMT
gsea,COPI-mediated Anterograde Transport R-HSA-6807878,-0.24997551689235814,-1.0214960603957401,0.40194174757281553,0.5200599693818874,1.0,27/72,27.95%,DYNLL2;DYNLL1;TMED2;TMED7;TMED9;CAPZA2;DCTN1;BET1;NSF;COG5;COPE;BET1L;ACTR10;COG1;DCTN4;ARF5;CAPZA1;DCTN3;ARF4;KDELR1;GOSR2;GORASP1;COG2;YKT6;NAPG;COG8;PTGES2
gsea,Semaphorin Interactions R-HSA-373755,-0.24878906093990136,-1.0211416008428809,0.4012738853503185,0.5199099902934213,1.0,17/61,26.33%,HSP90AB1;GSK3B;MYL6;RHOB;DPYSL2;SEMA5A;HSP90AA1;RHOA;MYL9;TYROBP;RNMT;PTPRC;TREM2;MYH14;CD72;ITGB1;TLN1
gsea,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.26666494494871307,-1.0201545408181554,0.4080338266384778,0.5209901958943375,1.0,5/54,5.79%,CALM1;HRAS;YWHAB;PEBP1;CNKSR2
gsea,Oxidative Stress Induced Senescence R-HSA-2559580,-0.24960560535541143,-1.019269076964092,0.4007936507936508,0.5217760097991065,1.0,16/64,20.01%,UBB;JUN;RPS27A;H2AZ1;UBA52;UBC;H2AJ;H2BC4;TXN2;CBX4;CDKN2D;FOS;H2AZ2;H2BC21;MAPK3;H2AX
gsea,Syndecan Interactions R-HSA-3000170,-0.33245008684277455,-1.016877642612172,0.4061855670103093,0.5255021260800197,1.0,7/18,29.19%,TGFB1;TRAPPC4;SDC4;ITGAV;FGF13;ITGB1;ITGB5
gsea,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.27265151004675425,-1.0157541197120448,0.4346076458752515,0.5268613433343302,1.0,7/39,11.39%,NSUN6;TRMT112;TRMT61A;TRMT9B;TRMT12;LAGE3;METTL1
gsea,Signaling To ERKs R-HSA-187687,-0.29961833802409554,-1.0151902863308242,0.4560327198364008,0.5270916033004736,1.0,3/30,2.37%,HRAS;RALA;YWHAB
gsea,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.32717315530093216,-1.0145363593694754,0.4382716049382716,0.5274524232778911,1.0,10/19,41.91%,GNG7;GNG3;GNA15;GNB2;GNG10;GNA11;AAMP;GNA13;GNG12;GNG2
gsea,Signal Amplification R-HSA-392518,-0.30035661634808036,-1.0137563315167994,0.4140625,0.52822960542351,1.0,9/27,31.59%,P2RY12;GNG7;P2RY1;GNG3;GNA15;GNB2;GNG10;GNA11;GNAI1
gsea,Mitochondrial Biogenesis R-HSA-1592230,-0.2431888549194042,-1.0106561694936298,0.4146825396825397,0.5336476915368087,1.0,14/69,20.70%,CALM1;CYCS;ATP5PB;MTX1;MICOS10;SIRT3;MICOS13;MTX2;SSBP1;PPARA;SAMM50;GABPA;TMEM11;TBL1XR1
gsea,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.27887155074594827,1.0089124541944159,0.4525691699604743,0.8469595062661002,1.0,12/35,20.63%,IQGAP1;RAPGEF4;ADCY8;PRKCA;PRKAR1B;KCNB1;ADCY6;RAPGEF3;GNB5;KCNC2;PRKAR2A;ADCY5
gsea,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.31582443686620404,1.0085850137900965,0.4584103512014787,0.8410836751967373,1.0,11/22,23.14%,ATM;BRIP1;BRCA2;RBBP8;DNA2;RAD50;TOP3A;RAD51D;RAD51AP1;BARD1;BLM
gsea,G2/M DNA Damage Checkpoint R-HSA-69473,-0.24659467697167411,-1.0082888078546528,0.44025157232704404,0.5375296470367631,1.0,19/55,29.96%,YWHAG;YWHAE;YWHAB;YWHAH;H2BC4;RAD9B;BABAM2;YWHAZ;H2BC21;CDC25C;H2AX;UBE2N;RMI1;RNF168;EXO1;RMI2;BABAM1;WEE1;RFC5
gsea,PKA Activation R-HSA-163615,-0.3483615548555028,-1.0066087247230948,0.4362934362934363,0.5401482608337306,1.0,1/15,0.07%,CALM1
gsea,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.3455745710221771,-1.005588676620295,0.43702290076335876,0.5412801275740835,1.0,11/16,41.94%,GSK3B;PPP2R1A;PPP2CA;FRAT1;PPP2R5B;PPP2R1B;FRAT2;CTNNB1;PPP2CB;AXIN1;AMER1
gsea,Glycosphingolipid Metabolism R-HSA-1660662,0.28080276165998985,1.003762982169248,0.4782608695652174,0.8489963143281241,1.0,11/34,19.40%,HEXB;SMPD3;CERK;NEU2;ASAH1;SUMF2;ESYT2;B3GALNT1;GLB1L;ARSK;ESYT3
gsea,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.34459787541704723,-1.0028069477268966,0.45866141732283466,0.5460047312778951,1.0,8/16,23.81%,AP1S1;B2M;AP2M1;AP1S3;AP2B1;AP1S2;AP2S1;AP1M1
gsea,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.3228837848661335,1.002678957863459,0.4296724470134875,0.8456185238848022,1.0,4/21,5.58%,STAT1;EP300;CREBBP;PLXND1
gsea,G Alpha (Q) Signaling Events R-HSA-416476,0.21918093111536607,1.0015515097430532,0.4581818181818182,0.8423841766015413,1.0,19/135,9.32%,TRIO;DGKG;TRPC3;RGS16;DGKQ;TACR3;HCRTR1;DGKA;RPS6KA2;TACR1;PIK3R2;GRB2;KALRN;PRKCE;PRKCA;DGKZ;HTR2A;GPR17;CCKBR
gsea,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.25636357012416017,1.0000059426031123,0.42830540037243947,0.8404075458285759,1.0,12/50,14.37%,SLC44A2;SLC41A2;SLC30A3;EMB;SLC22A4;SLC6A1;SLC39A2;SLC22A15;SLC6A7;SLC18A1;SLC5A7;SLC14A2
gsea,Signaling By MET R-HSA-6806834,-0.2508730014282816,-0.9983257682223475,0.44353182751540043,0.5538271141753288,1.0,6/58,5.23%,UBB;HRAS;RPS27A;UBA52;SH3GL1;UBC
gsea,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.2705451172412552,0.996380849857779,0.4910891089108911,0.8442982313047673,1.0,6/38,3.79%,TNRC6B;TNRC6A;EP300;MOV10;AGO4;CREBBP
gsea,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.29506387073607687,-0.9960933799687992,0.4385593220338983,0.5574761857411686,1.0,9/26,21.09%,GSK3B;MLST8;AKT3;RPS6KB2;AKT1;NR4A1;FOXO4;FOXO1;CDKN1B
gsea,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.2666663540290123,-0.9951211724442274,0.4639830508474576,0.5586613077104471,1.0,14/41,28.76%,POLR2K;ELOB;ERCC3;GTF2H5;POLR2G;POLR2F;TCEA1;CCNK;POLR2E;GTF2F2;CTDP1;NCBP2;NELFA;POLR2J
gsea,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.34144138671742963,0.9944373777886378,0.47947761194029853,0.8435126733210877,1.0,4/15,12.46%,SKIC3;HBS1L;SKIC2;DIS3
gsea,RHO GTPases Activate ROCKs R-HSA-5627117,-0.3250624129843471,-0.9914498980104581,0.4693446088794926,0.5650141874552285,1.0,4/19,13.19%,MYL6;RHOB;RHOA;MYL9
gsea,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.3405144817162413,-0.9911596015309847,0.47347740667976423,0.5647882970989795,1.0,2/15,3.59%,HRAS;LYN
gsea,Signaling By NTRKs R-HSA-166520,-0.22129686999478634,-0.9901616553555795,0.4376278118609407,0.5659164746300565,1.0,28/118,20.38%,HRAS;RALA;YWHAB;VRK3;CLTA;VGF;EGR4;PPP2R1A;JUND;ID3;CDK5R2;IRS2;RHOA;TCF12;NTRK3;AP2M1;PPP2CA;F3;ID2;FOS;MAP2K1;RIT2;DUSP6;LYL1;DUSP4;AP2B1;MAPK3;NAB1
gsea,Signaling By SCF-KIT R-HSA-1433557,0.2838210154546975,0.9897724909013054,0.454,0.8509491834256203,1.0,15/34,20.68%,STAT1;PIK3R2;GRB2;PRKCA;CBL;JAK2;STAT5B;PIK3CA;PTPRU;CHEK1;FYN;PTPN6;KIT;MMP9;SRC
gsea,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.2709160470062964,-0.9881040504306989,0.44874274661508706,0.5692196295613934,1.0,6/37,12.69%,UBB;RPS27A;UBA52;UBC;YWHAZ;AKT1
gsea,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.22235297417365144,0.9878001488705054,0.45875251509054327,0.8504811701156627,1.0,39/151,15.74%,EPB41L1;GRIA4;GABBR2;MAPT;GRIK4;NCALD;GABRG3;NRG1;ADCY8;RPS6KA2;PRKCG;GIT1;GRIK5;MPP3;PRKCB;CACNG2;MDM2;CAMK2D;PRKCA;APBA1;PRKAR1B;MPP2;CHRNB3;PRKAG1;ADCY1;MYO6;RPS6KA6;PRKAA2;CAMK2A;GRIN2D;CHRNA3;GRIK3;KIF17;AP2A1;GRIK1;NBEA;RASGRF1;ADCY6;GRIN3A
gsea,Signaling By FGFR1 In Disease R-HSA-5655302,0.2805896370424212,0.9874525784800073,0.45920303605313095,0.8451735623029623,1.0,8/30,13.68%,STAT1;ZMYM2;GRB2;MYO18A;CUX1;LRRFIP1;STAT5B;PIK3CA
gsea,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.26618094402104925,-0.9859780121221537,0.4811715481171548,0.5727770183409072,1.0,13/39,28.76%,POLR2K;ELOB;ERCC3;GTF2H5;POLR2G;POLR2F;TCEA1;POLR2E;GTF2F2;CTDP1;NCBP2;NELFA;POLR2J
gsea,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.23172438635255882,-0.9853664160011281,0.4690265486725664,0.5731325157802771,1.0,21/79,27.79%,GLP2R;CHGA;RAMP1;PTRH2;PTGER4;GNG7;HTR4;GNAS;POMC;CALCB;PTHLH;GNG3;CALCA;GNB2;GPR176;GPR150;GNG10;PRKX;MC1R;ADCY9;PRKAR1A
gsea,Signaling By Erythropoietin R-HSA-9006335,-0.3070510429056468,-0.9853044519178511,0.49064449064449067,0.5724406173398711,1.0,3/22,8.09%,HRAS;LYN;IRS2
gsea,Platelet Homeostasis R-HSA-418346,0.2439097195229997,0.9834494328630605,0.4781818181818182,0.8506834764340788,1.0,12/70,9.41%,GUCY1A2;ATP2B4;TRPC3;ATP2B3;PDE2A;PDE9A;PDE10A;SLC8A3;SLC8A1;PPP2R5C;PDE11A;MAPK14
gsea,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.27117346898650707,0.9831785975011975,0.46589018302828616,0.8452456682806287,1.0,21/45,28.11%,DST;COL24A1;LAMC2;COL7A1;MMP28;LAMA4;COL6A2;COL1A2;COL6A3;COL8A1;COL6A5;COL5A2;BMP1;MMP9;TLL2;PXDN;COL5A1;COL9A3;PLEC;COL11A1;COL11A2
gsea,Hemostasis R-HSA-109582,-0.19118767618619195,-0.9826290735519266,0.49665924276169265,0.57697462482015,1.0,89/415,22.37%,CALM1;TMSB4X;ATP1B1;TTR;PPIA;HRAS;P2RY12;ANGPT2;YES1;LYN;MANF;RHOB;TEK;APOA1;TUBA4A;CDC42;TGFB1;TIMP3;CAPZA2;GNG7;C1QBP;OLA1;KIF22;HSPA5;PPP2R1A;PFN1;PCDH7;ORAI2;BSG;SRI;SLC7A5;RAD51C;ATP1B2;CAP1;RHOA;CLU;P2RY1;PPP2CA;YWHAZ;PRCP;GNAS;ENDOD1;SLC16A1;AKT1;PCYOX1L;VTI1B;SDC4;CD63;F3;VEGFB;DOCK2;SLC3A2;SOD1;BCAR1;SPARC;PRKG1;KIF15;CLEC3B;FAM3C;RAB5A;VEGFC;EHD1;PIK3CG;DOCK1;ATP1B3;RAD51B;MAFK;APLP2;ATP2B1;FERMT3;GNG3;CAPZA1;MAPK3;PRTN3;SH2B3;STXBP3;EHD3;LHFPL2;KIF27;IRF1;GNA15;SELPLG;ITGAV;GNB2;SIN3A;SERPING1;ITGAM;PPP2R5B;PTPN1
gsea,CRMPs In Sema3A Signaling R-HSA-399956,-0.33147662149773405,-0.9818363273293016,0.4752475247524752,0.5777315057765157,1.0,2/15,7.92%,GSK3B;DPYSL2
gsea,PI-3K cascade:FGFR1 R-HSA-5654689,-0.3393667412883547,-0.9805727254443612,0.46466809421841543,0.5794616474599501,1.0,2/15,9.85%,FGF1;FGF10
gsea,Elastic Fibre Formation R-HSA-1566948,-0.28140282777248526,-0.9793425194696614,0.49327354260089684,0.5810875824500507,1.0,15/29,38.88%,TGFB1;ITGA8;ITGAV;LTBP1;ITGB1;FBLN1;MFAP3;FURIN;ITGB5;EFEMP2;VTN;LOXL1;TGFB3;EFEMP1;FBLN2
gsea,RHOC GTPase Cycle R-HSA-9013106,0.2372162849959557,0.9791426329724983,0.47046843177189407,0.8508375214599823,1.0,20/68,20.97%,MYO9B;IQGAP1;ARHGEF10L;OPHN1;ARHGAP32;ROCK1;ARHGEF11;VANGL1;ARHGAP35;ROCK2;MCF2L;ANLN;DIAPH1;ARHGAP21;DLC1;ARHGEF10;DHDDS;ARHGEF28;CCDC187;DAAM1
gsea,Signaling By GPCR R-HSA-372790,-0.1874325820637769,-0.9783838308126647,0.5035971223021583,0.58202573364479,1.0,101/421,28.10%,CALM1;GLP2R;P2RY14;HRAS;P2RY12;PLPPR4;RGS4;CX3CR1;CHGA;RAMP1;PTRH2;RHOB;CDC42;ARHGEF4;PLPPR5;PTGER4;NTSR2;GNG7;AHCYL1;BTK;NPY;PPP3R1;PPP2R1A;PPP3CA;PDE3B;HTR4;AKT3;PROK2;S1PR3;GRM1;NMUR1;SSTR2;RHOA;HEBP1;OPN4;GPNMB;CORT;PPP1CA;P2RY1;PPP2CA;RXFP3;PLCB1;GNAS;AKT1;PDE7A;FZD1;CXCL12;PNOC;PDE3A;POMC;RGS10;PPP1R1B;CALCB;PTHLH;NPFFR1;PIK3CG;ACKR3;PENK;ARHGEF9;PDE7B;HTR5A;FZD9;CAMK2B;CXCR4;LPAR1;GNG3;MAPK3;FZD2;EGFR;GNA15;CALCA;RGS8;GNB2;P2RY13;SSTR4;ADGRE1;TIAM2;NPFF;MRLN;ITPR2;CCL25;ITGB1;NTSR1;WNT2B;GPR176;ADRA1D;ADRA2C;GPR150;TIAM1;PLCB2;GNG10;EDNRA;CCR9;PRKX;PPP2R1B;CX3CL1;MC1R;ADCY9;PRKAR1A;ARHGEF1;ACKR4
gsea,Golgi-to-ER Retrograde Transport R-HSA-8856688,0.2217289673539428,0.9766618803912896,0.48919449901768175,0.8519592084653982,1.0,19/101,11.60%,KIF1B;DYNC1H1;KIFC2;KIF5A;KIF5B;RAB3GAP2;KIF21A;ZW10;KIF3C;DYNC1LI1;KIF16B;KIF13B;NBAS;KIF11;KIF1A;KIF3A;ARCN1;KIFC1;KLC4
gsea,Regulation Of KIT Signaling R-HSA-1433559,-0.3371348443579311,-0.9760523972037117,0.5116279069767442,0.585757049316134,1.0,3/15,8.28%,YES1;LYN;SOCS1
gsea,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.3017911605144926,-0.9752803326123656,0.5104602510460251,0.5864694844315912,1.0,4/22,8.37%,CHGA;B4GALT4;FUCA1;MGAT4B
gsea,HCMV Late Events R-HSA-9610379,-0.23524148876280648,-0.9728814008969618,0.5071283095723014,0.590373096092277,1.0,16/61,24.95%,CEBPD;NUP43;H2BC4;TXN2;CHMP2A;CHMP4B;MVB12B;NUP50;CHMP4C;VPS37C;H2BC21;CHMP1A;H2AC25;VPS4A;NUP35;MVB12A
gsea,Interleukin-10 Signaling R-HSA-6783783,-0.3283718102990392,-0.9727301829657642,0.4772727272727273,0.5897819841738181,1.0,4/17,22.07%,TNFRSF1A;TYK2;IL1R2;IL18
gsea,RHOA GTPase Cycle R-HSA-8980692,0.2194433043069754,0.9723482803951293,0.5074626865671642,0.8581576608352699,1.0,36/135,20.97%,TRIO;MYO9B;IQGAP1;MYO9A;ATP6AP1;ARHGEF10L;ARHGEF15;PIK3R2;KALRN;OPHN1;ARHGAP23;ARHGAP32;ROCK1;ARHGEF11;GMIP;SRGAP1;VANGL1;ARHGEF2;ARHGAP42;PLEKHG4;ARHGAP35;ROCK2;MCF2L;ANLN;DIAPH1;ARHGAP21;DLC1;ARAP1;ARHGEF10;DHDDS;RASGRF2;ARHGEF28;ECT2;ARHGEF18;ARAP3;DAAM1
gsea,TBC/RABGAPs R-HSA-8854214,0.2598221137018504,0.9717716167190398,0.503921568627451,0.8537464172141992,1.0,10/41,10.07%,TBC1D17;OPTN;RABGEF1;ULK1;RAB43;TSC1;TBC1D13;TBC1D24;GGA3;RABEP1
gsea,Ion Transport By P-type ATPases R-HSA-936837,-0.26316584563996237,-0.9717239311716759,0.517467248908297,0.5909645464804149,1.0,10/42,19.34%,CALM1;ATP1B1;ATP1A2;SRI;ATP1B2;PDZD11;FXYD1;ATP1B3;ATP2B1;CAMK2B
gsea,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.30873239529102464,-0.9710820183497775,0.4969574036511156,0.5914877163358131,1.0,2/19,1.77%,YWHAE;JUN
gsea,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.2360238130982585,-0.970868206676016,0.492,0.5911492956086454,1.0,19/55,28.76%,JUN;POLR2K;ELOB;ERCC3;MLH1;GTF2H5;POLR2G;POLR2F;TCEA1;CCNK;FOS;POLR2E;GTF2F2;CTDP1;CDK13;DDB2;MSH2;NELFA;POLR2J
gsea,Generation Of Second Messenger Molecules R-HSA-202433,-0.3301959498822369,-0.9705629645683318,0.49079754601226994,0.5909212538138982,1.0,8/15,46.96%,NCK1;CD247;ENAH;LCP2;ITK;ARHGEF7;VASP;PKN1
gsea,Interferon Signaling R-HSA-913531,-0.20908058427689316,-0.9703466226416569,0.5155925155925156,0.5904684596765687,1.0,31/124,25.54%,UBB;TRIM35;RPS27A;KPNA4;EIF4G2;IFNGR2;UBA52;UBC;NUP43;KPNA3;SOCS1;B2M;NUP50;TYK2;SMAD7;KPNA1;SUMO1;PDE12;CAMK2B;IFI30;PIAS1;MAPK3;IRF1;IFI35;UBE2N;IFI27;PTPN1;NUP35;ARIH1;EIF4A3;EGR1
gsea,Peptide Hormone Metabolism R-HSA-2980736,-0.24202588958360627,-0.970077240620948,0.5113871635610766,0.590112133011324,1.0,13/55,18.79%,VAMP2;CHGA;SPCS2;CTSZ;ATP6AP2;INHBA;INHA;SEC11C;SLC30A5;POMC;PLA2G7;SPCS1;EXOC3
gsea,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.3305865547809269,-0.966797120475001,0.5021186440677966,0.5958161526457598,1.0,8/16,36.25%,YWHAB;AKT1;EXOSC7;EXOSC5;ZFP36L1;DCP1A;EXOSC8;EXOSC4
gsea,Regulation Of Beta-Cell Development R-HSA-186712,-0.29856549975719504,-0.9660143152514714,0.4810126582278481,0.5965335811884279,1.0,8/25,21.07%,MAML3;AKT3;ONECUT1;SNW1;FGF10;AKT1;MAML2;FOXO1
gsea,TRP Channels R-HSA-3295583,0.312470126766227,0.9645669810049204,0.5170556552962298,0.8679799028912871,1.0,4/18,9.28%,TRPC3;MCOLN1;TRPM2;TRPM4
gsea,Myogenesis R-HSA-525793,-0.2941805717103769,-0.9606277676295146,0.500998003992016,0.6069917826581547,1.0,3/24,11.06%,CDC42;CTNNA1;TCF12
gsea,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.2531451963013358,-0.9587592824657406,0.5065502183406113,0.609903282833826,1.0,17/41,31.61%,CNOT6L;CNOT8;RBL1;PCNA;NPM1;GADD45A;CNOT3;CNOT4;CDC25C;CCNE2;CDKN1B;E2F4;BTG2;BAX;PRMT1;PLK2;TFDP2
gsea,GPCR Downstream Signaling R-HSA-388396,-0.18515698532849342,-0.95840578000993,0.5889145496535797,0.6097078940771475,1.0,94/383,28.10%,CALM1;GLP2R;P2RY14;HRAS;P2RY12;RGS4;CX3CR1;CHGA;RAMP1;PTRH2;RHOB;CDC42;ARHGEF4;PTGER4;NTSR2;GNG7;AHCYL1;BTK;NPY;PPP3R1;PPP2R1A;PPP3CA;PDE3B;HTR4;AKT3;PROK2;S1PR3;GRM1;NMUR1;SSTR2;RHOA;HEBP1;OPN4;GPNMB;CORT;PPP1CA;P2RY1;PPP2CA;RXFP3;PLCB1;GNAS;AKT1;PDE7A;CXCL12;PNOC;PDE3A;POMC;RGS10;PPP1R1B;CALCB;PTHLH;NPFFR1;PIK3CG;ACKR3;PENK;ARHGEF9;PDE7B;HTR5A;CAMK2B;CXCR4;LPAR1;GNG3;MAPK3;EGFR;GNA15;CALCA;RGS8;GNB2;P2RY13;SSTR4;TIAM2;NPFF;MRLN;ITPR2;CCL25;ITGB1;NTSR1;GPR176;ADRA1D;ADRA2C;GPR150;TIAM1;PLCB2;GNG10;EDNRA;CCR9;PRKX;PPP2R1B;CX3CL1;MC1R;ADCY9;PRKAR1A;ARHGEF1;ACKR4
gsea,Branched-chain Amino Acid Catabolism R-HSA-70895,0.297924533738665,0.9582375708760619,0.5030674846625767,0.8800389109311241,1.0,7/21,25.64%,MCCC1;BCKDHB;BCAT2;IVD;ACADSB;LDHD;HSD17B10
gsea,Intraflagellar Transport R-HSA-5620924,0.2672291704116597,0.9566224822852152,0.5009746588693957,0.8786198660571962,1.0,13/38,16.49%,DYNC2H1;IFT140;KIF3C;TRIP11;IFT172;CLUAP1;IFT122;KIF3A;KIF17;IFT88;TRAF3IP1;WDR35;IFT80
gsea,DAG And IP3 Signaling R-HSA-1489509,0.27698523846712464,0.9564778264694597,0.5090180360721442,0.8729398935711571,1.0,17/37,23.45%,ADCY8;PRKCG;CAMK2D;PRKCE;PRKCA;PRKAR1B;ADCY1;CAMK2A;GRK2;NBEA;ADCY6;PRKAR2A;ADCY2;ADCY7;ADCY5;PLCG1;CREB1
gsea,Inwardly Rectifying K+ Channels R-HSA-1296065,-0.28212081168231545,-0.9561466606893505,0.5573122529644269,0.613276393428322,1.0,13/25,41.91%,KCNJ3;GNG7;KCNJ2;GNG3;GNB2;KCNJ14;GNG10;KCNJ10;KCNJ4;KCNJ6;GNG12;KCNJ11;GNG2
gsea,Signal Transduction By L1 R-HSA-445144,-0.30153487876747964,-0.9554066315079327,0.5042016806722689,0.6138990029470313,1.0,6/19,24.93%,CSNK2B;MAP2K1;MAPK3;EGFR;ITGAV;ITGB1
gsea,RAC2 GTPase Cycle R-HSA-9013404,0.22816931406699845,0.9552022655848174,0.5435606060606061,0.8704350226851263,1.0,17/82,14.34%,TRIO;DOCK3;IQGAP1;VRK2;GIT1;TAOK3;PIK3R2;PLD2;OPHN1;ARHGAP32;VANGL1;ARHGAP42;SYDE1;ARHGAP35;PIK3CA;LEMD3;GIT2
gsea,Cardiac Conduction R-HSA-5576891,-0.2165437289630986,-0.9544075618808913,0.5362637362637362,0.6150657016072247,1.0,28/96,26.03%,CALM1;ATP1B1;AHCYL1;ATP1A2;ORAI2;KCNK2;SRI;RANGRF;ATP1B2;KCNK1;KCNJ2;SCN9A;FGF11;KCND2;FXYD1;SCN1B;WWTR1;ATP1B3;ATP2B1;CAMK2B;CORIN;FGF13;KCNJ14;ITPR2;HIPK1;FXYD2;HIPK2;ATP1A3
gsea,Synthesis Of PA R-HSA-1483166,0.27995892459462896,0.9542924129462789,0.5611510791366906,0.8670473041188343,1.0,7/27,16.07%,MIGA1;MIGA2;PLD2;DDHD1;GPAT3;GPAT4;PLA2G4A
gsea,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.25713042484814486,-0.9529719556392107,0.5318275154004107,0.6172138770624409,1.0,15/36,28.38%,H2AZ1;H2AJ;H2BC4;H2AZ2;RUVBL1;TERT;H2BC21;RBBP5;H2AX;MYC;PYGO2;ASH2L;AXIN2;TLE2;TLE4
gsea,PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.32355842349863434,-0.9523410030503936,0.5239043824701195,0.617555951631523,1.0,1/17,0.07%,CALM1
gsea,Sphingolipid Metabolism R-HSA-428157,0.2272189204975824,0.9521449887721876,0.5307971014492754,0.8674222378637025,1.0,21/73,20.54%,HEXB;CERS4;CERS1;SMPD3;CERK;ALDH3B1;NEU2;ASAH1;SUMF2;SPTLC2;ESYT2;B3GALNT1;CERT1;CERS6;FA2H;GLB1L;ARSK;ESYT3;SGMS2;SPNS2;OSBP
gsea,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.2817173740482344,-0.9516027641744501,0.5506072874493927,0.6181276986929233,1.0,8/26,23.11%,POLR2K;ERCC3;GTF2H5;POLR2G;POLR2F;RNMT;POLR2E;GTF2F2
gsea,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.29901883269954843,-0.9510427779649461,0.4947589098532495,0.6183329269094552,1.0,7/20,29.35%,PPP2R1A;PPP2CA;LCMT1;CDC25C;CCNB2;PPP2R1B;WEE1
gsea,Platelet Calcium Homeostasis R-HSA-418360,-0.295365973567952,-0.949680226545671,0.5056689342403629,0.620152088163351,1.0,3/22,8.40%,CALM1;ORAI2;SRI
gsea,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.3357496386251728,0.9490736815712965,0.5298969072164949,0.8701927531448972,1.0,4/16,7.51%,GRIA4;PRKCG;PRKCB;PRKCA
gsea,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.31449992723547815,0.9490356451070874,0.5158730158730159,0.8644483940879715,1.0,4/18,15.33%,LARS2;EARS2;PPA2;PARS2
gsea,Molecules Associated With Elastic Fibres R-HSA-2129379,-0.28491063291387714,-0.9489487401423672,0.5207877461706784,0.6208108801565209,1.0,13/23,38.88%,TGFB1;ITGA8;ITGAV;LTBP1;ITGB1;FBLN1;MFAP3;ITGB5;EFEMP2;VTN;TGFB3;EFEMP1;FBLN2
gsea,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.33125295823942735,-0.9489035175662579,0.5270833333333333,0.6200122926144129,1.0,9/15,30.65%,NFYA;STK11;FOXO4;FOXO1;CITED2;BBC3;DDIT3;FOXO3;NFYB
gsea,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,0.31703361657746565,0.9448801088014936,0.5319148936170213,0.8702726943281235,1.0,3/18,3.38%,DHX9;CHUK;IKBKB
gsea,Cellular Senescence R-HSA-2559583,0.2075023712150899,0.9440274900861763,0.5812133072407045,0.8667558372431371,1.0,36/119,20.10%,EHMT1;TNRC6B;TNRC6A;MAPK10;ANAPC1;EP400;MOV10;MAP4K4;AGO4;RPS6KA2;ATM;ANAPC5;MAP3K5;MDM2;CDC23;MAPK14;TNIK;KDM6B;TNRC6C;ANAPC11;RBBP4;CDC27;TERF2;CABIN1;RAD50;E2F2;HMGA2;AGO3;ANAPC15;MAPK8;EED;LMNB1;UBE2S;HMGA1;HIRA;MINK1
gsea,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.2707813678514621,0.9428288560526842,0.5399239543726235,0.8644099433584694,1.0,11/33,23.14%,ERCC4;ATM;RAD9A;BRIP1;RBBP8;DNA2;RAD50;TOP3A;BARD1;ERCC1;BLM
gsea,Smooth Muscle Contraction R-HSA-445355,-0.27366745963368916,-0.9427314458391108,0.5356371490280778,0.6315098855158799,1.0,13/33,29.75%,CALM1;MYL6;ACTA2;TPM1;MYL9;CALD1;MYL12A;TLN1;TPM2;VCL;ITGB5;GUCY1B1;MYL12B
gsea,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.2695916823607497,-0.9408934434625792,0.5517241379310345,0.6343187040893996,1.0,14/29,37.77%,TRIAP1;BNIP3L;NLRC4;STEAP3;RABGGTB;BBC3;PRELID1;BAX;NDRG1;PERP;TNFRSF10B;IGFBP3;APAF1;PRELID3A
gsea,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.22138137289178353,-0.9389200807016121,0.5606694560669456,0.6373817780303543,1.0,24/74,28.76%,POLR2K;ELOB;TAF13;ERCC3;TAF11;GTF2H5;POLR2G;GTF2B;POLR2F;TCEA1;CCNK;SKIC8;TAF7L;POLR2E;GTF2E2;GTF2F2;TAF10;GTF2A1;CTDP1;TAF12;NCBP2;AFF4;NELFA;POLR2J
gsea,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.23602013702136065,-0.9388577613021825,0.5426829268292683,0.6366183208554169,1.0,7/55,9.61%,UBB;RPS27A;UBA52;UBC;HDAC11;MAML3;SNW1
gsea,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.31370573065010754,-0.9388133310659484,0.5456349206349206,0.6358119455104472,1.0,3/17,14.79%,DPM2;PIGP;PIGW
gsea,NS1 Mediated Effects On Host Pathways R-HSA-168276,0.25610220660805283,0.9387043429611036,0.5580448065173116,0.8698985757722132,1.0,10/36,18.46%,NUP214;NUP205;PABPN1;RANBP2;NUP188;KPNA7;NUP155;NUP88;NUP98;NUP133
gsea,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.26001494529929015,0.9370654381013611,0.5336048879837068,0.868745282754058,1.0,9/31,18.46%,NUP214;NUP205;RANBP2;PBRM1;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,FGFR2 Alternative Splicing R-HSA-6803529,0.28280718111339415,0.9370332359052226,0.530214424951267,0.8632182260606647,1.0,5/24,5.42%,HNRNPH1;TIA1;TIAL1;HNRNPM;POLR2A
gsea,Processive Synthesis On Lagging Strand R-HSA-69183,-0.3171112095742749,-0.9363414273877333,0.551440329218107,0.6399764932528861,1.0,3/15,13.90%,POLD4;PCNA;POLA2
gsea,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.21130829139266433,-0.9338043220583452,0.5936170212765958,0.6442933388964406,1.0,12/90,12.96%,DYNLL2;RPS27;DYNLL1;ITGB3BP;NUP43;PPP2R1A;NUDC;NDEL1;CENPP;PPP2CA;MIS12;BUB3
gsea,Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,-0.31590474314371364,-0.9336999745132101,0.5537757437070938,0.6435558465081201,1.0,5/15,24.48%,CYP7B1;SYCP2;PTGIS;AMACR;ACOX2
gsea,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.3032417969326908,-0.9309193088327014,0.5405982905982906,0.6481804718795483,1.0,9/18,34.79%,B4GAT1;B4GALT4;OGN;CHST2;B4GALT5;B4GALT3;B4GALT1;ST3GAL6;ST3GAL2
gsea,DAP12 Interactions R-HSA-2172127,-0.28443529337392437,-0.9288345597111464,0.5587044534412956,0.6506932398903267,1.0,4/22,14.46%,HRAS;BTK;B2M;TYROBP
gsea,DAP12 Signaling R-HSA-2424491,-0.28443529337392437,-0.9288345597111464,0.5587044534412956,0.6506932398903267,1.0,4/22,14.46%,HRAS;BTK;B2M;TYROBP
gsea,HIV Transcription Initiation R-HSA-167161,-0.2443011638643114,-0.9285354235703497,0.5762004175365344,0.6503348407475693,1.0,14/45,24.52%,POLR2K;TAF13;ERCC3;TAF11;GTF2H5;POLR2G;GTF2B;POLR2F;TAF7L;POLR2E;GTF2E2;GTF2F2;TAF10;GTF2A1
gsea,Interleukin-7 Signaling R-HSA-1266695,0.3110479188714975,0.9283739500548653,0.5438931297709924,0.8814730312930089,1.0,5/17,13.61%,PIK3R2;SOCS2;JAK3;BRWD1;STAT5B
gsea,mRNA Capping R-HSA-72086,-0.26710150129577725,-0.9256964908032236,0.596,0.65492614322683,1.0,13/28,36.09%,POLR2K;ERCC3;GTF2H5;POLR2G;POLR2F;RNMT;POLR2E;GTF2F2;NCBP2;POLR2J;POLR2L;POLR2H;GTF2F1
gsea,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.3092699585712353,-0.9253111718089682,0.563169164882227,0.6547854067727834,1.0,3/16,16.37%,SNX3;TMED5;VPS29
gsea,Signaling By PDGF R-HSA-186797,-0.23863025720953848,-0.9229769629000134,0.5707865168539326,0.6586973905549326,1.0,9/47,18.27%,HRAS;NCK1;COL4A2;COL6A1;PDGFRA;PDGFC;BCAR1;THBS3;COL9A2
gsea,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.2997001047034814,-0.9222340029890825,0.5699797160243407,0.6592398967308024,1.0,5/18,22.73%,RBL1;PCNA;LIN37;MYC;E2F4
gsea,Formation Of Early Elongation Complex R-HSA-113418,-0.2626693372324997,-0.9208074615302235,0.5987124463519313,0.6612483212655009,1.0,13/31,33.71%,POLR2K;ERCC3;GTF2H5;POLR2G;POLR2F;POLR2E;GTF2F2;CTDP1;NCBP2;NELFA;POLR2J;POLR2L;POLR2H
gsea,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.23721282614157216,-0.9202485032236977,0.5821501014198783,0.661466994570118,1.0,13/52,21.63%,RAN;FDFT1;INSIG2;SREBF2;SAR1B;GPAM;NFYA;ELOVL6;HMGCR;PPARA;HMGCS1;TBL1XR1;SQLE
gsea,Downstream Signal Transduction R-HSA-186763,0.2760316637984207,0.9187281114969704,0.5653061224489796,0.901937431939686,1.0,8/26,14.47%,STAT1;PIK3R2;GRB2;CRKL;STAT5B;PIK3CA;SYNGAP1;CRK
gsea,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.2820411077105108,0.9169167411040868,0.5735294117647058,0.9012264109562398,1.0,11/23,23.14%,ATM;BRIP1;BRCA2;RBBP8;DNA2;RAD50;TOP3A;RAD51D;RAD51AP1;BARD1;BLM
gsea,Pre-NOTCH Expression And Processing R-HSA-1912422,0.23418199114832913,0.916118929656383,0.6166328600405679,0.897655331030066,1.0,7/51,3.79%,TNRC6B;TNRC6A;ST3GAL3;EP300;MOV10;AGO4;CREBBP
gsea,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.29334223402202664,-0.9155221193920262,0.5450819672131147,0.6699102811508154,1.0,4/19,13.19%,MYL6;RHOB;RHOA;MYL9
gsea,Growth Hormone Receptor Signaling R-HSA-982772,0.30408013702677933,0.9134484151416286,0.5743494423791822,0.8991921914385674,1.0,7/18,17.06%,STAT1;ADAM17;SOCS2;JAK2;PRLR;STAT5B;PTPN6
gsea,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.28406313942350503,-0.9124126521123871,0.5917030567685589,0.6753014841912507,1.0,1/20,0.07%,CALM1
gsea,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.21518664019141273,0.9118755979890895,0.621832358674464,0.8978405567757759,1.0,17/83,13.30%,STAT1;CHUK;NUP214;NUP205;IKBKB;CREBBP;RANBP2;STAT2;SIKE1;NUP188;IL17RA;NUP155;G3BP2;IFNAR1;TAB1;MAP3K7;SEC24C
gsea,Metal Ion SLC Transporters R-HSA-425410,-0.29270430726865876,-0.9084636106821755,0.56312625250501,0.68218325404686,1.0,9/20,29.26%,SLC30A5;SLC40A1;SLC39A3;SLC41A1;SLC39A10;SLC30A6;SLC30A10;SLC31A1;SLC11A2
gsea,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.24865153925194383,0.9080402034005324,0.572289156626506,0.9021731731552517,1.0,9/32,18.46%,NUP214;NUP205;RANBP2;PBRM1;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,Glycerophospholipid Biosynthesis R-HSA-1483206,0.2040323000369344,0.9055798373781143,0.6705202312138728,0.9029584890895177,1.0,20/103,16.07%,SLC44A2;MIGA1;CPNE1;MIGA2;CHEK2;PLD2;TMEM86B;DDHD1;LPIN1;OSBPL10;STARD10;CPNE7;PLA2G4E;CHKA;PEMT;HADHB;PITPNM3;GPAT3;GPAT4;PLA2G4A
gsea,Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.24722807758525864,0.9011618500959279,0.6056603773584905,0.9088972105075549,1.0,9/36,19.25%,ATRX;ANAPC1;ANAPC5;CDC23;ANAPC11;CDC27;E2F2;ANAPC15;UBE2S
gsea,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.25507295856856627,0.8996830461505395,0.5991649269311065,0.9073545095858975,1.0,6/34,10.33%,EP300;PCGF5;ARID2;PBRM1;SMARCA2;RYBP
gsea,Striated Muscle Contraction R-HSA-390522,-0.28489612507986917,-0.8996044796385998,0.5838509316770186,0.6994491426760092,1.0,6/19,30.21%,TTR;TPM1;TMOD1;VIM;TPM2;MYH6
gsea,Mitotic Prophase R-HSA-68875,-0.20850834997119724,-0.8981824295674784,0.657314629258517,0.7014444368785138,1.0,18/82,20.01%,SET;H2AZ1;H2AJ;NUP43;PPP2R1A;RAB2A;H2BC4;BANF1;PPP2CA;NUP50;ARPP19;NEK7;GORASP2;H2AZ2;H2BC21;EMD;MAPK3;H2AX
gsea,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.2773299112665564,-0.896942574366799,0.6381709741550696,0.7030873656340965,1.0,11/22,41.91%,KCNJ3;GNG7;KCNJ2;GNG3;GNB2;GNG10;KCNJ10;KCNJ4;KCNJ6;GNG12;GNG2
gsea,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.2811309557830556,0.8968361801771344,0.594541910331384,0.9092479435032088,1.0,9/24,15.74%,MPP3;CAMK2D;APBA1;MPP2;CAMK2A;GRIN2D;KIF17;NBEA;GRIN3A
gsea,Oncogenic MAPK Signaling R-HSA-6802957,-0.2252224739810124,-0.8961714669932379,0.6836518046709129,0.7037655909980605,1.0,17/68,26.79%,CALM1;HRAS;YWHAB;PEBP1;CNKSR2;MAP2K1;AGTRAP;DUSP6;SPRED1;CAMK2B;MAPK3;QKI;KDM7A;DUSP7;SND1;TLN1;FAM131B
gsea,Lagging Strand Synthesis R-HSA-69186,-0.2780189576475741,-0.892858277126405,0.6186440677966102,0.7094572057007327,1.0,3/20,13.90%,POLD4;PCNA;POLA2
gsea,MET Activates PTK2 Signaling R-HSA-8874081,0.2986799311673225,0.892255443083463,0.6125954198473282,0.9158949317852267,1.0,5/17,12.69%,ITGA3;PTK2;LAMC2;LAMA4;LMNB2
gsea,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.2939047133383392,-0.8918767259667717,0.6175298804780877,0.7104636189478631,1.0,5/18,19.98%,YES1;CBFB;WWTR1;YAP1;MAPK3
gsea,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.26351377274527193,0.8901437730421803,0.6186131386861314,0.9159003568608558,1.0,10/29,18.04%,ATM;EME2;BRIP1;BRCA2;RBBP8;DNA2;RAD50;TOP3A;RAD51D;RAD51AP1
gsea,Integrin Cell Surface Interactions R-HSA-216083,-0.22692231490583895,-0.8896817116271628,0.6369710467706013,0.7139909054637545,1.0,18/50,35.63%,COL4A2;ITGA8;ICAM5;BSG;COL9A2;ITGAV;AGRN;ITGAM;ITGB1;ITGA7;ITGA10;ITGA4;COL18A1;ITGB5;ITGA11;VTN;ITGAD;PECAM1
gsea,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.2770546534852092,0.8872631409244829,0.6066176470588235,0.917894491774385,1.0,3/23,3.94%,HEXB;ST3GAL3;ACAN
gsea,RHOF GTPase Cycle R-HSA-9035034,0.2383817930350371,0.8866649788024086,0.6513026052104208,0.9139943289259963,1.0,10/39,16.78%,MYO9B;PIK3R2;FAM169A;ARHGAP32;VANGL1;SRGAP2;SYDE1;SENP1;DIAPH1;ARHGAP21
gsea,Azathioprine ADME R-HSA-9748787,-0.2993225564350174,-0.8851587823313426,0.6294736842105263,0.7219667553743704,1.0,2/15,8.27%,NME2;TPMT
gsea,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.26844916770110316,-0.8847972086602047,0.6144329896907217,0.7216608252284591,1.0,8/23,33.15%,SLC16A10;SLC7A5;SLC38A3;SLC3A2;SLC7A10;SLC6A15;SLC7A1;SLC38A2
gsea,Circadian Clock R-HSA-400253,-0.22319296245316134,-0.8832747782795247,0.6387225548902196,0.7237124595318335,1.0,7/59,10.89%,UBB;RPS27A;BHLHE41;UBA52;UBC;PPP1CA;BHLHE40
gsea,Cell Junction Organization R-HSA-446728,0.21786128016082093,0.8825824016266661,0.650375939849624,0.9190537643380768,1.0,14/65,15.14%,DST;FLNA;AFDN;CDH4;CDH13;LAMC2;NECTIN4;LAMA4;SDK2;CDH12;CADM3;CDH19;CDH10;PARD6B
gsea,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.22591802628862687,0.8820938953513223,0.6553784860557769,0.9150001772399066,1.0,16/46,21.33%,CREBBP;NCOA6;NCOR1;NCOA1;CARM1;HDAC3;RXRA;NRF1;PPARGC1B;CRTC2;PPRC1;NCOA2;CHD9;CRTC1;CRTC3;MEF2D
gsea,Diseases Of DNA Repair R-HSA-9675135,0.23502804847994188,0.8802682256987933,0.6563071297989032,0.9143268996263495,1.0,13/47,18.04%,ATM;PMS2;RAD9A;OGG1;BRIP1;BRCA2;NEIL3;RBBP8;DNA2;RAD50;TOP3A;RAD51D;RAD51AP1
gsea,G Alpha (Z) Signaling Events R-HSA-418597,0.2424242948368609,0.8782898180583957,0.6542239685658153,0.9139178847882169,1.0,12/40,20.63%,RGS16;ADCY8;PRKCG;PRKCB;PRKCE;PRKCA;ADCY1;ADCY6;GNB5;ADCY2;ADCY7;ADCY5
gsea,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,0.3010839719818721,0.8762296815753735,0.6200787401574803,0.913794108316614,1.0,4/15,7.51%,CLTC;PRKCG;PRKCB;PRKCA
gsea,Phototransduction Cascade R-HSA-2514856,-0.26852098193302554,-0.875981592924316,0.6601731601731602,0.7371221278629768,1.0,1/21,0.07%,CALM1
gsea,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.252783658688016,-0.8742012300527566,0.6586433260393874,0.7395654514574946,1.0,1/26,0.07%,CALM1
gsea,Muscle Contraction R-HSA-397014,-0.1870659394966895,-0.8723319555544892,0.7342342342342343,0.7422554265846957,1.0,23/143,15.74%,CALM1;ATP1B1;TTR;MYL6;AHCYL1;ACTA2;ATP1A2;ORAI2;KCNK2;SRI;RANGRF;ATP1B2;KCNK1;TPM1;KCNJ2;MYL9;SCN9A;FGF11;KCND2;FXYD1;SCN1B;CALD1;WWTR1
gsea,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.29596497646381126,-0.8722435770074884,0.6300813008130082,0.7414028053140012,1.0,2/16,8.40%,POLD4;PCNA
gsea,RNA Polymerase II Transcription Termination R-HSA-73856,0.21079110544130658,0.872223782661465,0.7063829787234043,0.9185993594659809,1.0,6/65,4.12%,SRSF5;SRRM1;SRSF1;CPSF3;CSTF2;PABPN1
gsea,GPER1 Signaling R-HSA-9634597,0.2443847575810252,0.8700910084298946,0.691089108910891,0.9186573169818172,1.0,12/35,20.68%,ADCY8;SHC1;PRKCA;PRKAR1B;ADCY1;ADCY6;GNB5;PRKAR2A;ADCY2;ADCY7;ADCY5;SRC
gsea,NCAM1 Interactions R-HSA-419037,-0.242329063261097,-0.868893190730757,0.6868250539956804,0.7469763971769294,1.0,7/31,21.83%,PRNP;COL4A2;GFRA4;COL6A1;CACNB3;COL9A2;AGRN
gsea,RMTs Methylate Histone Arginines R-HSA-3214858,-0.24240381299261587,-0.8681638579637837,0.6613226452905812,0.7473854520372603,1.0,4/37,6.13%,PRMT7;H2AZ1;H2AJ;RPS2
gsea,Diseases Of Glycosylation R-HSA-3781865,-0.18841214974703904,-0.8676320820002915,0.76,0.7474165462947467,1.0,13/115,10.33%,DPM1;DPM2;ALG11;B4GAT1;DOLK;DPM3;MUC15;CSPG5;PAPSS2;SEMA5A;EGFL7;ADAMTS1;GPC4
gsea,Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.2958780269249573,-0.8653804047200697,0.6219739292364991,0.7509937326721872,1.0,7/15,34.45%,TMED2;RAB6A;LFNG;FURIN;B4GALT1;NOTCH1;ST3GAL6
gsea,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.2991163117734973,-0.865176225338446,0.6560636182902585,0.7503519537579603,1.0,9/15,39.19%,CBX4;SUMO1;PHC3;UBE2I;PCGF2;RING1;DNMT3B;RNF2;SCMH1
gsea,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.26706593033950604,0.8642604593845772,0.6357012750455373,0.9274711404579806,1.0,10/25,20.54%,OSBPL6;SLC27A5;NCOA1;RXRA;OSBPL1A;HSD3B7;CYP27A1;NCOA2;OSBPL3;OSBP
gsea,Deadenylation-dependent mRNA Decay R-HSA-429914,0.21716365728799167,0.8619762380656731,0.7203219315895373,0.9277282458602587,1.0,11/54,14.72%,CNOT1;CNOT6;XRN1;SKIC3;HBS1L;EDC3;SKIC2;DIS3;EIF4G1;PAN3;CNOT10
gsea,Glycosaminoglycan Metabolism R-HSA-1630316,0.20182022067827085,0.8615597735388659,0.7301038062283737,0.9236553630008003,1.0,20/100,14.51%,HEXB;ABCC5;CSGALNACT2;ST3GAL3;ACAN;CEMIP;HS6ST1;SDC2;DCN;HS3ST1;HPSE;CHPF;HS6ST3;SLC26A2;CD44;VCAN;XYLT1;NDST2;B4GALT2;HAS3
gsea,Mitotic Spindle Checkpoint R-HSA-69618,-0.19504483881278334,-0.8601198348585118,0.7645739910313901,0.7594208834432686,1.0,12/96,12.96%,DYNLL2;RPS27;DYNLL1;ITGB3BP;NUP43;PPP2R1A;NUDC;NDEL1;CENPP;PPP2CA;MIS12;BUB3
gsea,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.2405016217911973,0.8600864097178176,0.6848739495798319,0.9220762535167423,1.0,9/31,19.46%,NUP214;NUP205;RANBP2;NUP188;NUP155;NUP88;NUP98;NUP133;HMGA1
gsea,HDACs Deacetylate Histones R-HSA-3214815,0.2382125977266878,0.8587744876242653,0.7013752455795678,0.9200043806819092,1.0,10/36,15.95%,HDAC8;NCOR1;CHD4;HDAC3;GATAD2B;MTA1;RBBP4;ARID4B;RCOR1;MTA2
gsea,Nuclear Receptor Transcription Pathway R-HSA-383280,0.23672501982315608,0.8587379776361058,0.6883365200764818,0.9150453285850414,1.0,13/43,17.36%,NCOR1;PGR;NR1D2;RORA;NR2F1;RXRA;ESRRG;NRBP1;ESRRB;PPARD;RARG;ESR2;NR1H2
gsea,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.24726636672302407,-0.8551614146641047,0.6978557504873294,0.7680240952170074,1.0,10/28,27.97%,SNRPF;SNRPG;SNRPD3;WDR33;FIP1L1;CSTF2T;SNRPB;CPSF2;CSTF1;NCBP2
gsea,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.25769617767156794,0.8548705364416462,0.6772983114446529,0.9190890451866854,1.0,11/25,23.14%,ATM;BRIP1;BRCA2;RBBP8;DNA2;RAD50;TOP3A;RAD51D;RAD51AP1;BARD1;BLM
gsea,HCMV Early Events R-HSA-9609690,0.20440362357421984,0.8544695695181355,0.7114228456913828,0.9151319225243211,1.0,12/67,11.69%,DYNC1H1;CD46;NUP214;NUP205;DYNC1LI1;RANBP2;NCOR1;HDAC3;NUP188;NUP155;USH2A;RBBP4
gsea,N-Glycan Antennae Elongation R-HSA-975577,-0.289848726195407,-0.8536432964914561,0.6881496881496881,0.7697489357603341,1.0,5/15,30.70%,B4GALT4;MGAT4B;B4GALT5;B4GALT3;B4GALT1
gsea,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.28807562689563815,-0.8531866999400265,0.6412825651302605,0.7696855588168883,1.0,4/16,17.52%,YWHAZ;AKT1;EXOSC7;EXOSC5
gsea,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.21483273179096757,-0.8514908589306529,0.758985200845666,0.7719069401843447,1.0,17/53,30.10%,POLR2K;ELOB;ERCC3;GTF2H5;POLR2G;POLR2F;TCEA1;CCNK;SKIC8;POLR2E;GTF2F2;CTDP1;NCBP2;AFF4;NELFA;POLR2J;MLLT3
gsea,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.20277583540086358,-0.8505782843241986,0.7408993576017131,0.7726332927625108,1.0,20/70,28.76%,POLR2K;TAF13;POU2F1;TAF11;POLR2G;GTF2B;POLR2F;SSU72;CCNK;INTS5;PHAX;POLR2E;SNAPC1;GTF2E2;TAF8;GTF2F2;GTF2A1;SNAPC5;NCBP2;POLR2J
gsea,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.25142849513891014,-0.8485973438647131,0.6725838264299803,0.7753255483398905,1.0,6/27,13.74%,CHD3;PIP4K2A;AKT3;PIP4P1;AKT1;ING3
gsea,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.2850252425407076,-0.8474998593018033,0.6780684104627767,0.776332186179311,1.0,9/15,42.48%,SLC25A16;PDZD11;AASDHPPT;PANK2;ENPP1;PPCS;PANK3;ENPP3;COASY
gsea,Resolution Of D-Loop Structures R-HSA-5693537,0.24928589251876754,0.8456365201305653,0.6891385767790262,0.9297793400053279,1.0,10/30,18.04%,ATM;EME2;BRIP1;BRCA2;RBBP8;DNA2;RAD50;TOP3A;RAD51D;RAD51AP1
gsea,ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.2823123155279742,-0.8451517368225947,0.6729166666666667,0.7796106048953428,1.0,2/15,6.10%,APOA1;ABCD3
gsea,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.24727959715108938,0.8441644720609448,0.6943396226415094,0.9281155115789718,1.0,8/31,16.33%,ATM;RAD9A;BRIP1;BRCA2;RBBP8;DNA2;RAD50;TOP3A
gsea,Metabolism Of Porphyrins R-HSA-189445,-0.2696944837222522,-0.8427459402815497,0.7095516569200779,0.7830306979958015,1.0,6/19,32.94%,HMOX2;FECH;ALAD;HMBS;UROS;BLVRB
gsea,Interferon Gamma Signaling R-HSA-877300,-0.22285364313396502,-0.8410129744400595,0.7361702127659574,0.7852312796414626,1.0,11/46,22.37%,TRIM35;IFNGR2;SOCS1;B2M;SMAD7;SUMO1;CAMK2B;IFI30;PIAS1;IRF1;PTPN1
gsea,PLC Beta Mediated Events R-HSA-112043,0.22892984249657716,0.8398297918298988,0.6927480916030534,0.9326447063900876,1.0,17/45,20.63%,ADCY8;PRKCG;CAMK2D;PRKCA;PRKAR1B;ADCY1;CAMK2A;GRK2;NBEA;ADCY6;PLA2G4A;GNA14;PRKAR2A;PLCB4;ADCY2;ADCY7;ADCY5
gsea,Ca2+ Pathway R-HSA-4086398,-0.20926305410369395,-0.8359735509107582,0.7575757575757576,0.7933218932155667,1.0,16/55,27.22%,CALM1;GNG7;PPP3R1;PPP3CA;PLCB1;PRKG1;FZD9;GNG3;MYC;FZD2;GNB2;NFATC1;ITPR2;PLCB2;GNG10;AXIN2
gsea,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.24423441784615735,-0.8356565981660097,0.7054108216432866,0.7928079150412336,1.0,8/25,27.90%,CALM1;GNG7;PLCB1;GNG3;GNB2;PLCB2;GNG10;DLG1
gsea,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.26877966991692515,-0.8353763172472963,0.7045009784735812,0.7923332407305217,1.0,3/17,11.16%,PPP2R1A;BANF1;PPP2CA
gsea,RHOD GTPase Cycle R-HSA-9013405,0.21776771858717173,0.8335262834178142,0.7428571428571429,0.9415280871072608,1.0,12/48,16.78%,VRK2;PIK3R2;MOSPD2;ARHGAP32;VANGL1;ARHGAP35;LEMD3;EFHD2;ANKFY1;DIAPH1;ARHGAP17;ARHGAP21
gsea,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.2644894967656837,-0.8317052326568698,0.7063655030800822,0.7980690067402691,1.0,7/21,30.19%,GNG7;P2RY1;GNG3;GNA15;GNB2;GNG10;GNA11
gsea,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.2739574381314755,0.8313795258047532,0.7002053388090349,0.941040891330864,1.0,6/17,19.87%,CLTC;KIF5B;ALK;MECP2;EML4;FN1
gsea,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.23204763352401497,0.8293501586806515,0.743879472693032,0.9404302664933132,1.0,10/36,16.53%,ATM;RAD9A;BRIP1;BRCA2;RBBP8;DNA2;RAD50;CHEK1;TOP3A;RAD51D
gsea,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.18913950038484978,-0.8290580232722305,0.7847826086956522,0.8017989502059037,1.0,21/77,29.96%,UBB;RPS27A;UBA52;TAF13;UBC;TAF11;RAD9B;CSNK2B;TAF7L;STK11;NOC2L;TAF10;HIPK1;MDM4;HIPK2;RMI1;TAF12;EXO1;RMI2;CDK5R1;RFC5
gsea,Cell-cell Junction Organization R-HSA-421270,-0.22083659759763083,-0.8286212119585552,0.7396694214876033,0.8014632987624113,1.0,15/42,31.83%,CADM2;PARD6A;CTNNA1;CDH8;CLDN5;PARD6G;CDH24;CDH9;JUP;SDK1;PALS1;PRKCI;CLDN18;CDH2;CDH11
gsea,Voltage Gated Potassium Channels R-HSA-1296072,0.22757326993841012,0.8284871807890154,0.7379576107899807,0.9372943514133545,1.0,13/39,18.44%,KCNB2;KCNH5;KCNA6;KCNG1;KCNAB3;KCNB1;KCNQ2;KCNH3;KCNH2;KCNH4;KCNAB1;KCNQ3;KCNC2
gsea,RNA Polymerase I Transcription Initiation R-HSA-73762,-0.21199499655312565,-0.8216188018905234,0.7565392354124748,0.812965115840277,1.0,8/45,15.29%,POLR2K;CHD3;ERCC3;GTF2H5;TTF1;POLR1D;POLR2F;POLR1H
gsea,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.2860192234901484,-0.8201818980249945,0.7148936170212766,0.814223550568442,1.0,4/15,22.15%,SPCS2;SEC11C;SPCS1;SPCS3
gsea,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.26311365495410455,0.819720815411763,0.719626168224299,0.9505070524534184,1.0,2/20,0.90%,CNOT1;CNOT6
gsea,SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.24518982912290294,-0.8166496110102686,0.740041928721174,0.819269507713628,1.0,5/24,19.81%,SUMO2;NR3C2;SUMO1;PPARA;PIAS1
gsea,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.2230094602911831,0.8142042600583895,0.7799642218246869,0.9566719914332249,1.0,11/39,18.04%,ATM;RAD9A;BRIP1;BRCA2;RBBP8;DNA2;RAD50;CHEK1;TOP3A;RAD51D;RAD51AP1
gsea,Extracellular Matrix Organization R-HSA-1474244,0.17186585718178085,0.8133879514099445,0.8549222797927462,0.9534438057295523,1.0,53/218,19.97%,PTPRS;DST;ITGA3;ACAN;KLKB1;CAPN15;LTBP3;COL24A1;SDC2;ADAMTS2;DMTF1;PCOLCE2;LAMC2;ADAM17;PRKCA;ADAMTS5;ADAM15;BMP4;COL7A1;MMP16;COL20A1;MMP28;DCN;LAMA4;COL16A1;CAPN2;MFAP2;CD44;COL6A2;NCSTN;VCAN;COL14A1;CAPN1;COL1A2;ADAMTS14;LMNB2;COL6A3;COL12A1;COL8A1;COL6A5;ITGAE;TGFB2;COL19A1;COL28A1;JAM3;P4HA3;COL5A2;BMP1;DAG1;COLGALT2;ADAM8;FN1;MMP9
gsea,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.23439887234375806,-0.8123714422060546,0.7664670658682635,0.8254026329832097,1.0,10/32,27.79%,AQP4;RAB11A;GNG7;GNAS;GNG3;MINDY4;GNB2;GNG10;ADCY9;PRKAR1A
gsea,Sema4D In Semaphorin Signaling R-HSA-400685,-0.2515103779281434,-0.8086360654387461,0.7322175732217573,0.830495677104032,1.0,5/22,17.35%,MYL6;RHOB;RHOA;MYL9;RNMT
gsea,Notch-HLH Transcription Pathway R-HSA-350054,0.23535356983667838,0.8076520554520101,0.7435387673956262,0.959578677127627,1.0,4/28,8.31%,HDAC8;CREBBP;NCOR1;HDAC3
gsea,G Alpha (S) Signaling Events R-HSA-418555,-0.1797886183081433,-0.8026983063737909,0.8587699316628702,0.8393304079257417,1.0,25/101,27.79%,GLP2R;CHGA;RAMP1;PTRH2;PTGER4;GNG7;PDE3B;HTR4;GNAS;PDE7A;PDE3A;POMC;CALCB;PTHLH;PDE7B;GNG3;CALCA;GNB2;ITGB1;GPR176;GPR150;GNG10;MC1R;ADCY9;PRKAR1A
gsea,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.17312436403401246,0.8008757298456628,0.8862745098039215,0.9681277243639207,1.0,31/142,18.46%,HERC2;SMC3;EP300;NUP214;NUP205;CREBBP;SATB1;RANBP2;DDX17;PGR;NCOA1;MDM2;DNMT3A;RORA;NUP188;PIAS4;MRTFA;RXRA;MTA1;NUP155;SATB2;SMC6;NUP88;DNMT1;PIAS2;NUP98;NR1H2;HDAC4;NCOA2;HNRNPK;NUP133
gsea,Miscellaneous Transport And Binding Events R-HSA-5223345,0.2651635112121231,0.8006705118750906,0.7394789579158316,0.9636304388458823,1.0,3/19,10.77%,NIPAL2;ADD1;MAGT1
gsea,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.18047715239916354,-0.8006393965727417,0.8856502242152466,0.8415360397219903,1.0,46/98,42.99%,THTPA;NAXE;GSTO1;SLC19A2;SLC25A16;PDZD11;PTGIS;CD38;PARP10;RFK;GPHN;MTHFD2;NAXD;MTHFD1;PDXK;AASDHPPT;PNPO;MOCOS;SP8;SLC23A1;MMAB;NADSYN1;PANK2;CUBN;ENPP1;MOCS3;NNMT;NMRK1;SLC52A2;CD320;HLCS;PPCS;AOX1;SLC2A1;NMNAT1;PARP14;NADK;MTHFD2L;MOCS2;PANK3;FLAD1;ENPP3;COASY;MTHFR;SLC46A1;NMNAT3
gsea,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.2201469516811479,-0.800332834984215,0.7864271457085829,0.8409544915282875,1.0,10/39,21.63%,FDFT1;SREBF2;GPAM;NFYA;ELOVL6;HMGCR;PPARA;HMGCS1;TBL1XR1;SQLE
gsea,Adherens Junctions Interactions R-HSA-418990,0.2507524731674699,0.798660797915173,0.7535641547861507,0.9625001955621387,1.0,8/25,15.12%,AFDN;CDH4;CDH13;NECTIN4;CDH12;CADM3;CDH19;CDH10
gsea,G-protein Mediated Events R-HSA-112040,0.21344545450556143,0.7986252449377644,0.7839388145315488,0.9577591108526428,1.0,17/49,20.63%,ADCY8;PRKCG;CAMK2D;PRKCA;PRKAR1B;ADCY1;CAMK2A;GRK2;NBEA;ADCY6;PLA2G4A;GNA14;PRKAR2A;PLCB4;ADCY2;ADCY7;ADCY5
gsea,Viral Messenger RNA Synthesis R-HSA-168325,0.2085335053963729,0.7972663576600768,0.8123711340206186,0.9553680204637146,1.0,8/43,11.29%,NUP214;NUP205;RANBP2;POLR2A;PBRM1;NUP188;POLR2B;NUP155
gsea,Deadenylation Of mRNA R-HSA-429947,0.24419953054843835,0.796279474943927,0.7693877551020408,0.9525653008689215,1.0,2/24,0.90%,CNOT1;CNOT6
gsea,Sensory Perception Of Taste R-HSA-9717189,-0.2709784206871354,-0.7962140840498279,0.7408207343412527,0.8463220624436932,1.0,4/16,14.93%,GRM1;KCNJ2;SCN9A;SCN1B
gsea,HATs Acetylate Histones R-HSA-3214847,0.19116467891133898,0.7947658829284059,0.8266666666666667,0.9506235306571835,1.0,10/78,7.95%,TRRAP;EP400;EP300;OGT;CREBBP;BRPF3;NCOA1;ELP3;ATXN7;PHF20
gsea,Sensory Perception R-HSA-9709957,0.1743290168906388,0.7944543779404603,0.9056603773584906,0.9465018589997168,1.0,29/146,13.91%,SPTAN1;PCLO;EPB41L1;ATP2B4;SCN2A;CLIC5;ADCY8;PCDH15;CDH23;FNTA;CAMKMT;GRK4;SDC2;CACNA2D2;RIMBP2;PDE6G;PRKCA;SYN1;TRPM4;STX1A;MYO7A;OTOF;BSN;OR10H5;EPB41L3;SPTBN1;KCNMA1;GRM4;TAS1R1
gsea,RAC3 GTPase Cycle R-HSA-9013423,0.190810780810543,0.7921553415844698,0.8284132841328413,0.9458583953483298,1.0,16/86,14.34%,TRIO;VRK2;NCOA3;GIT1;TAOK3;PIK3R2;OCRL;OPHN1;ARHGAP32;VANGL1;ARHGAP42;SRGAP2;SYDE1;ARHGAP35;LEMD3;GIT2
gsea,NOD1/2 Signaling Pathway R-HSA-168638,0.23292409559197585,0.7906507547207963,0.7937743190661478,0.9438734568631034,1.0,6/29,12.74%,CHUK;IKBKB;MAPK14;ITCH;TAB1;MAP3K7
gsea,SUMOylation R-HSA-2990846,0.17061861035434683,0.7904495059801587,0.9289940828402367,0.9396759381426562,1.0,32/148,18.46%,HERC2;SMC3;EP300;NUP214;NUP205;CREBBP;SATB1;RANBP2;DDX17;PGR;NCOA1;MDM2;DNMT3A;RORA;NUP188;PIAS4;MRTFA;RXRA;MTA1;NUP155;SATB2;SENP1;SMC6;NUP88;DNMT1;PIAS2;NUP98;NR1H2;HDAC4;NCOA2;HNRNPK;NUP133
gsea,Aquaporin-mediated Transport R-HSA-445717,-0.2268529947608618,-0.7892061105101668,0.8228105906313645,0.8567017631739088,1.0,10/33,27.79%,AQP4;RAB11A;GNG7;GNAS;GNG3;MINDY4;GNB2;GNG10;ADCY9;PRKAR1A
gsea,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.22077100880122963,-0.7889527911622621,0.8058823529411765,0.855957858013548,1.0,5/33,13.45%,RAN;NUP43;NPM1;NUP50;RANBP1
gsea,Bile Acid And Bile Salt Metabolism R-HSA-194068,0.23611585812605385,0.7857107321637107,0.765017667844523,0.9430724239431986,1.0,10/27,20.54%,OSBPL6;SLC27A5;NCOA1;RXRA;OSBPL1A;HSD3B7;CYP27A1;NCOA2;OSBPL3;OSBP
gsea,G0 And Early G1 R-HSA-1538133,-0.23578266873653658,-0.785190883109225,0.7974413646055437,0.8605058452381863,1.0,6/24,22.73%,RBL1;PCNA;LIN37;CCNE2;MYC;E2F4
gsea,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.24145085509024006,-0.7838817656819687,0.8068669527896996,0.8613170154304621,1.0,3/21,13.90%,POLD4;PCNA;POLA2
gsea,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.2588742660427069,-0.7788456420461584,0.7614107883817427,0.86784126642838,1.0,3/18,13.41%,CSPG5;GPC4;SDC4
gsea,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.20572377943995365,-0.7778646594427848,0.837890625,0.8682620691789744,1.0,5/38,15.92%,SUMO2;NUP43;PCNA;NUP50;SUMO1
gsea,Nuclear Import Of Rev Protein R-HSA-180746,0.2161967749596937,0.7733934826132087,0.8190854870775348,0.9585925498092768,1.0,8/30,18.46%,NUP214;NUP205;RANBP2;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.2636028908916742,-0.7729662349716013,0.7902542372881356,0.8742958074157797,1.0,3/16,17.52%,YWHAB;EXOSC7;EXOSC5
gsea,Potassium Channels R-HSA-1296071,-0.18350441969266085,-0.7720263041993669,0.8835758835758836,0.8744998057553692,1.0,19/81,26.46%,KCNJ3;GNG7;KCNA1;KCNA3;HCN1;KCNK2;KCNK1;KCNJ2;KCNS3;KCND2;KCNG4;GNG3;KCNF1;GNB2;HCN2;KCNN2;KCNJ14;KCNH7;GNG10
gsea,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.2529823867001028,-0.7719262127428758,0.7975951903807615,0.8735202251983321,1.0,2/18,8.40%,POLD4;PCNA
gsea,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.21590834764146832,0.7672937059541228,0.8305084745762712,0.9635903766895946,1.0,7/34,14.07%,HERC2;PRKDC;ATM;UIMC1;PIAS4;NSD2;RAD50
gsea,tRNA Aminoacylation R-HSA-379724,0.2252148439718091,0.7664159090410713,0.8217821782178217,0.9604345766509577,1.0,1/26,0.10%,LARS2
gsea,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.21382749413306204,0.7662743254497257,0.8213552361396304,0.9561126626857162,1.0,8/31,18.46%,NUP214;NUP205;RANBP2;NUP188;NUP155;NUP88;NUP98;NUP133
gsea,Signaling By NOTCH1 R-HSA-1980143,-0.18610847768341887,-0.7652612505133483,0.8817427385892116,0.8819605457455835,1.0,7/71,9.61%,UBB;RPS27A;UBA52;UBC;HDAC11;MAML3;SNW1
gsea,SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.2143774344961524,0.7628337079776616,0.8263473053892215,0.9566783320855259,1.0,9/31,18.46%,NUP214;NUP205;RANBP2;NUP188;PIAS4;NUP155;NUP88;NUP98;NUP133
gsea,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.2185888679344139,-0.7536200985110119,0.8276553106212425,0.8965326621842462,1.0,7/27,30.19%,GNG7;GNG3;MAPK3;GNA15;GNB2;GNG10;GNA11
gsea,Integration Of Energy Metabolism R-HSA-163685,0.17485170310640621,0.7514311985608576,0.9099616858237548,0.9687812857915861,1.0,26/93,20.63%,IQGAP1;CACNA1A;RAPGEF4;ACACA;ADCY8;STXBP1;CACNA2D2;MLXIPL;PRKCA;PRKAR1B;ADCY1;STX1A;PRKAA2;KCNB1;ADCY6;CHRM3;RAPGEF3;CACNA1C;GNB5;KCNC2;GNA14;PRKAG2;PRKAR2A;ADCY2;ADCY7;ADCY5
gsea,Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.22495529204107806,0.7511321844049721,0.837890625,0.964690537185083,1.0,12/26,26.38%,ADCY8;PRKCA;PRKAR1B;ADCY1;ADCY6;PRKAR2A;ADCY2;ADCY7;ADCY5;PRKAR2B;GNB4;GNB1
gsea,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.19930894853130995,0.7510917111853789,0.8503521126760564,0.9602760383644308,1.0,19/48,26.51%,HS6ST1;SDC2;DCN;HS3ST1;HPSE;HS6ST3;VCAN;XYLT1;NDST2;HPSE2;GLB1L;GLCE;NAGLU;GPC6;HSPG2;NDST1;GPC1;IDUA;HS3ST5
gsea,G Alpha (12/13) Signaling Events R-HSA-416482,0.18316274770075738,0.7493187256656116,0.8886756238003839,0.958115472272157,1.0,24/68,26.38%,TRIO;ARHGEF10L;ARHGEF15;KALRN;ROCK1;ARHGEF11;ARHGEF2;ROCK2;MCF2L;GNB5;ARHGEF10;RASGRF2;SOS2;ITSN1;ECT2;ARHGEF18;FGD4;PLEKHG5;PREX1;ARHGEF17;GNB4;GNA12;ARHGEF3;GNB1
gsea,Ephrin Signaling R-HSA-3928664,0.25545444800723055,0.7491646718692935,0.7659574468085106,0.953941575523718,1.0,2/16,3.89%,GIT1;EPHB2
gsea,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.2537664072881939,-0.7479381983519785,0.8279352226720648,0.9028321765223793,1.0,3/15,14.66%,LSM4;LSM7;LSM1
gsea,RHOG GTPase Cycle R-HSA-9013408,-0.18454935243557313,-0.7479057187760649,0.8668076109936576,0.9017191853884499,1.0,17/68,25.97%,HSPE1;CDC42;LAMTOR1;LMAN1;ELMO2;ARHGDIG;NDUFA5;VAMP3;DOCK2;TFRC;ESYT1;DOCK1;EMD;PGRMC2;DEPDC1B;ITGB1;YKT6
gsea,Signaling By BMP R-HSA-201451,0.22906594419965273,0.7474593838132884,0.8374760994263862,0.9518969235883631,1.0,2/23,2.36%,SMURF1;SMURF2
gsea,RUNX2 Regulates Bone Development R-HSA-8941326,-0.23104400738556874,-0.7472387847016569,0.819838056680162,0.9014626302550454,1.0,5/23,19.98%,YES1;CBFB;WWTR1;YAP1;MAPK3
gsea,G1/S-Specific Transcription R-HSA-69205,-0.21631010097051406,-0.746002512056375,0.8551307847082495,0.9019432431973046,1.0,3/27,13.13%,RBL1;PCNA;LIN37
gsea,Sialic Acid Metabolism R-HSA-4085001,0.210383504210484,0.7449484209609493,0.853309481216458,0.9508893527698639,1.0,12/32,26.42%,ST3GAL3;ST6GALNAC5;NEU2;ST8SIA4;ST6GAL1;ST6GALNAC6;ST8SIA6;ST3GAL4;ST8SIA2;NEU4;NEU3;ST8SIA1
gsea,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.20799532600062695,0.7447550798548931,0.8584558823529411,0.9468229898442319,1.0,10/37,18.04%,ATM;RAD9A;BRIP1;BRCA2;RBBP8;DNA2;RAD50;TOP3A;RAD51D;RAD51AP1
gsea,Olfactory Signaling Pathway R-HSA-381753,0.2639312761388041,0.7433371330516445,0.8027923211169284,0.944297184487171,1.0,15/15,73.63%,ADCY8;OR10H5;LHX2;GNB1;GNAL;OR2K2;CNGA2;OR52B2;EBF1;GNG13;ANO2;OR4A47;OR10H1;LDB2;REEP1
gsea,Regulation Of Insulin Secretion R-HSA-422356,0.18151676133536154,0.7425648050040139,0.9186046511627907,0.9410254265146781,1.0,18/69,19.21%,IQGAP1;CACNA1A;RAPGEF4;ADCY8;STXBP1;CACNA2D2;PRKCA;PRKAR1B;STX1A;KCNB1;ADCY6;CHRM3;RAPGEF3;CACNA1C;GNB5;KCNC2;GNA14;PRKAR2A
gsea,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,-0.24842495563212108,-0.742169904890526,0.8202959830866807,0.9055396319404757,1.0,3/18,13.41%,CSPG5;GPC4;SDC4
gsea,Other Semaphorin Interactions R-HSA-416700,0.24164420655061508,0.7411496304923375,0.8560885608856088,0.9385918930814432,1.0,8/19,24.10%,PLXNC1;SEMA6A;PLXND1;PLXNA4;SEMA4D;ITGA1;PLXNA2;SEMA6D
gsea,Activation Of Pre-Replicative Complex R-HSA-68962,-0.2168934453698112,-0.7411094209171936,0.8961038961038961,0.9056282181062243,1.0,6/27,23.74%,POLE4;POLE3;POLA2;ORC4;MCM6;ORC5
gsea,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,0.25200640070689545,0.7406096569786664,0.80859375,0.9351206497431678,1.0,4/19,9.41%,PRKCB;S100A9;PRKCA;MAPK14
gsea,Cell-extracellular Matrix Interactions R-HSA-446353,0.24940657850118672,0.7377933621026391,0.8092592592592592,0.9345103110056477,1.0,15/15,75.08%,FLNA;PXDN;PARVB;LIMS2;RSU1;PARVA;ACTN1;LIMS1;TESK1;VASP;ILK;ARHGEF6;FERMT2;FBLIM1;ITGB1
gsea,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.24668618069259934,-0.7374823537600111,0.8329938900203666,0.9086330726042261,1.0,4/17,21.42%,TRAF6;UBE2V1;IKBKG;UBE2N
gsea,Metabolism Of Non-Coding RNA R-HSA-194441,-0.18709932669948803,-0.7358600586174849,0.9092664092664092,0.909456301127398,1.0,7/48,16.32%,SNRPF;SNRPG;NUP43;SNRPD2;NUP50;SNRPD3;PHAX
gsea,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.21960412631298948,-0.7332090454770323,0.8508064516129032,0.9114034501167486,1.0,6/24,26.46%,GNG7;CACNB3;GNG3;GNB2;ADRA2C;GNG10
gsea,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.21452544135217677,-0.7330846208406693,0.855787476280835,0.9103736619772603,1.0,2/26,5.93%,RAN;NUP43
gsea,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.2231789672520231,-0.7306620629933811,0.8308668076109936,0.9120485195940234,1.0,5/24,21.83%,CSPG5;GPC4;SDC4;B3GAT1;AGRN
gsea,Telomere Extension By Telomerase R-HSA-171319,-0.2315910665591524,-0.728119746091926,0.847457627118644,0.91362446879051,1.0,9/20,35.96%,NOP10;PPP6C;RUVBL1;TERT;NHP2;TINF2;RTEL1;RUVBL2;DKC1
gsea,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.2512540070377829,0.7258946956387025,0.8212180746561886,0.9445588007407446,1.0,4/15,17.17%,MYBL2;LIN54;RBBP4;E2F5
gsea,Interferon Alpha/Beta Signaling R-HSA-909733,0.2125158383550689,0.7244595112095334,0.8725314183123878,0.9420761139921812,1.0,4/31,6.19%,STAT1;ADAR;STAT2;IRF2
gsea,ECM Proteoglycans R-HSA-3000178,-0.19055621352846117,-0.7240884286452403,0.8938053097345132,0.9169945373270467,1.0,12/43,25.07%,ASPN;TGFB1;ITGA8;LAMB1;SPARC;COL9A2;MATN4;LAMA5;ITGAV;AGRN;ITGB1;ITGA7
gsea,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.24093230593523352,-0.7219075723063698,0.8535031847133758,0.9181082497937422,1.0,3/18,9.61%,ACTA2;MAML3;SNW1
gsea,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.19697636542414618,0.7185279761730867,0.8933333333333333,0.9443865900327582,1.0,7/44,12.42%,HEXB;CSGALNACT2;SDC2;DCN;CHPF;VCAN;XYLT1
gsea,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,-0.2407459033063875,-0.7182549828862574,0.8448637316561844,0.9208160994918227,1.0,3/18,13.41%,CSPG5;GPC4;SDC4
gsea,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.2255384517667235,0.7126686010557458,0.8637236084452975,0.9463703507818482,1.0,7/21,22.57%,PIK3R2;PLD2;PRKCE;PIK3CA;PLPP5;PLPP4;PLCG1
gsea,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.21031338368442287,-0.7081554737353681,0.9032258064516129,0.9296584147317658,1.0,4/24,13.38%,RAN;POLR2K;POLR2G;POLR2F
gsea,Collagen Degradation R-HSA-1442490,-0.21022688001936074,-0.7023627157336603,0.9394618834080718,0.9338237007529879,1.0,8/27,29.46%,CTSB;MMP19;CTSL;MMP15;COL9A2;COL18A1;FURIN;CTSD
gsea,GABA Receptor Activation R-HSA-977443,-0.18898253705293952,-0.6964281568692143,0.910828025477707,0.9381003985156975,1.0,18/47,37.00%,KCNJ3;GNG7;KCNJ2;GABRB3;GABRG2;ARHGEF9;GABRB2;GNG3;GNB2;GNG10;ADCY9;KCNJ10;GNAI1;NPTN;KCNJ4;GABRA2;KCNJ6;GABRA5
gsea,Extension Of Telomeres R-HSA-180786,-0.18132430076694162,-0.6853094249315793,0.9485458612975392,0.9462926920627003,1.0,14/44,33.96%,POLD4;NOP10;PCNA;PPP6C;POLA2;RUVBL1;TERT;NHP2;LRIG1;TINF2;RFC5;RTEL1;POLD2;RUVBL2
gsea,Formation Of Cornified Envelope R-HSA-6809371,0.22862487153337818,0.6814905556498417,0.9063063063063063,0.9707066909367935,1.0,3/18,11.75%,KAZN;DSC3;CAPN1
gsea,HS-GAG Biosynthesis R-HSA-2022928,-0.20755436486555134,-0.6811382864497952,0.8980044345898004,0.9484875353824117,1.0,5/26,21.83%,NDST4;GPC4;SDC4;HS2ST1;AGRN
gsea,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.19061099364098227,0.6809873390952673,0.9179389312977099,0.9668920048636941,1.0,8/34,19.25%,ANAPC1;ANAPC5;CDC23;ANAPC11;CDC27;E2F2;ANAPC15;UBE2S
gsea,Laminin Interactions R-HSA-3000157,-0.21358730195977776,-0.678880569233874,0.9122401847575058,0.9489864160736609,1.0,8/21,29.88%,LAMC3;LAMB1;LAMA5;ITGAV;ITGB1;ITGA7;COL18A1;LAMB3
gsea,Inositol Phosphate Metabolism R-HSA-1483249,0.17297715470110844,0.6735733518225498,0.9438405797101449,0.968443294931467,1.0,13/46,19.29%,PLCH1;PPIP5K1;SYNJ1;OCRL;IP6K1;INPP5B;INPP5J;INPP4A;ITPKC;IPMK;PLCD3;INPP5A;PLCB4
gsea,SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.17603997489449955,-0.669914319085166,0.9449901768172888,0.9543700510810901,1.0,5/42,15.92%,SUMO2;NUP43;NUP50;CBX4;SUMO1
gsea,Keratinization R-HSA-6805567,-0.19858740084484722,-0.6684066976868863,0.9203539823008849,0.9541830448168509,1.0,11/25,32.92%,KRT10;PKP2;KLK8;JUP;KRT20;TCHH;RCAN1;FURIN;PERP;KRT73;EVPL
gsea,Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.1820653589499199,0.6623292042198026,0.948,0.9724820399922681,1.0,10/39,20.54%,CERS4;CERS1;ALDH3B1;SPTLC2;CERT1;CERS6;FA2H;SGMS2;SPNS2;OSBP
gsea,Nucleotide Catabolism R-HSA-8956319,0.1989458370741417,0.6615014377349682,0.9163636363636364,0.9689212266722927,1.0,7/26,16.13%,ENTPD5;UPP2;NT5C2;NUDT1;XDH;ENTPD7;ENTPD3
gsea,Signaling By Retinoic Acid R-HSA-5362517,0.20090667022618872,0.6565394502199313,0.9276437847866419,0.9680686997981891,1.0,11/26,26.61%,RXRA;PPARD;RDH11;RARG;DHRS4;RARB;RDH10;PDPK1;LDHD;RDH13;ALDH1A2
gsea,Amine Ligand-Binding Receptors R-HSA-375280,0.19314338308814696,0.6496658235747388,0.9365942028985508,0.9682083542776807,1.0,12/27,31.00%,HTR7;HTR2A;CHRM3;HTR1F;DRD1;HTR1D;HTR6;CHRM1;CHRM2;ADRA1A;ADRB3;DRD5
gsea,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.1572716322503674,0.6457382947413977,0.985655737704918,0.9664376502861147,1.0,12/69,16.96%,HERC2;SMC3;NUP214;NUP205;RANBP2;NUP188;PIAS4;NUP155;SMC6;NUP88;PIAS2;NUP98
gsea,HS-GAG Degradation R-HSA-2024096,0.20765222083570822,0.6373271658510317,0.9399293286219081,0.9671955269020012,1.0,9/20,26.18%,SDC2;HPSE;HPSE2;GLB1L;NAGLU;GPC6;HSPG2;GPC1;IDUA
gsea,Signaling By WNT In Cancer R-HSA-4791275,0.1907590196532748,0.636934546595076,0.9617590822179732,0.9633794223851231,1.0,4/29,8.21%,TNKS2;CSNK1A1;DKK2;PPP2R5C
gsea,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.16232470715435818,-0.6357873409258903,0.9595959595959596,0.9734043306235748,1.0,6/50,15.92%,SUMO2;CHD3;NUP43;NUP50;CBX4;SUMO1
gsea,SLC Transporter Disorders R-HSA-5619102,-0.15010015024810072,-0.6233777884796919,0.9898785425101214,0.9781468721322254,1.0,14/65,25.84%,SLC24A5;NUP43;BSG;SLC35A1;SLC16A1;NUP50;SLC12A6;SLC3A2;SLC24A1;SLC40A1;SLC12A1;NUP35;SLC35A3;SLC35C1
gsea,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.17169846861982413,-0.6128321339934281,0.9763440860215054,0.9815498805616265,1.0,8/29,33.62%,RAD9B;ORC4;CDC25C;MCM6;ORC5;RFC5;RAD17;ORC6
gsea,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.19985043090889715,-0.6092716417372591,0.9586776859504132,0.9817785163148984,1.0,5/18,22.37%,FKBP5;RNMT;GRIA2;SIN3A;PTPN1
gsea,Signaling By NODAL R-HSA-1181150,-0.20002111373879145,-0.5908131686607776,0.9605809128630706,0.9870870091652875,1.0,4/16,28.78%,SMAD2;MAPK3;FOXO3;FURIN
gsea,Acyl Chain Remodelling Of PE R-HSA-1482839,-0.191619214121189,-0.5745970720762203,0.9695740365111561,0.9905667361603346,1.0,1/16,6.76%,PLA2G3
gsea,Platelet Sensitization By LDL R-HSA-432142,-0.19984821902171307,-0.5664908963701687,0.9710144927536232,0.9913129378193986,1.0,7/15,39.77%,PPP2R1A;PPP2CA;PPP2R5B;PPP2R1B;PTPN11;PECAM1;PPP2CB
gsea,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.16039956138876946,-0.5638580217802619,0.9916317991631799,0.9907338998313562,1.0,3/29,13.90%,POLD4;PCNA;POLA2
gsea,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.19186176182271986,-0.5581473012831122,0.9758551307847082,0.9908142250068944,1.0,4/17,21.42%,TRAF6;UBE2V1;IKBKG;UBE2N
gsea,Activation Of GABAB Receptors R-HSA-991365,-0.1434594916627116,-0.5093897058012471,0.9979633401221996,0.9972791442140455,1.0,9/33,31.59%,KCNJ3;GNG7;KCNJ2;GNG3;GNB2;GNG10;ADCY9;KCNJ10;GNAI1
gsea,Acyl Chain Remodelling Of PC R-HSA-1482788,0.16480593747247652,0.49360972972867323,0.9921875,0.9963217658487257,1.0,3/17,16.07%,TMEM86B;PLA2G4E;PLA2G4A
gsea,O-linked Glycosylation Of Mucins R-HSA-913709,-0.13215413387013508,-0.47187355873953873,1.0,0.999051687114394,1.0,6/33,21.53%,MUC15;GCNT7;B3GNT9;C1GALT1C1;GALNT2;B4GALT5
gsea,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.11911357340720222,-0.375639166796244,1.0,0.9999139056131584,1.0,20/20,88.11%,TXN2;ADI1;MPST;TSTD1;ADO;CDO1;CSAD;MTAP;ENOPH1;ETHE1;GOT2;SQOR;MRI1;AHCY;SUOX;APIP;MTRR;GADL1;SLC25A10;MTR
